{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:06:35Z","timestamp":1792613195692,"version":"4.5.0"},"reference-count":916,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T00:00:00Z","timestamp":1560816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T00:00:00Z","timestamp":1560816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00702-019-02028-6","type":"journal-article","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T06:02:36Z","timestamp":1560837756000},"page":"933-995","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update\u2014I. Hypokinetic-rigid movement disorders"],"prefix":"10.1007","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9641-7649","authenticated-orcid":false,"given":"Kurt A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,18]]},"reference":[{"key":"2028_CR1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1750-3639.2009.00369.x","volume":"20","author":"D Aarsland","year":"2010","unstructured":"Aarsland D, Kurz MW (2010) The epidemiology of dementia associated with Parkinson\u2019s disease. Brain Pathol 20:633\u2013639","journal-title":"Brain Pathol"},{"key":"2028_CR2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/nan.12419","volume":"43","author":"RD Abbott","year":"2017","unstructured":"Abbott RD, Nelson JS, Ross GW, Uyehara-Lock JH, Tanner CM, Masaki KH, Launer LJ, White LR, Petrovitch H (2017) Marinesco bodies and substantia nigra neuron density in Parkinson\u2019s disease. Neuropathol Appl Neurobiol 43:621\u2013630","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature20414","volume":"539","author":"A Abeliovich","year":"2016","unstructured":"Abeliovich A, Gitler AD (2016) Defects in trafficking bridge Parkinson\u2019s disease pathology and genetics. Nature 539:207\u2013216","journal-title":"Nature"},{"key":"2028_CR4","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1523\/JNEUROSCI.3047-16.2016","volume":"37","author":"DH Adamowicz","year":"2017","unstructured":"Adamowicz DH, Roy S, Salmon DP, Galasko DR, Hansen LA, Masliah E, Gage FH (2017) Hippocampal alpha-synuclein in dementia with Lewy bodies contributes to memory impairment and is consistent with spread of pathology. J Neurosci 37:1675\u20131684","journal-title":"J Neurosci"},{"key":"2028_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00401-010-0744-4","volume":"120","author":"CH Adler","year":"2010","unstructured":"Adler CH, Caviness JN, Sabbagh MN, Shill HA, Connor DJ, Sue L, Evidente VG, Driver-Dunckley E, Beach TG (2010a) Heterogeneous neuropathological findings in Parkinson\u2019s disease with mild cognitive impairment. Acta Neuropathol 120:827\u2013828","journal-title":"Acta Neuropathol"},{"key":"2028_CR6","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/mds.22971","volume":"25","author":"CH Adler","year":"2010","unstructured":"Adler CH, Connor DJ, Hentz JG, Sabbagh MN, Caviness JN, Shill HA, Noble B, Beach TG (2010b) Incidental Lewy body disease: clinical comparison to a control cohort. Mov Disord 25:642\u2013646","journal-title":"Mov Disord"},{"key":"2028_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/mds.26476","volume":"31","author":"CH Adler","year":"2016","unstructured":"Adler CH, Dugger BN, Hentz JG, Hinni ML, Lott DG, Driver-Dunckley E, Mehta S, Serrano G, Sue LI, Duffy A, Intorcia A, Filon J, Pullen J, Walker DG, Beach TG (2016) Peripheral synucleinopathy in early Parkinson\u2019s disease: submandibular gland needle biopsy findings. Mov Disord 31:250\u2013256","journal-title":"Mov Disord"},{"key":"2028_CR8","volume-title":"Progressive supranuclear palsy","author":"S Agarwal","year":"2019","unstructured":"Agarwal S, Gilbert R (2019) Progressive supranuclear palsy, 2018\/09\/26 edn. StatPearls Publishing, Treasure Island","edition":"2018\/09\/26"},{"key":"2028_CR9","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/brain\/awm301","volume":"131","author":"Z Ahmed","year":"2008","unstructured":"Ahmed Z, Josephs KA, Gonzalez J, DelleDonne A, Dickson DW (2008) Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. Brain 131:460\u2013472","journal-title":"Brain"},{"key":"2028_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1365-2990.2011.01234.x","volume":"38","author":"Z Ahmed","year":"2012","unstructured":"Ahmed Z, Asi YT, Sailer A, Lees AJ, Houlden H, Revesz T, Holton JL (2012) The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol 38:4\u201324","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR11","first-page":"339","volume-title":"Handbook of clinical neurology. Neuropathology","author":"I Alafuzoff","year":"2017","unstructured":"Alafuzoff I, Hartikainen P (2017) Alpha-synucleinopathies. In: Kovacs GG, Alafuzoff I (eds) Handbook of clinical neurology. Neuropathology, vol 145. Elsevier B.V., New York, pp 339\u2013353"},{"key":"2028_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00401-009-0523-2","volume":"117","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovacs GG, Meyronet D, Monoranu C, Parchi P, Parkkinen L, Patsouris E, Roggendorf W, Rozemuller A, Stadelmann-Nessler C, Streichenberger N, Thal DR, Kretzschmar H (2009) Staging\/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:635\u2013652","journal-title":"Acta Neuropathol"},{"key":"2028_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.baga.2015.06.001","volume":"5","author":"SL Alberico","year":"2015","unstructured":"Alberico SL, Cassell MD, Narayanan NS (2015) The vulnerable ventral tegmental area in Parkinson\u2019s disease. Basal Ganglia 5:51\u201355","journal-title":"Basal Ganglia"},{"key":"2028_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41531-017-0012-6","volume":"3","author":"F Albrecht","year":"2017","unstructured":"Albrecht F, Bisenius S, Morales Schaack R, Neumann J, Schroeter ML (2017) Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses. NPJ Parkinsons Dis 3:12","journal-title":"NPJ Parkinsons Dis"},{"key":"2028_CR15","doi-asserted-by":"publisher","first-page":"e7114","DOI":"10.1371\/journal.pone.0007114","volume":"4","author":"A Al-Chalabi","year":"2009","unstructured":"Al-Chalabi A, Durr A, Wood NW, Parkinson MH, Camuzat A, Hulot JS, Morrison KE, Renton A, Sussmuth SD, Landwehrmeyer BG, Ludolph A, Agid Y, Brice A, Leigh PN, Bensimon G (2009) Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PLoS One 4:e7114. https:\/\/doi.org\/10.1371\/journal.pone.0007114","journal-title":"PLoS One"},{"key":"2028_CR16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fnins.2019.00328","volume":"13","author":"I Alecu","year":"2019","unstructured":"Alecu I, Bennett SAL (2019) Dysregulated lipid metabolism and its role in alpha-synucleinopathy in Parkinson\u2019s disease. Front Neurosci 13:328","journal-title":"Front Neurosci"},{"key":"2028_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-00019-02010-00402","author":"J Alegre-Abarrategui","year":"2019","unstructured":"Alegre-Abarrategui J, Brimblecombe KR, Roberts RF, Velentza-Almpani E, Tilley BS, Bengoa-Vergniory N, Proukakis C (2019) Selective vulnerability in alpha-synucleinopathies. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-00019-02010-00402","journal-title":"Acta Neuropathol"},{"key":"2028_CR18","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/jnnp-2013-307035","volume":"85","author":"SK Alexander","year":"2014","unstructured":"Alexander SK, Rittman T, Xuereb JH, Bak TH, Hodges JR, Rowe JB (2014) Validation of the new consensus criteria for the diagnosis of corticobasal degeneration. J Neurol Neurosurg Psychiatry 85:925\u2013929","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2028_CR19","doi-asserted-by":"crossref","unstructured":"Alexandris A, Walker L, Liu AKL, McAleese KE, Johnson M, Pearce RK, Gentleman SM, Attems J (2019) Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer\u2019s disease and Lewy body disorders. Neuropathol Appl Neurobiol (accepted article)","DOI":"10.1111\/nan.12577"},{"key":"2028_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/14737175.2018.1489241","volume":"18","author":"F Ali","year":"2018","unstructured":"Ali F, Josephs K (2018a) The diagnosis of progressive supranuclear palsy: current opinions and challenges. Expert Rev Neurother 18:603\u2013616","journal-title":"Expert Rev Neurother"},{"key":"2028_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00415-017-8644-3","volume":"265","author":"F Ali","year":"2018","unstructured":"Ali F, Josephs KA (2018b) Corticobasal degeneration: key emerging issues. J Neurol 265:439\u2013445","journal-title":"J Neurol"},{"key":"2028_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27619","author":"F Ali","year":"2019","unstructured":"Ali F, Martin PR, Botha H, Ahlskog JE, Bower JH, Masumoto JY, Maraganore D, Hassan A, Eggers S, Boeve BF, Knopman DS, Drubach D, Petersen RC, Dunkley ED, van Gerpen J, Uitti R, Whitwell JL, Dickson DW, Josephs KA (2019) Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy. Mov Disord. https:\/\/doi.org\/10.1002\/mds.27619","journal-title":"Mov Disord"},{"key":"2028_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00401-016-1576-7","volume":"132","author":"M Allen","year":"2016","unstructured":"Allen M, Burgess JD, Ballard T, Serie D, Wang X, Younkin CS, Sun Z, Kouri N, Baheti S, Wang C, Carrasquillo MM, Nguyen T, Lincoln S, Malphrus K, Murray M, Golde TE, Price ND, Younkin SG, Schellenberg GD, Asmann Y, Ordog T, Crook J, Dickson D, Ertekin-Taner N (2016) Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci. Acta Neuropathol 132:197\u2013211","journal-title":"Acta Neuropathol"},{"key":"2028_CR904","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00401-018-1900-5","volume":"136","author":"M Allen","year":"2018","unstructured":"Allen M, Wang X, Serie DJ, Strickland SL, Burgess JD, Koga S, Younkin CS, Nguyen TT, Malphrus KG, Lincoln SJ, Alamprese M, Zhu K, Chang R, Carrasquillo MM, Kouri N, Murray ME, Reddy JS, Funk C, Price ND, Golde TE, Younkin SG, Asmann YW, Crook JE, Dickson DW, Ertekin-Taner N (2018) Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy. Acta Neuropathol 136:709\u2013727","journal-title":"Acta Neuropathol"},{"key":"2028_CR24","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders: DSM\u20135","author":"American P, Association, Force D-T","year":"2013","unstructured":"American P, Association, Force D-T (2013) Diagnostic and statistical manual of mental disorders: DSM\u20135, 5th edn. American Psychiatric Publishing Inc., Arlington","edition":"5"},{"key":"2028_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neuint.2018.03.001","volume":"117","author":"N Ammal Kaidery","year":"2018","unstructured":"Ammal Kaidery N, Thomas B (2018) Current perspective of mitochondrial biology in Parkinson\u2019s disease. Neurochem Int 117:91\u2013113","journal-title":"Neurochem Int"},{"key":"2028_CR26","doi-asserted-by":"publisher","first-page":"e39465","DOI":"10.1371\/journal.pone.0039465","volume":"7","author":"E Angot","year":"2012","unstructured":"Angot E, Steiner JA, Lema Tome CM, Ekstrom P, Mattsson B, Bjorklund A, Brundin P (2012) Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons In vivo. PLoS One 7:e39465","journal-title":"PLoS One"},{"key":"2028_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1017\/S1041610218000170","volume":"31","author":"M Ansari","year":"2019","unstructured":"Ansari M, Adib Moradi S, Ghazi Sherbaf F, Hedayatnia A, Aarabi MH (2019) Comparison of structural connectivity in Parkinson\u2019s disease with depressive symptoms versus non-depressed: a diffusion MRI connectometry study. Int Psychogeriatr 31:5\u201312","journal-title":"Int Psychogeriatr"},{"key":"2028_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00401-015-1442-z","volume":"130","author":"N Aoki","year":"2015","unstructured":"Aoki N, Boyer PJ, Lund C, Lin WL, Koga S, Ross OA, Weiner M, Lipton A, Powers JM, White CL 3rd, Dickson DW (2015) Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with alpha-synuclein. Acta Neuropathol 130:93\u2013105","journal-title":"Acta Neuropathol"},{"key":"2028_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40478-017-0452-6","volume":"5","author":"S Arawaka","year":"2017","unstructured":"Arawaka S, Sato H, Sasaki A, Koyama S, Kato T (2017) Mechanisms underlying extensive Ser129-phosphorylation in alpha-synuclein aggregates. Acta Neuropathol Commun 5:48","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1440-1789.2006.00669.x","volume":"26","author":"K Arima","year":"2006","unstructured":"Arima K (2006) Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies. Neuropathology 26:475\u2013483","journal-title":"Neuropathology"},{"key":"2028_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.5414\/NP300608","volume":"32","author":"RA Armstrong","year":"2013","unstructured":"Armstrong RA (2013) White matter pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases. Clin Neuropathol 32:399\u2013405","journal-title":"Clin Neuropathol"},{"key":"2028_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11910-018-0819-5","volume":"18","author":"MJ Armstrong","year":"2018","unstructured":"Armstrong MJ (2018) Progressive supranuclear palsy: an update. Curr Neurol Neurosci Rep 18:12","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2028_CR33","first-page":"128","volume":"25","author":"MJ Armstrong","year":"2019","unstructured":"Armstrong MJ (2019) Lewy body dementias. Continuum (Minneap Minn) 25:128\u2013146","journal-title":"Continuum (Minneap Minn)"},{"key":"2028_CR34","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, Riley DE, Tolosa E, Troster AI, Vidailhet M, Weiner WJ (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496\u2013503","journal-title":"Neurology"},{"key":"2028_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00702-013-1084-z","volume":"121","author":"RA Armstrong","year":"2014","unstructured":"Armstrong RA, Kotzbauer PT, Perlmutter JS, Campbell MC, Hurth KM, Schmidt RE, Cairns NJ (2014) A quantitative study of alpha-synuclein pathology in fifteen cases of dementia associated with Parkinson disease. J Neural Transm 121:171\u2013181","journal-title":"J Neural Transm"},{"key":"2028_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41582-018-0107-7","volume":"15","author":"NA Arnaoutoglou","year":"2019","unstructured":"Arnaoutoglou NA, O\u2019Brien JT, Underwood BR (2019) Dementia with Lewy bodies\u2014from scientific knowledge to clinical insights. Nat Rev Neurol 15:103\u2013112","journal-title":"Nat Rev Neurol"},{"key":"2028_CR37","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/prca.201500092","volume":"10","author":"M Aroso","year":"2016","unstructured":"Aroso M, Ferreira R, Freitas A, Vitorino R, Gomez-Lazaro M (2016) New insights on the mitochondrial proteome plasticity in Parkinson\u2019s disease. Proteom Clin Appl 10:416\u2013429","journal-title":"Proteom Clin Appl"},{"key":"2028_CR38","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/mds.25887","volume":"29","author":"YT Asi","year":"2014","unstructured":"Asi YT, Ling H, Ahmed Z, Lees AJ, Revesz T, Holton JL (2014) Neuropathological features of multiple system atrophy with cognitive impairment. Mov Disord 29:884\u2013888","journal-title":"Mov Disord"},{"key":"2028_CR39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1903054116","author":"M Atias","year":"2019","unstructured":"Atias M, Tevet Y, Sun J, Stavsky A, Tal S, Kahn J, Roy S, Gitler D (2019) Synapsins regulate alpha-synuclein functions. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.1903054116","journal-title":"Proc Natl Acad Sci USA"},{"key":"2028_CR40","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2990.2008.00937.x","volume":"34","author":"J Attems","year":"2008","unstructured":"Attems J, Jellinger KA (2008) The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson\u2019s disease. Neuropathol Appl Neurobiol 34:466\u2013467","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR41","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00401-014-1261-7","volume":"127","author":"J Attems","year":"2014","unstructured":"Attems J, Walker L, Jellinger KA (2014) Olfactory bulb involvement in neurodegenerative diseases. Acta Neuropathol 127:459\u2013475","journal-title":"Acta Neuropathol"},{"key":"2028_CR42","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.biopsych.2017.04.003","volume":"83","author":"JI Ayers","year":"2018","unstructured":"Ayers JI, Giasson BI, Borchelt DR (2018) Prion-like spreading in tauopathies. Biol Psychiatry 83:337\u2013346","journal-title":"Biol Psychiatry"},{"key":"2028_CR43","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/nm.3885","volume":"21","author":"T Bachhuber","year":"2015","unstructured":"Bachhuber T, Katzmarski N, McCarter JF, Loreth D, Tahirovic S, Kamp F, Abou-Ajram C, Nuscher B, Serrano-Pozo A, Muller A, Prinz M, Steiner H, Hyman BT, Haass C, Meyer-Luehmann M (2015) Inhibition of amyloid-beta plaque formation by alpha-synuclein. Nat Med 21:802\u2013807","journal-title":"Nat Med"},{"key":"2028_CR44","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1038\/ncomms5755","volume":"5","author":"EJ Bae","year":"2014","unstructured":"Bae EJ, Yang NY, Song M, Lee CS, Lee JS, Jung BC, Lee HJ, Kim S, Masliah E, Sardi SP, Lee SJ (2014) Glucocerebrosidase depletion enhances cell-to-cell transmission of alpha-synuclein. Nat Commun 5:4755","journal-title":"Nat Commun"},{"key":"2028_CR45","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1042\/BST0380493","volume":"38","author":"V Bagetta","year":"2010","unstructured":"Bagetta V, Ghiglieri V, Sgobio C, Calabresi P, Picconi B (2010) Synaptic dysfunction in Parkinson\u2019s disease. Biochem Soc Trans 38:493\u2013497","journal-title":"Biochem Soc Trans"},{"key":"2028_CR46","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00401-013-1188-4","volume":"126","author":"RM Bailey","year":"2013","unstructured":"Bailey RM, Covy JP, Melrose HL, Rousseau L, Watkinson R, Knight J, Miles S, Farrer MJ, Dickson DW, Giasson BI, Lewis J (2013) LRRK2 phosphorylates novel tau epitopes and promotes tauopathy. Acta Neuropathol 126:809\u2013827","journal-title":"Acta Neuropathol"},{"key":"2028_CR47","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/1073858417748875","volume":"24","author":"R Balestrino","year":"2018","unstructured":"Balestrino R, Schapira AHV (2018) Glucocerebrosidase and Parkinson disease: molecular, clinical, and therapeutic implications. Neuroscientist 24:540\u2013559","journal-title":"Neuroscientist"},{"key":"2028_CR48","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/mds.23895","volume":"27","author":"B Ballanger","year":"2012","unstructured":"Ballanger B, Klinger H, Eche J, Lerond J, Vallet AE, Le Bars D, Tremblay L, Sgambato-Faure V, Broussolle E, Thobois S (2012) Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson\u2019s disease. Mov Disord 27:84\u201389","journal-title":"Mov Disord"},{"key":"2028_CR49","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/mds.27614","volume":"34","author":"S Bandres-Ciga","year":"2019","unstructured":"Bandres-Ciga S, Saez-Atienzar S, Bonet-Ponce L, Billingsley K, Vitale D, Blauwendraat C, Gibbs JR, Pihlstrom L, Gan-Or Z, Cookson MR, Nalls MA, Singleton AB (2019) The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson\u2019s disease. Mov Disord 34:460\u2013468","journal-title":"Mov Disord"},{"key":"2028_CR50","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/jnen\/nlw037","volume":"75","author":"E Barca","year":"2016","unstructured":"Barca E, Kleiner G, Tang G, Ziosi M, Tadesse S, Masliah E, Louis ED, Faust P, Kang UJ, Torres J, Cortes EP, Vonsattel JP, Kuo SH, Quinzii CM (2016) Decreased coenzyme q10 levels in multiple system atrophy cerebellum. J Neuropathol Exp Neurol 75:663\u2013672","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR51","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/mds.27041","volume":"32","author":"F Bassil","year":"2017","unstructured":"Bassil F, Guerin PA, Dutheil N, Li Q, Klugmann M, Meissner WG, Bezard E, Fernagut PO (2017) Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy. Mov Disord 32:1230\u20131239","journal-title":"Mov Disord"},{"key":"2028_CR52","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/mds.27450","volume":"33","author":"A Batla","year":"2018","unstructured":"Batla A, De Pablo-Fernandez E, Erro R, Reich M, Calandra-Buonaura G, Barbosa P, Balint B, Ling H, Islam S, Cortelli P, Volkmann J, Quinn N, Holton JL, Warner TT, Bhatia KP (2018) Young-onset multiple system atrophy: clinical and pathological features. Mov Disord 33:1099\u20131107","journal-title":"Mov Disord"},{"key":"2028_CR53","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00401-007-0313-7","volume":"115","author":"TG Beach","year":"2008","unstructured":"Beach TG, Adler CH, Sue LI, Peirce JB, Bachalakuri J, Dalsing-Hernandez JE, Lue LF, Caviness JN, Connor DJ, Sabbagh MN, Walker DG (2008) Reduced striatal tyrosine hydroxylase in incidental Lewy body disease. Acta Neuropathol 115:445\u2013451","journal-title":"Acta Neuropathol"},{"key":"2028_CR54","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL 3rd, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613\u2013634","journal-title":"Acta Neuropathol"},{"key":"2028_CR55","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG (2010) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119:689\u2013702","journal-title":"Acta Neuropathol"},{"key":"2028_CR56","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00702-017-1744-5","volume":"125","author":"G Beck","year":"2018","unstructured":"Beck G, Singh A, Papa SM (2018) Dysregulation of striatal projection neurons in Parkinson\u2019s disease. J Neural Transm (Vienna) 125:449\u2013460","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR57","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","volume":"134","author":"N Bengoa-Vergniory","year":"2017","unstructured":"Bengoa-Vergniory N, Roberts RF, Wade-Martins R, Alegre-Abarrategui J (2017) Alpha-Synuclein oligomers: a new hope. Acta Neuropathol 134:819\u2013838","journal-title":"Acta Neuropathol"},{"key":"2028_CR58","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/jnc.13570","volume":"137","author":"MJ Benskey","year":"2016","unstructured":"Benskey MJ, Perez RG, Manfredsson FP (2016) The contribution of alpha synuclein to neuronal survival and function\u2014implications for Parkinson\u2019s disease. J Neurochem 137:331\u2013359","journal-title":"J Neurochem"},{"key":"2028_CR59","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/mds.10190","volume":"17","author":"J Berciano","year":"2002","unstructured":"Berciano J, Valldeoriola F, Ferrer I, Rumia J, Pascual J, Marin C, Rey MJ, Tolosa E (2002) Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson\u2019s disease: a clinicopathological case study. Mov Disord 17:812\u2013816","journal-title":"Mov Disord"},{"key":"2028_CR60","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.jalz.2016.04.005","volume":"12","author":"E Bereczki","year":"2016","unstructured":"Bereczki E, Francis PT, Howlett D, Pereira JB, Hoglund K, Bogstedt A, Cedazo-Minguez A, Baek JH, Hortobagyi T, Attems J, Ballard C, Aarsland D (2016) Synaptic proteins predict cognitive decline in Alzheimer\u2019s disease and Lewy body dementia. Alzheimers Dement 12:1149\u20131158","journal-title":"Alzheimers Dement"},{"key":"2028_CR61","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/mds.25844","volume":"29","author":"D Berg","year":"2014","unstructured":"Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G (2014) Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson\u2019s disease. Mov Disord 29:454\u2013462","journal-title":"Mov Disord"},{"key":"2028_CR62","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415\u2013455","journal-title":"J Neurol Sci"},{"key":"2028_CR63","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/mds.27121","volume":"33","author":"KP Bhatia","year":"2018","unstructured":"Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, Raethjen J, Stamelou M, Testa CM, Deuschl G (2018) Consensus Statement on the classification of tremors from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord 33:75\u201387","journal-title":"Mov Disord"},{"key":"2028_CR64","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1021\/acs.jproteome.8b00982","volume":"18","author":"P Bhattacharjee","year":"2019","unstructured":"Bhattacharjee P, Ohrfelt A, Lashley T, Blennow K, Brinkmalm A, Zetterberg H (2019) Mass spectrometric analysis of Lewy body-enriched alpha-synuclein in Prkinson\u2019s disease. J Proteome Res 18:2109\u20132120","journal-title":"J Proteome Res"},{"key":"2028_CR65","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00401-019-01995-0","volume":"137","author":"G Bieri","year":"2019","unstructured":"Bieri G, Brahic M, Bousset L, Couthouis J, Kramer NJ, Ma R, Nakayama L, Monbureau M, Defensor E, Schule B, Shamloo M, Melki R, Gitler AD (2019) LRRK2 modifies alpha-syn pathology and spread in mouse models and human neurons. Acta Neuropathol 137:961\u2013980","journal-title":"Acta Neuropathol"},{"key":"2028_CR66","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/mds.10211","volume":"17","author":"S Birdi","year":"2002","unstructured":"Birdi S, Rajput AH, Fenton M, Donat JR, Rozdilsky B, Robinson C, Macaulay R, George D (2002) Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases. Mov Disord 17:1255\u20131264","journal-title":"Mov Disord"},{"key":"2028_CR67","unstructured":"Bitan G, Dutta S, Del Rosario I, Paul K, Palma JA, Perlman SL, Poon WW, Kaufmann H, Fogel BL, Bronstein JM, Ritz B (2019) Alpha-synuclein in brain-derived exosomes distinguishes Parkinson\u2019s disease from multiple system atrophy (abstr.). AD\/PD Conference 2019, Lisbon 14th Int. Conf. on Alzheimer\u2019s & Parkinson\u2019s Disease, March 26\u201331, 2019, Lisbon. https:\/\/cmoffice.kenes.com\/cmsearchableprogrammeV15\/conferencemanager\/programme\/personid\/anonymous\/abstractdetails\/0000253720"},{"key":"2028_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40211-014-0132-8","volume":"29","author":"JV Bizzarri","year":"2015","unstructured":"Bizzarri JV, Giupponi G, Maniscalco I, Schroffenegger P, Conca A, Kapfhammer HP (2015) Parkinson\u2019s disease and psychoses. Neuropsychiatry 29:1\u201313","journal-title":"Neuropsychiatry"},{"key":"2028_CR69","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/mds.27583","volume":"34","author":"F Blandini","year":"2018","unstructured":"Blandini F, Cilia R, Cerri S, Pezzoli G, Schapira AHV, Mullin S, Lanciego JL (2018) Glucocerebrosidase mutations and synucleinopathies: toward a model of precision medicine. Mov Disord 34:9\u201321","journal-title":"Mov Disord"},{"key":"2028_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27659","author":"C Blauwendraat","year":"2019","unstructured":"Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, von Coelln R, Pihlstrom L, Simon-Sanchez J, Schulte C, Sharma M, Krohn L, Siitonen A, Iwaki H, Leonard H, Noyce AJ, Tan M, Gibbs JR, Hernandez DG, Scholz SW, Jankovic J, Shulman LM, Lesage S, Corvol JC, Brice A, van Hilten JJ, Marinus J, Eerola-Rautio J, Tienari P, Majamaa K, Toft M, Grosset DG, Gasser T, Heutink P, Shulman JM, Wood N, Hardy J, Morris HR, Hinds DA, Gratten J, Visscher PM, Gan-Or Z, Nalls MA, Singleton AB (2019) Parkinson\u2019s disease age at onset genome-wide association study: defining heritability, genetic loci, and alpha-synuclein mechanisms. Mov Disord. https:\/\/doi.org\/10.1002\/mds.27659","journal-title":"Mov Disord"},{"key":"2028_CR71","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2051-5960-2-15","volume":"2","author":"JM Bleasel","year":"2014","unstructured":"Bleasel JM, Wong JH, Halliday GM, Kim WS (2014) Lipid dysfunction and pathogenesis of multiple system atrophy. Acta Neuropathol Commun 2:15","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR72","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-016-0279-6","volume":"4","author":"JM Bleasel","year":"2016","unstructured":"Bleasel JM, Halliday GM, Kim WS (2016) Animal modeling an oligodendrogliopathy\u2013multiple system atrophy. Acta Neuropathol Commun 4:12","journal-title":"Acta Neuropathol Commun"},{"issue":"Suppl 1","key":"2028_CR73","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/jnc.13600","volume":"138","author":"LG Bodea","year":"2016","unstructured":"Bodea LG, Eckert A, Ittner LM, Piguet O, Gotz J (2016) Tau physiology and pathomechanisms in frontotemporal lobar degeneration. J Neurochem 138(Suppl 1):71\u201394","journal-title":"J Neurochem"},{"key":"2028_CR74","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jamaneurol.2014.2757","volume":"72","author":"NI Bohnen","year":"2015","unstructured":"Bohnen NI, Albin RL, Muller ML, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Frey KA (2015) Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects. JAMA Neurol 72:194\u2013200","journal-title":"JAMA Neurol"},{"key":"2028_CR75","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11910-017-0789-z","volume":"17","author":"NI Bohnen","year":"2017","unstructured":"Bohnen NI, Muller M, Frey KA (2017) Molecular imaging and updated diagnostic criteria in Lewy body dementias. Curr Neurol Neurosci Rep 17:73","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2028_CR76","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/ana.25430","volume":"85","author":"NI Bohnen","year":"2019","unstructured":"Bohnen NI, Kanel P, Zhou Z, Koeppe RA, Frey KA, Dauer WT, Albin RL, M\u00fcller MLTM (2019) Cholinergic system changes of falls and freezing of gait in Parkinson disease. Ann Neurol 85:538\u2013549","journal-title":"Ann Neurol"},{"key":"2028_CR905","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3389\/fneur.2018.01021","volume":"9","author":"A Book","year":"2018","unstructured":"Book A, Guella I, Candido T, Brice A, Hattori N, Jeon B, Farrer MJ (2018) A meta-analysis of alpha-synuclein multiplication in familial parkinsonism. Front Neurol 9:1021","journal-title":"Front Neurol"},{"key":"2028_CR77","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/ejn.14048","volume":"49","author":"T Bordia","year":"2019","unstructured":"Bordia T, Perez XA (2019) Cholinergic control of striatal neurons to modulate l-dopa-induced dyskinesias. Eur J Neurosci 49:859\u2013868","journal-title":"Eur J Neurosci"},{"key":"2028_CR78","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnsyn.2018.00020","volume":"10","author":"DO Borroto-Escuela","year":"2018","unstructured":"Borroto-Escuela DO, Perez De La Mora M, Manger P, Narvaez M, Beggiato S, Crespo-Ramirez M, Navarro G, Wydra K, Diaz-Cabiale Z, Rivera A, Ferraro L, Tanganelli S, Filip M, Franco R, Fuxe K (2018) Brain dopamine transmission in health and Parkinson\u2019s disease: modulation of synaptic transmission and plasticity through volume transmission and dopamine heteroreceptors. Front Synaptic Neurosci 10:20","journal-title":"Front Synaptic Neurosci"},{"key":"2028_CR79","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41583-018-0002-7","volume":"19","author":"AC Bostan","year":"2018","unstructured":"Bostan AC, Strick PL (2018) The basal ganglia and the cerebellum: nodes in an integrated network. Nat Rev Neurosci 19:338\u2013350","journal-title":"Nat Rev Neurosci"},{"key":"2028_CR80","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/brainsci8110194","volume":"8","author":"E Botsford","year":"2018","unstructured":"Botsford E, George J, Buckley EE (2018) Parkinson\u2019s disease and metal storage disorders: a systematic review. Brain Sci 8:194. https:\/\/doi.org\/10.3390\/brainsci8110194","journal-title":"Brain Sci"},{"key":"2028_CR81","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pneurobio.2015.07.003","volume":"155","author":"M Bourdenx","year":"2017","unstructured":"Bourdenx M, Koulakiotis NS, Sanoudou D, Bezard E, Dehay B, Tsarbopoulos A (2017) Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: examples of amyloidopathies, tauopathies and synucleinopathies. Prog Neurobiol 155:171\u2013193","journal-title":"Prog Neurobiol"},{"key":"2028_CR82","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1152\/jn.00056.2019","volume":"121","author":"C Bove","year":"2019","unstructured":"Bove C, Travagli RA (2019) Neurophysiology of the brain stem in Parkinson\u2019s disease. J Neurophysiol 121:1856\u20131864","journal-title":"J Neurophysiol"},{"key":"2028_CR83","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/01.wnl.0000312279.49272.9f","volume":"70","author":"H Braak","year":"2008","unstructured":"Braak H, Del Tredici K (2008) Nervous system pathology in sporadic Parkinson disease. Neurology 70:1916\u20131925","journal-title":"Neurology"},{"key":"2028_CR84","first-page":"1","volume":"201","author":"H Braak","year":"2009","unstructured":"Braak H, Del Tredici K (2009) Neuroanatomy and pathology of sporadic Parkinson\u2019s disease. Adv Anat Embryol Cell Biol 201:1\u2013119","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"2028_CR85","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.3233\/JPD-179001","volume":"7","author":"H Braak","year":"2017","unstructured":"Braak H, Del Tredici K (2017) Neuropathological staging of brain pathology in sporadic Parkinson\u2019s disease: separating the wheat from the chaff. J Parkinsons Dis 7:S71\u2013S85","journal-title":"J Parkinsons Dis"},{"key":"2028_CR86","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/mds.21065","volume":"21","author":"H Braak","year":"2006","unstructured":"Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del Tredici K (2006) Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson\u2019s disease reconsidered. Mov Disord 21:2042\u20132051","journal-title":"Mov Disord"},{"key":"2028_CR87","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/mds.27556","volume":"34","author":"DP Breen","year":"2019","unstructured":"Breen DP, Halliday GM, Lang AE (2019) Gut-brain axis and the spread of alpha-synuclein pathology: Vagal highway or dead end? Mov Disord 34:307\u2013316","journal-title":"Mov Disord"},{"key":"2028_CR88","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/nan.12362","volume":"43","author":"J Brettschneider","year":"2017","unstructured":"Brettschneider J, Irwin DJ, Boluda S, Byrne MD, Fang L, Lee EB, Robinson JL, Suh E, Van Deerlin VM, Toledo JB, Grossman M, Hurtig H, Dengler R, Petri S, Lee VM, Trojanowski JQ (2017) Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type. Neuropathol Appl Neurobiol 43:315\u2013329","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR89","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/jnen\/nly080","volume":"77","author":"J Brettschneider","year":"2018","unstructured":"Brettschneider J, Suh E, Robinson JL, Fang L, Lee EB, Irwin DJ, Grossman M, Van Deerlin VM, Lee VM, Trojanowski JQ (2018) Converging patterns of alpha-synuclein pathology in multiple system atrophy. J Neuropathol Exp Neurol 77:1005\u20131016","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR90","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnins.2018.00080","volume":"12","author":"JC Bridi","year":"2018","unstructured":"Bridi JC, Hirth F (2018) Mechanisms of alpha-synuclein induced synaptopathy in Parkinson\u2019s disease. Front Neurosci 12:80","journal-title":"Front Neurosci"},{"key":"2028_CR91","first-page":"235","volume":"46","author":"G Bringmann","year":"1995","unstructured":"Bringmann G, God R, Feineis D, Wesemann W, Riederer P, Rausch WD, Reichmann H, Sontag KH (1995) The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons. J Neural Transm Suppl 46:235\u2013244","journal-title":"J Neural Transm Suppl"},{"key":"2028_CR92","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/mds.26071","volume":"30","author":"K Brockmann","year":"2015","unstructured":"Brockmann K, Srulijes K, Pflederer S, Hauser AK, Schulte C, Maetzler W, Gasser T, Berg D (2015) GBA-associated Parkinson\u2019s disease: reduced survival and more rapid progression in a prospective longitudinal study. Mov Disord 30:407\u2013411","journal-title":"Mov Disord"},{"issue":"548","key":"2028_CR93","first-page":"e545","volume":"32","author":"JA Brooks","year":"2011","unstructured":"Brooks JA, Houlden H, Melchers A, Islam AJ, Ding J, Li A, Paudel R, Revesz T, Holton JL, Wood N, Lees A, Singleton AB, Scholz SW (2011) Mutational analysis of parkin and PINK1 in multiple system atrophy. Neurobiol Aging 32(548):e545\u2013e547","journal-title":"Neurobiol Aging"},{"key":"2028_CR94","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.nbd.2015.03.003","volume":"85","author":"D Br\u00fcck","year":"2016","unstructured":"Br\u00fcck D, Wenning GK, Stefanova N, Fellner L (2016) Glia and alpha-synuclein in neurodegeneration: A complex interaction. Neurobiol Dis 85:262\u2013274","journal-title":"Neurobiol Dis"},{"key":"2028_CR95","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/jnc.13392","volume":"136","author":"T Brudek","year":"2016","unstructured":"Brudek T, Winge K, Rasmussen NB, Bahl JM, Tanassi J, Agander TK, Hyde TM, Pakkenberg B (2016) Altered alpha-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains. J Neurochem 136:172\u2013185","journal-title":"J Neurochem"},{"key":"2028_CR96","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrm2873","volume":"11","author":"P Brundin","year":"2010","unstructured":"Brundin P, Melki R, Kopito R (2010) Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 11:301\u2013307","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2028_CR97","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.bbr.2019.02.039","volume":"364","author":"J Bu","year":"2019","unstructured":"Bu J, Liu J, Liu K, Wang Z (2019) Diagnostic utility of gut alpha-synuclein in Parkinson\u2019s disease: a systematic review and meta-analysis. Behav Brain Res 364:340\u2013347","journal-title":"Behav Brain Res"},{"key":"2028_CR98","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/bpa.12560","volume":"28","author":"AS Buchman","year":"2018","unstructured":"Buchman AS, Nag S, Leurgans SE, Miller J, VanderHorst V, Bennett DA, Schneider JA (2018) Spinal Lewy body pathology in older adults without an antemortem diagnosis of Parkinson\u2019s disease. Brain Pathol 28:560\u2013568","journal-title":"Brain Pathol"},{"key":"2028_CR99","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/ana.21541","volume":"64","author":"RE Burke","year":"2008","unstructured":"Burke RE, Dauer WT, Vonsattel JP (2008) A critical evaluation of the Braak staging scheme for Parkinson\u2019s disease. Ann Neurol 64:485\u2013491","journal-title":"Ann Neurol"},{"key":"2028_CR100","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024091","author":"J Burre","year":"2018","unstructured":"Burre J, Sharma M, Sudhof TC (2018) Cell biology and pathophysiology of alpha-synuclein. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a024091","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2028_CR101","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/neup.12205","volume":"35","author":"NJ Cairns","year":"2015","unstructured":"Cairns NJ, Perrin RJ, Franklin EE, Carter D, Vincent B, Xie M, Bateman RJ, Benzinger T, Friedrichsen K, Brooks WS, Halliday GM, McLean C, Ghetti B, Morris JC (2015) Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN). Neuropathology 35:390\u2013400","journal-title":"Neuropathology"},{"key":"2028_CR102","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/brain\/awn340","volume":"132","author":"P Calabresi","year":"2009","unstructured":"Calabresi P, Mercuri NB, Di Filippo M (2009) Synaptic plasticity, dopamine and Parkinson\u2019s disease: one step ahead. Brain 132:285\u2013287","journal-title":"Brain"},{"key":"2028_CR103","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.celrep.2015.04.043","volume":"11","author":"S Calafate","year":"2015","unstructured":"Calafate S, Buist A, Miskiewicz K, Vijayan V, Daneels G, de Strooper B, de Wit J, Verstreken P, Moechars D (2015) Synaptic contacts enhance cell-to-cell tau pathology propagation. Cell Rep 11:1176\u20131183","journal-title":"Cell Rep"},{"key":"2028_CR104","doi-asserted-by":"publisher","first-page":"e0215277","DOI":"10.1371\/journal.pone.0215277","volume":"14","author":"N Callizot","year":"2019","unstructured":"Callizot N, Combes M, Henriques A, Poindron P (2019) Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins. PLoS One 14:e0215277","journal-title":"PLoS One"},{"key":"2028_CR105","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mds.26479","volume":"31","author":"L Calo","year":"2016","unstructured":"Calo L, Wegrzynowicz M, Santivanez-Perez J, Grazia Spillantini M (2016) Synaptic failure and alpha-synuclein. Mov Disord 31:169\u2013177","journal-title":"Mov Disord"},{"key":"2028_CR106","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13195-019-0473-4","volume":"11","author":"SP Caminiti","year":"2019","unstructured":"Caminiti SP, Sala A, Iaccarino L, Beretta L, Pilotto A, Gianolli L, Iannaccone S, Magnani G, Padovani A, Ferini-Strambi L, Perani D (2019) Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria. Alzheimers Res Ther 11:20","journal-title":"Alzheimers Res Ther"},{"key":"2028_CR107","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1046\/j.1471-4159.2001.00021.x","volume":"76","author":"BC Campbell","year":"2001","unstructured":"Campbell BC, McLean CA, Culvenor JG, Gai WP, Blumbergs PC, Jakala P, Beyreuther K, Masters CL, Li QX (2001) The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson\u2019s disease. J Neurochem 76:87\u201396","journal-title":"J Neurochem"},{"key":"2028_CR108","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ana.25446","volume":"85","author":"N Candelise","year":"2019","unstructured":"Candelise N, Schmitz M, Llorens F, Villar-Pique A, Cramm M, Thom T, da Silva Correia SM, Gomes Eriton, da Cunha J, Mobius W, Outeiro TF, Alvarez VG, Banchelli M, D\u2019Andrea C, de Angelis M, Zafar S, Rabano A, Matteini P, Zerr I (2019) Seeding variability of different alpha synuclein strains in synucleinopathies. Ann Neurol 85:691\u2013703","journal-title":"Ann Neurol"},{"key":"2028_CR109","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fnins.2019.00382","volume":"13","author":"A Canerina-Amaro","year":"2019","unstructured":"Canerina-Amaro A, Pereda D, Diaz M, Rodriguez-Barreto D, Casanas-Sanchez V, Heffer M, Garcia-Esparcia P, Ferrer I, Puertas-Avendano R, Marin R (2019) Differential aggregation and phosphorylation of alpha synuclein in membrane compartments associated with Parkinson disease. Front Neurosci 13:382","journal-title":"Front Neurosci"},{"key":"2028_CR110","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/mds.26282","volume":"30","author":"M Cazorla","year":"2015","unstructured":"Cazorla M, Kang UJ, Kellendonk C (2015) Balancing the basal ganglia circuitry: a possible new role for dopamine D2 receptors in health and disease. Mov Disord 30:895\u2013903","journal-title":"Mov Disord"},{"key":"2028_CR111","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/mds.27337","volume":"33","author":"MA Cenci","year":"2018","unstructured":"Cenci MA, Crossman AR (2018) Animal models of l-dopa-induced dyskinesia in Parkinson\u2019s disease. Mov Disord 33:889\u2013899","journal-title":"Mov Disord"},{"key":"2028_CR112","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00702-018-1886-0","volume":"125","author":"MA Cenci","year":"2018","unstructured":"Cenci MA, Jorntell H, Petersson P (2018) On the neuronal circuitry mediating l-DOPA-induced dyskinesia. J Neural Transm (Vienna) 125:1157\u20131169","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR113","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00441-017-2733-6","volume":"373","author":"MG Cersosimo","year":"2018","unstructured":"Cersosimo MG (2018) Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies. Cell Tissue Res 373:233\u2013243","journal-title":"Cell Tissue Res"},{"key":"2028_CR114","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jns.2011.09.030","volume":"313","author":"MG Cersosimo","year":"2012","unstructured":"Cersosimo MG, Benarroch EE (2012a) Autonomic involvement in Parkinson\u2019s disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers. J Neurol Sci 313:57\u201363","journal-title":"J Neurol Sci"},{"key":"2028_CR115","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.nbd.2011.10.014","volume":"46","author":"MG Cersosimo","year":"2012","unstructured":"Cersosimo MG, Benarroch EE (2012b) Pathological correlates of gastrointestinal dysfunction in Parkinson\u2019s disease. Neurobiol Dis 46:559\u2013564","journal-title":"Neurobiol Dis"},{"key":"2028_CR116","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s40265-016-0600-5","volume":"76","author":"A Chang","year":"2016","unstructured":"Chang A, Fox SH (2016) Psychosis in parkinson\u2019s disease: epidemiology, pathophysiology, and management. Drugs 76:1093\u20131118","journal-title":"Drugs"},{"key":"2028_CR117","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/ng.3955","volume":"49","author":"D Chang","year":"2017","unstructured":"Chang D, Nalls MA, Hallgrimsdottir IB, Hunkapiller J, van der Brug M, Cai F, Kerchner GA, Ayalon G, Bingol B, Sheng M, Hinds D, Behrens TW, Singleton AB, Bhangale TR, Graham RR (2017) A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci. Nat Genet 49:1511\u20131516","journal-title":"Nat Genet"},{"key":"2028_CR118","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00441-018-2854-6","volume":"373","author":"S Chartier","year":"2018","unstructured":"Chartier S, Duyckaerts C (2018) Is Lewy pathology in the human nervous system chiefly an indicator of neuronal protection or of toxicity? Cell Tissue Res 373:149\u2013160","journal-title":"Cell Tissue Res"},{"key":"2028_CR119","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1042\/BCJ20180297","volume":"475","author":"C Chavarria","year":"2018","unstructured":"Chavarria C, Rodriguez-Bottero S, Quijano C, Cassina P, Souza JM (2018) Impact of monomeric, oligomeric and fibrillar alpha-synuclein on astrocyte reactivity and toxicity to neurons. Biochem J 475:3153\u20133169","journal-title":"Biochem J"},{"key":"2028_CR120","doi-asserted-by":"publisher","first-page":"216 e15","DOI":"10.1016\/j.neurobiolaging.2016.09.021","volume":"49","author":"V Chelban","year":"2017","unstructured":"Chelban V, Manole A, Pihlstrom L, Schottlaender L, Efthymiou S, Oconnor E, Meissner WG, Holton JL, Houlden H (2017) Analysis of the prion protein gene in multiple system atrophy. Neurobiol Aging 49:216 e15\u2013216 e18","journal-title":"Neurobiol Aging"},{"key":"2028_CR121","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jns.2014.09.002","volume":"346","author":"YF Chen","year":"2014","unstructured":"Chen YF, Tseng YL, Lan MY, Lai SL, Su CS, Liu JS, Chang YY (2014) The relationship of leukoaraiosis and the clinical severity of vascular parkinsonism. J Neurol Sci 346:255\u2013259","journal-title":"J Neurol Sci"},{"key":"2028_CR122","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aam6790","author":"ZC Chen","year":"2017","unstructured":"Chen ZC, Zhang W, Chua LL, Chai C, Li R, Lin L, Cao Z, Angeles DC, Stanton LW, Peng JH, Zhou ZD, Lim KL, Zeng L, Tan EK (2017) Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson\u2019s disease. Sci Signal. https:\/\/doi.org\/10.1126\/scisignal.aam6790","journal-title":"Sci Signal"},{"key":"2028_CR123","first-page":"38","volume":"8","author":"C Chen","year":"2019","unstructured":"Chen C, Turnbull DM, Reeve AK (2019a) Mitochondrial dysfunction in Parkinson\u2019s disease-cause or consequence? Biology (Basel) 8:38","journal-title":"Biology (Basel)"},{"key":"2028_CR124","doi-asserted-by":"crossref","unstructured":"Chen Z, Chen JA, Shatunov A, Jones AR, Kravitz SN, Huang AY, Lawrence L, Lowe JK, Lewis CM, Payan CAM, Lieb W, Franke A, Deloukas P, Amouyel P, Tzourio C, Dartigues JF, Ludolph A, Bensimon G, Leigh PN, Bronstein JM, Coppola G, Geschwind DH, Al-Chalabi A (2019b) Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy. Mov Disord","DOI":"10.1002\/mds.27702"},{"key":"2028_CR125","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"HC Cheng","year":"2010","unstructured":"Cheng HC, Ulane CM, Burke RE (2010) Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol 67:715\u2013725","journal-title":"Ann Neurol"},{"key":"2028_CR126","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1007\/s12035-018-1118-5","volume":"56","author":"CC Chiu","year":"2019","unstructured":"Chiu CC, Lu CS, Weng YH, Chen YL, Huang YZ, Chen RS, Cheng YC, Huang YC, Liu YC, Lai SC, Lin KJ, Lin YW, Chen YJ, Chen CL, Yeh TH, Wang HL (2019) PARK14 (D331Y) PLA2G6 causes early-onset degeneration of substantia nigra dopaminergic neurons by inducing mitochondrial dysfunction, er stress, mitophagy impairment and transcriptional dysregulation in a knockin mouse model. Mol Neurobiol 56:3835\u20133853","journal-title":"Mol Neurobiol"},{"key":"2028_CR127","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ana.24323","volume":"77","author":"L Christopher","year":"2015","unstructured":"Christopher L, Duff-Canning S, Koshimori Y, Segura B, Boileau I, Chen R, Lang AE, Houle S, Rusjan P, Strafella AP (2015) Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease. Ann Neurol 77:269\u2013280","journal-title":"Ann Neurol"},{"key":"2028_CR128","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1093\/brain\/aws133","volume":"135","author":"Y Chu","year":"2012","unstructured":"Chu Y, Morfini GA, Langhamer LB, He Y, Brady ST, Kordower JH (2012) Alterations in axonal transport motor proteins in sporadic and experimental Parkinson\u2019s disease. Brain 135:2058\u20132073","journal-title":"Brain"},{"key":"2028_CR129","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.neuron.2014.12.022","volume":"85","author":"HY Chu","year":"2015","unstructured":"Chu HY, Atherton JF, Wokosin D, Surmeier DJ, Bevan MD (2015) Heterosynaptic regulation of external globus pallidus inputs to the subthalamic nucleus by the motor cortex. Neuron 85:364\u2013376","journal-title":"Neuron"},{"key":"2028_CR130","doi-asserted-by":"publisher","first-page":"9535","DOI":"10.1073\/pnas.1301175110","volume":"110","author":"F Clavaguera","year":"2013","unstructured":"Clavaguera F, Akatsu H, Fraser G, Crowther RA, Frank S, Hench J, Probst A, Winkler DT, Reichwald J, Staufenbiel M, Ghetti B, Goedert M, Tolnay M (2013) Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci USA 110:9535\u20139540","journal-title":"Proc Natl Acad Sci USA"},{"key":"2028_CR131","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1093\/brain\/aws211","volume":"135","author":"SJ Colloby","year":"2012","unstructured":"Colloby SJ, McParland S, O\u2019Brien JT, Attems J (2012) Neuropathological correlates of dopaminergic imaging in Alzheimer\u2019s disease and Lewy body dementias. Brain 135:2798\u20132808","journal-title":"Brain"},{"key":"2028_CR132","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/NEN.0000000000000018","volume":"72","author":"M Colom-Cadena","year":"2013","unstructured":"Colom-Cadena M, Gelpi E, Charif S, Belbin O, Blesa R, Marti MJ, Clarimon J, Lleo A (2013a) Confluence of alpha-synuclein, tau, and beta-amyloid pathologies in dementia with Lewy bodies. J Neuropathol Exp Neurol 72:1203\u20131212","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR133","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.neurobiolaging.2012.06.015","volume":"34","author":"M Colom-Cadena","year":"2013","unstructured":"Colom-Cadena M, Gelpi E, Marti MJ, Charif S, Dols-Icardo O, Blesa R, Clarimon J, Lleo A (2013b) MAPT H1 haplotype is associated with enhanced alpha-synuclein deposition in dementia with Lewy bodies. Neurobiol Aging 34:936\u2013942","journal-title":"Neurobiol Aging"},{"key":"2028_CR134","first-page":"216","volume":"76","author":"M Colom-Cadena","year":"2017","unstructured":"Colom-Cadena M, Grau-Rivera O, Planellas L, Cerquera C, Morenas E, Helgueta S, Munoz L, Kulisevsky J, Marti MJ, Tolosa E, Clarimon J, Lleo A, Gelpi E (2017a) Regional overlap of pathologies in Lewy body disorders. J Neuropathol Exp Neurol 76:216\u2013224","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR135","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1093\/brain\/awx275","volume":"140","author":"M Colom-Cadena","year":"2017","unstructured":"Colom-Cadena M, Pegueroles J, Herrmann AG, Henstridge CM, Munoz L, Querol-Vilaseca M, Martin-Paniello CS, Luque-Cabecerans J, Clarimon J, Belbin O, Nunez-Llaves R, Blesa R, Smith C, McKenzie CA, Frosch MP, Roe A, Fortea J, Andilla J, Loza-Alvarez P, Gelpi E, Hyman BT, Spires-Jones TL, Lleo A (2017b) Synaptic phosphorylated alpha-synuclein in dementia with Lewy bodies. Brain 140:3204\u20133214","journal-title":"Brain"},{"key":"2028_CR136","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.27186","volume":"33","author":"EA Coon","year":"2018","unstructured":"Coon EA, Cutsforth-Gregory JK, Benarroch EE (2018) Neuropathology of autonomic dysfunction in synucleinopathies. Mov Disord 33:349\u2013358","journal-title":"Mov Disord"},{"key":"2028_CR138","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ana.25392","volume":"85","author":"D Coughlin","year":"2018","unstructured":"Coughlin D, Xie SX, Liang M, Williams A, Peterson C, Weintraub D, McMillan CT, Wolk DA, Akhtar RS, Hurtig HI, Branch Coslett H, Hamilton RH, Siderowf AD, Duda JE, Rascovsky K, Lee EB, Lee VM, Grossman M, Trojanowski JQ, Irwin DJ (2018) Cognitive and pathological influences of tau pathology in Lewy body disorders. Ann Neurol 85:259\u2013271","journal-title":"Ann Neurol"},{"key":"2028_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.1003.1023","author":"DG Coughlin","year":"2019","unstructured":"Coughlin DG, Petrovitch H, White LR, Noorigian JV, Masaki K, Webster RG, Duda JE (2019) Most cases with Lewy pathology in a population-based cohort adhere to the Braak progression pattern but \u2018failure to fit\u2019 is highly dependent on staging system applied. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.1003.1023","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR140","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/bs.irn.2018.10.007","volume":"144","author":"O Cousins","year":"2019","unstructured":"Cousins O, Yousaf T, Wilson H, Pagano G, Politis M (2019) Molecular imaging of dementia with Lewy bodies. Int Rev Neurobiol 144:59\u201393","journal-title":"Int Rev Neurobiol"},{"key":"2028_CR141","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/nan.12402","volume":"43","author":"DJ Covell","year":"2017","unstructured":"Covell DJ, Robinson JL, Akhtar RS, Grossman M, Weintraub D, Bucklin HM, Pitkin RM, Riddle D, Yousef A, Trojanowski JQ, Lee VM (2017) Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson\u2019s disease. Neuropathol Appl Neurobiol 43:604\u2013620","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR142","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000002638","volume":"86","author":"IT Coyle-Gilchrist","year":"2016","unstructured":"Coyle-Gilchrist IT, Dick KM, Patterson K, Vazquez Rodriquez P, Wehmann E, Wilcox A, Lansdall CJ, Dawson KE, Wiggins J, Mead S, Brayne C, Rowe JB (2016) Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology 86:1736\u20131743","journal-title":"Neurology"},{"key":"2028_CR143","volume-title":"Research Progress in Parkinson\u2019s disease","author":"M Critchley","year":"1981","unstructured":"Critchley M (1981) Arteriosclerotic pseudoparkinsonism. In: Rose FC, Capildeo R (eds) Research Progress in Parkinson\u2019s disease. Pitman, London"},{"key":"2028_CR144","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1093\/brain\/awv114","volume":"138","author":"MD Cykowski","year":"2015","unstructured":"Cykowski MD, Coon EA, Powell SZ, Jenkins SM, Benarroch EE, Low PA, Schmeichel AM, Parisi JE (2015) Expanding the spectrum of neuronal pathology in multiple system atrophy. Brain 138:2293\u20132309","journal-title":"Brain"},{"key":"2028_CR145","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-3-319-49969-7_11","volume":"14","author":"JP Daher","year":"2017","unstructured":"Daher JP (2017) Interaction of LRRK2 and alpha-synuclein in Parkinson\u2019s disease. Adv Neurobiol 14:209\u2013226","journal-title":"Adv Neurobiol"},{"key":"2028_CR146","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/BF00310030","volume":"83","author":"GE Dale","year":"1992","unstructured":"Dale GE, Probst A, Luthert P, Martin J, Anderton BH, Leigh PN (1992) Relationships between Lewy bodies and pale bodies in Parkinson\u2019s disease. Acta Neuropathol (Berl) 83:525\u2013529","journal-title":"Acta Neuropathol (Berl)"},{"key":"2028_CR903","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2019.1005.1001","author":"T Das","year":"2019","unstructured":"Das T, Eliezer D (2019) Membrane interactions of intrinsically disordered proteins: the example of alpha-synuclein. Biochim Biophys Acta Proteins Proteomics. https:\/\/doi.org\/10.1016\/j.bbapap.2019.1005.1001","journal-title":"Biochim Biophys Acta Proteins Proteomics"},{"key":"2028_CR147","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/ane.13039","volume":"139","author":"D Dash","year":"2019","unstructured":"Dash D, Pandey S (2019) Movement disorders associated with neuronal antibodies. Acta Neurol Scand 139:106\u2013117","journal-title":"Acta Neurol Scand"},{"key":"2028_CR148","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/jamaneurol.2016.2245","volume":"73","author":"MY Davis","year":"2016","unstructured":"Davis MY, Johnson CO, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Quinn JF, Chung KA, Peterson-Hiller AL, Rosenthal LS, Dawson TM, Albert MS, Goldman JG, Stebbins GT, Bernard B, Wszolek ZK, Ross OA, Dickson DW, Eidelberg D, Mattis PJ, Niethammer M, Yearout D, Hu SC, Cholerton BA, Smith M, Mata IF, Montine TJ, Edwards KL, Zabetian CP (2016) Association of GBA mutations and the E326K polymorphism with motor and cognitive progression in Parkinson disease. JAMA Neurol 73:1217\u20131224","journal-title":"JAMA Neurol"},{"key":"2028_CR149","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1146\/annurev-cellbio-100617-062636","volume":"34","author":"AA Davis","year":"2018","unstructured":"Davis AA, Leyns CEG, Holtzman DM (2018) Intercellular spread of protein aggregates in neurodegenerative disease. Annu Rev Cell Dev Biol 34:545\u2013568","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2028_CR150","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/19336896.2017.1423186","volume":"12","author":"E De Cecco","year":"2018","unstructured":"De Cecco E, Legname G (2018) The role of the prion protein in the internalization of alpha-synuclein amyloids. Prion 12:23\u201327","journal-title":"Prion"},{"key":"2028_CR151","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27632","author":"A de Iure","year":"2019","unstructured":"de Iure A, Napolitano F, Beck G, Quiroga Varela A, Durante V, Sciaccaluga M, Mazzocchetti P, Megaro A, Tantucci M, Cardinale A, Punzo D, Mancini A, Costa C, Ghiglieri V, Tozzi A, Picconi B, Papa SM, Usiello A, Calabresi P (2019) Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior. Mov Disord. https:\/\/doi.org\/10.1002\/mds.27632","journal-title":"Mov Disord"},{"key":"2028_CR152","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/ana.22284","volume":"69","author":"R de la Fuente-Fernandez","year":"2011","unstructured":"de la Fuente-Fernandez R, Schulzer M, Kuramoto L, Cragg J, Ramachandiran N, Au WL, Mak E, McKenzie J, McCormick S, Sossi V, Ruth TJ, Lee CS, Calne DB, Stoessl AJ (2011) Age-specific progression of nigrostriatal dysfunction in Parkinson\u2019s disease. Ann Neurol 69:803\u2013810","journal-title":"Ann Neurol"},{"key":"2028_CR153","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/jnnp-2016-314601","volume":"88","author":"E De Pablo-Fernandez","year":"2017","unstructured":"De Pablo-Fernandez E, Breen DP, Bouloux PM, Barker RA, Foltynie T, Warner TT (2017) Neuroendocrine abnormalities in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 88:176\u2013185","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2028_CR154","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/mds.27370","volume":"33","author":"E De Pablo-Fernandez","year":"2018","unstructured":"De Pablo-Fernandez E, Cerdan Santacruz D, Warner TT, Holton JL (2018) No evidence of iatrogenic human transmission in autopsy confirmed multiple system atrophy. Mov Disord 33:1183\u20131184","journal-title":"Mov Disord"},{"key":"2028_CR155","first-page":"101","volume":"1","author":"J De Reuck","year":"2018","unstructured":"De Reuck J, Auger F, Durieux N, Cordonnier C, Maurage CA, Deramecourt V, Pasquier F, Leys D, Bordet R (2018) The impact of cerebral amyloid angiopathy in Lewy body dementia: a neuropathological study with magnetic resonance imaging correlations. J Neurodegener Dis Res 1:101","journal-title":"J Neurodegener Dis Res"},{"key":"2028_CR156","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/mds.25793","volume":"29","author":"B Dehay","year":"2014","unstructured":"Dehay B (2014) Evidence piles up for prion-like propagation mechanisms in synucleinopathies. Mov Disord 29:187","journal-title":"Mov Disord"},{"key":"2028_CR157","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.neurol.2016.04.003","volume":"172","author":"B Dehay","year":"2016","unstructured":"Dehay B, Fernagut PO (2016) Alpha-synuclein-based models of Parkinson\u2019s disease. Rev Neurol (Paris) 172:371\u2013378","journal-title":"Rev Neurol (Paris)"},{"key":"2028_CR158","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fnana.2018.00113","volume":"12","author":"NL Del Rey","year":"2018","unstructured":"Del Rey NL, Quiroga-Varela A, Garbayo E, Carballo-Carbajal I, Fernandez-Santiago R, Monje MHG, Trigo-Damas I, Blanco-Prieto MJ, Blesa J (2018) Advances in Parkinson\u2019s disease: 200 years later. Front Neuroanat 12:113","journal-title":"Front Neuroanat"},{"key":"2028_CR159","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-012-1028-y","volume":"124","author":"K Del Tredici","year":"2012","unstructured":"Del Tredici K, Braak H (2012) Spinal cord lesions in sporadic Parkinson\u2019s disease. Acta Neuropathol 124:643\u2013664","journal-title":"Acta Neuropathol"},{"key":"2028_CR160","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1136\/jnnp-2011-301817","volume":"84","author":"K Del Tredici","year":"2013","unstructured":"Del Tredici K, Braak H (2013) Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson\u2019s disease-related dementia. J Neurol Neurosurg Psychiatry 84:774\u2013783","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2028_CR161","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/00005072-199602000-00004","volume":"55","author":"A Delacourte","year":"1996","unstructured":"Delacourte A, Robitaille Y, Sergeant N, Buee L, Hof PR, Wattez A, Laroche-Cholette A, Mathieu J, Chagnon P, Gauvreau D (1996) Specific pathological Tau protein variants characterize Pick\u2019s disease. J Neuropathol Exp Neurol 55:159\u2013168","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR162","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1001\/archneur.65.8.1074","volume":"65","author":"A DelleDonne","year":"2008","unstructured":"DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, Wszolek ZK, Uitti RJ, Ahlskog JE, Dickson DW (2008) Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol 65:1074\u20131080","journal-title":"Arch Neurol"},{"key":"2028_CR163","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/01.jnen.0000205145.54457.ea","volume":"65","author":"V Deramecourt","year":"2006","unstructured":"Deramecourt V, Bombois S, Maurage CA, Ghestem A, Drobecq H, Vanmechelen E, Lebert F, Pasquier F, Delacourte A (2006) Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. J Neuropathol Exp Neurol 65:278\u2013288","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR164","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.conb.2015.07.007","volume":"36","author":"U Dettmer","year":"2016","unstructured":"Dettmer U, Selkoe D, Bartels T (2016) New insights into cellular alpha-synuclein homeostasis in health and disease. Curr Opin Neurobiol 36:15\u201322","journal-title":"Curr Opin Neurobiol"},{"key":"2028_CR165","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40478-019-0733-3","volume":"7","author":"JS Dhillon","year":"2019","unstructured":"Dhillon JS, Trejo-Lopez JA, Riffe C, Levites Y, Sacino AN, Borchelt DR, Yachnis AY, Giasson BI (2019a) Comparative analyses of the in vivo induction and transmission of alpha-synuclein pathology in transgenic mice by MSA brain lysate and recombinant alpha-synuclein fibrils. Acta Neuropathol Commun 7:80","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR166","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-41019-40198-41379","author":"JS Dhillon","year":"2019","unstructured":"Dhillon JS, Trejo-Lopez JA, Riffe C, McFarland NR, Hiser WM, Giasson BI, Yachnis AT (2019b) Dissecting alpha-synuclein inclusion pathology diversity in multiple system atrophy: implications for the prion-like transmission hypothesis. Lab Invest. https:\/\/doi.org\/10.1038\/s41374-41019-40198-41379","journal-title":"Lab Invest"},{"key":"2028_CR167","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.stemcr.2018.12.011","volume":"12","author":"A di Domenico","year":"2019","unstructured":"di Domenico A, Carola G, Calatayud C, Pons-Espinal M, Munoz JP, Richaud-Patin Y, Fernandez-Carasa I, Gut M, Faella A, Parameswaran J, Soriano J, Ferrer I, Tolosa E, Zorzano A, Cuervo AM, Raya A, Consiglio A (2019) Patient-specific IPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson\u2019s disease. Stem Cell Rep 12:213\u2013229","journal-title":"Stem Cell Rep"},{"key":"2028_CR168","doi-asserted-by":"publisher","first-page":"a009258","DOI":"10.1101\/cshperspect.a009258","volume":"2","author":"DW Dickson","year":"2012","unstructured":"Dickson DW (2012) Parkinson\u2019s disease and parkinsonism: neuropathology. Cold Spring Harb Perspect Med 2:a009258","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"Suppl 1","key":"2028_CR169","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","volume":"46","author":"DW Dickson","year":"2018","unstructured":"Dickson DW (2018) Neuropathology of Parkinson disease. Parkinsonism Relat Disord 46(Suppl 1):S30\u2013S33","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR170","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00401-008-0345-7","volume":"115","author":"DW Dickson","year":"2008","unstructured":"Dickson DW, Fujishiro H, Delledonne A, Menke J, Ahmed Z, Klos KJ, Josephs KA, Frigerio R, Burnett M, Parisi JE, Ahlskog JE (2008) Evidence that incidental Lewy body disease is pre-symptomatic Parkinson\u2019s disease. Acta Neuropathol 115:437\u2013444","journal-title":"Acta Neuropathol"},{"key":"2028_CR171","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I (2009) Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol 8:1150\u20131157","journal-title":"Lancet Neurol"},{"key":"2028_CR172","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/WCO.0b013e32833be924","volume":"23","author":"DW Dickson","year":"2010","unstructured":"Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA (2010a) Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 23:394\u2013400","journal-title":"Curr Opin Neurol"},{"issue":"Suppl 1","key":"2028_CR173","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1002\/mds.22637","volume":"25","author":"DW Dickson","year":"2010","unstructured":"Dickson DW, Uchikado H, Fujishiro H, Tsuboi Y (2010b) Evidence in favor of Braak staging of Parkinson\u2019s disease. Mov Disord 25(Suppl 1):S78\u2013S82","journal-title":"Mov Disord"},{"key":"2028_CR174","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/9781444341256.ch15","volume-title":"Neurodegeneration: the molecular pathology of dementia and movement disorders","author":"DW Dickson","year":"2011","unstructured":"Dickson DW, Hauw JJ, Agid Y, Litvan I (2011a) Progressive supranuclear palsy and corticobasal degeneration. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 135\u2013155","edition":"2"},{"key":"2028_CR175","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s12031-011-9589-0","volume":"45","author":"DW Dickson","year":"2011","unstructured":"Dickson DW, Kouri N, Murray ME, Josephs KA (2011b) Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J Mol Neurosci 45:384\u2013389","journal-title":"J Mol Neurosci"},{"key":"2028_CR176","doi-asserted-by":"publisher","first-page":"e1182","DOI":"10.1212\/WNL.0000000000006212","volume":"91","author":"DW Dickson","year":"2018","unstructured":"Dickson DW, Heckman MG, Murray ME, Soto AI, Walton RL, Diehl NN, van Gerpen JA, Uitti RJ, Wszolek ZK, Ertekin-Taner N, Knopman DS, Petersen RC, Graff-Radford NR, Boeve BF, Bu G, Ferman TJ, Ross OA (2018) APOE epsilon4 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology 91:e1182\u2013e1195","journal-title":"Neurology"},{"key":"2028_CR177","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/mds.25952","volume":"29","author":"AA Dijkstra","year":"2014","unstructured":"Dijkstra AA, Voorn P, Berendse HW, Groenewegen HJ, Rozemuller AJ, van de Berg WD (2014) Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson\u2019s disease. Mov Disord 29:1244\u20131251","journal-title":"Mov Disord"},{"key":"2028_CR178","first-page":"721","volume":"140","author":"MF Dirkx","year":"2017","unstructured":"Dirkx MF, den Ouden HE, Aarts E, Timmer MH, Bloem BR, Toni I, Helmich RC (2017) Dopamine controls Parkinson\u2019s tremor by inhibiting the cerebellar thalamus. Brain 140:721\u2013734","journal-title":"Brain"},{"key":"2028_CR179","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/mds.23380","volume":"26","author":"R Djaldetti","year":"2011","unstructured":"Djaldetti R, Lorberboym M, Karmon Y, Treves TA, Ziv I, Melamed E (2011) Residual striatal dopaminergic nerve terminals in very long-standing Parkinson\u2019s disease: a single photon emission computed tomography imaging study. Mov Disord 26:327\u2013330","journal-title":"Mov Disord"},{"key":"2028_CR180","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10863-019-09798-4","volume":"51","author":"LP Dolgacheva","year":"2019","unstructured":"Dolgacheva LP, Berezhnov AV, Fedotova EI, Zinchenko VP, Abramov AY (2019) Role of DJ-1 in the mechanism of pathogenesis of Parkinson\u2019s disease. J Bioenerg Biomembr 51:175\u2013188","journal-title":"J Bioenerg Biomembr"},{"key":"2028_CR181","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s40478-014-0150-6","volume":"2","author":"AS Don","year":"2014","unstructured":"Don AS, Hsiao JH, Bleasel JM, Couttas TA, Halliday GM, Kim W (2014) Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy. Acta Neuropathol Commun 2:150","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR182","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-10018-10581-10284","author":"V Donadio","year":"2018","unstructured":"Donadio V (2018) Skin nerve alpha-synuclein deposits in Parkinson\u2019s disease and other synucleinopathies: a review. Clin Auton Res. https:\/\/doi.org\/10.1007\/s10286-10018-10581-10284","journal-title":"Clin Auton Res"},{"key":"2028_CR183","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13939","author":"V Donadio","year":"2019","unstructured":"Donadio V, Doppler K, Incensi A, Kuzkina A, Janzen A, Mayer G, Volkmann J, Rizzo G, Antelmi E, Plazzi G, Sommer C, Liguori R, Oertel WH (2019) Abnormal alpha-synuclein deposits in skin nerves: intra- and inter-laboratory reproducibility. Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.13939","journal-title":"Eur J Neurol"},{"key":"2028_CR184","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/alzrt274","volume":"6","author":"PC Donaghy","year":"2014","unstructured":"Donaghy PC, McKeith I (2014) The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimers Res Ther 6:46","journal-title":"Alzheimers Res Ther"},{"key":"2028_CR185","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1212\/WNL.0b013e3181a92bcc","volume":"73","author":"L Donker Kaat","year":"2009","unstructured":"Donker Kaat L, Boon AJ, Azmani A, Kamphorst W, Breteler MM, Anar B, Heutink P, van Swieten JC (2009) Familial aggregation of parkinsonism in progressive supranuclear palsy. Neurology 73:98\u2013105","journal-title":"Neurology"},{"key":"2028_CR186","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/mds.26293","volume":"30","author":"K Doppler","year":"2015","unstructured":"Doppler K, Weis J, Karl K, Ebert S, Ebentheuer J, Trenkwalder C, Klebe S, Volkmann J, Sommer C (2015) Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy. Mov Disord 30:1688\u20131692","journal-title":"Mov Disord"},{"key":"2028_CR187","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the Parkinson pandemic. J Parkinsons Dis 8:S3\u2013S8","journal-title":"J Parkinsons Dis"},{"key":"2028_CR188","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.pneurobio.2010.06.001","volume":"92","author":"KL Double","year":"2010","unstructured":"Double KL, Reyes S, Werry EL, Halliday GM (2010) Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions? Prog Neurobiol 92:316\u2013329","journal-title":"Prog Neurobiol"},{"key":"2028_CR189","doi-asserted-by":"crossref","unstructured":"Driver-Dunckley ED, Zhang N, Adler CH, Serrano GE, Sue LI, Shill H, Mehta SH, Belden CM, Zamrini E, Davis K, Beach T (2019) Brain Lewy-type synucleinopathy density is associated with a lower prevalence of atherosclerotic cardiovascular disease risk factors in patients with Parkinson\u2019s disease. J Parkinsons Dis (in print)","DOI":"10.3233\/JPD-191610"},{"key":"2028_CR190","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/mds.21844","volume":"22","author":"B Dubois","year":"2007","unstructured":"Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007) Diagnostic procedures for Parkinson\u2019s disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314\u20132324","journal-title":"Mov Disord"},{"key":"2028_CR191","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-018-1171-z","volume":"15","author":"MF Duffy","year":"2018","unstructured":"Duffy MF, Collier TJ, Patterson JR, Kemp CJ, Luk KC, Tansey MG, Paumier KL, Kanaan NM, Fischer DL, Polinski NK, Barth OL, Howe JW, Vaikath NN, Majbour NK, El-Agnaf OMA, Sortwell CE (2018) Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration. J Neuroinflamm 15:129","journal-title":"J Neuroinflamm"},{"key":"2028_CR192","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00401-010-0739-1","volume":"120","author":"BN Dugger","year":"2010","unstructured":"Dugger BN, Dickson DW (2010) Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies. Acta Neuropathol 120:633\u2013639","journal-title":"Acta Neuropathol"},{"key":"2028_CR193","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neulet.2018.12.031","volume":"696","author":"BN Dugger","year":"2018","unstructured":"Dugger BN, Hoffman BR, Scroggins A, Serrano GE, Adler CH, Shill HA, Belden CM, Sabbagh MN, Caviness JN, Driver Dunckley E, Beach TG (2018) Tau immunoreactivity in peripheral tissues of human aging and select tauopathies. Neurosci Lett 696:132\u2013139","journal-title":"Neurosci Lett"},{"key":"2028_CR194","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/gps.5071","volume":"34","author":"R Durcan","year":"2019","unstructured":"Durcan R, Donaghy P, Osborne C, Taylor JP, Thomas AJ (2019) Imaging in prodromal dementia with Lewy bodies: where do we stand? Int J Geriatr Psychiatry 34:635\u2013646","journal-title":"Int J Geriatr Psychiatry"},{"key":"2028_CR195","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/WCO.0000000000000672","volume":"32","author":"C Duyckaerts","year":"2019","unstructured":"Duyckaerts C, Clavaguera F, Potier MC (2019) The prion-like propagation hypothesis in Alzheimer\u2019s and Parkinson\u2019s disease. Curr Opin Neurol 32:266\u2013271","journal-title":"Curr Opin Neurol"},{"key":"2028_CR196","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/mds.26892","volume":"32","author":"N Dzamko","year":"2017","unstructured":"Dzamko N, Gysbers AM, Bandopadhyay R, Bolliger MF, Uchino A, Zhao Y, Takao M, Wauters S, van de Berg WD, Takahashi-Fujigasaki J, Nichols RJ, Holton JL, Murayama S, Halliday GM (2017) LRRK2 levels and phosphorylation in Parkinson\u2019s disease brain and cases with restricted Lewy bodies. Mov Disord 32:423\u2013432","journal-title":"Mov Disord"},{"key":"2028_CR197","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40478-019-0708-4","volume":"7","author":"M Ebashi","year":"2019","unstructured":"Ebashi M, Ito Y, Uematsu M, Nakamura A, Hirokawa K, Kamei S, Uchihara T (2019) How to demix Alzheimer-type and PSP-type tau lesions out of their mixture-hybrid approach to dissect comorbidity. Acta Neuropathol Commun 7:71","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR198","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S1474-4422(12)70138-2","volume":"11","author":"U Ekman","year":"2012","unstructured":"Ekman U, Eriksson J, Forsgren L, Mo SJ, Riklund K, Nyberg L (2012) Functional brain activity and presynaptic dopamine uptake in patients with Parkinson\u2019s disease and mild cognitive impairment: a cross-sectional study. Lancet Neurol 11:679\u2013687","journal-title":"Lancet Neurol"},{"key":"2028_CR199","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/gps.4719","volume":"32","author":"GJ Elder","year":"2017","unstructured":"Elder GJ, Mactier K, Colloby SJ, Watson R, Blamire AM, O\u2019Brien JT, Taylor JP (2017) The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies. Int J Geriatr Psychiatry 32:1182\u20131189","journal-title":"Int J Geriatr Psychiatry"},{"key":"2028_CR200","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/9780470713990.ch2","volume-title":"Therapeutics of Parkinson\u2019s disease and other movement disorders","author":"S Elias","year":"2008","unstructured":"Elias S, Israel Z, Bergman H (2008) Physiology of Parkinson\u2019s disease. In: Hallett M, Poewe W (eds) Therapeutics of Parkinson\u2019s disease and other movement disorders. Wiley-Blackwell, New York, pp 25\u201336"},{"key":"2028_CR201","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/bpa.12373","volume":"26","author":"E Emmanouilidou","year":"2016","unstructured":"Emmanouilidou E, Vekrellis K (2016) Exocytosis and spreading of normal and aberrant alpha-synuclein. Brain Pathol 26:398\u2013403","journal-title":"Brain Pathol"},{"key":"2028_CR202","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22:1689\u20131707","journal-title":"Mov Disord"},{"key":"2028_CR203","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1093\/cercor\/bhu076","volume":"25","author":"M Engeln","year":"2015","unstructured":"Engeln M, De Deurwaerdere P, Li Q, Bezard E, Fernagut PO (2015) Widespread monoaminergic dysregulation of both motor and non-motor circuits in parkinsonism and dyskinesia. Cereb Cortex 25:2783\u20132792","journal-title":"Cereb Cortex"},{"key":"2028_CR204","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/ene.13968","volume":"1","author":"R Erro","year":"2019","unstructured":"Erro R, Picillo M, Amboni M, Savastano R, Scannapieco S, Cuoco S, Santangelo G, Vitale C, Pellecchia MT, Barone P (2019) Comparing postural instability and gait disorder and akinetic-rigid subtyping of Parkinson disease and their stability over time. Eur J Neurol 1:5. https:\/\/doi.org\/10.1111\/ene.13968","journal-title":"Eur J Neurol"},{"key":"2028_CR205","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jagp.2017.01.005","volume":"25","author":"D Erskine","year":"2017","unstructured":"Erskine D, Thomas AJ, Taylor JP, Savage MA, Attems J, McKeith IG, Morris CM, Khundakar AA (2017) Neuronal loss and alpha-synuclein pathology in the superior colliculus and its relationship to visual hallucinations in dementia with Lewy bodies. Am J Geriatr Psychiatry 25:595\u2013604","journal-title":"Am J Geriatr Psychiatry"},{"key":"2028_CR206","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/mds.27333","volume":"33","author":"D Erskine","year":"2018","unstructured":"Erskine D, Ding J, Thomas AJ, Kaganovich A, Khundakar AA, Hanson PS, Taylor JP, McKeith IG, Attems J, Cookson MR, Morris CM (2018) Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies. Mov Disord 33:982\u2013991","journal-title":"Mov Disord"},{"key":"2028_CR207","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/mds.26048","volume":"29","author":"AJ Espay","year":"2014","unstructured":"Espay AJ, LeWitt PA, Kaufmann H (2014) Norepinephrine deficiency in Parkinson\u2019s disease: the case for noradrenergic enhancement. Mov Disord 29:1710\u20131719","journal-title":"Mov Disord"},{"key":"2028_CR208","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1212\/WNL.0000000000006926","volume":"92","author":"AJ Espay","year":"2019","unstructured":"Espay AJ, Vizcarra JA, Marsili L, Lang AE, Simon DK, Merola A, Josephs KA, Fasano A, Morgante F, Savica R, Greenamyre JT, Cambi F, Yamasaki TR, Tanner CM, Gan-Or Z, Litvan I, Mata IF, Zabetian CP, Brundin P, Fernandez HH, Standaert DG, Kauffman MA, Schwarzschild MA, Sardi SP, Sherer T, Perry G, Leverenz JB (2019) Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology 92:329\u2013337","journal-title":"Neurology"},{"key":"2028_CR209","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2017.12.026","volume":"1681","author":"T Evans","year":"2018","unstructured":"Evans T, Kok WL, Cowan K, Hefford M, Anichtchik O (2018) Accumulation of beta-synuclein in cortical neurons is associated with autophagy attenuation in the brains of dementia with Lewy body patients. Brain Res 1681:1\u201313","journal-title":"Brain Res"},{"key":"2028_CR210","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","volume":"561","author":"B Falcon","year":"2018","unstructured":"Falcon B, Zhang W, Murzin AG, Murshudov G, Garringer HJ, Vidal R, Crowther RA, Ghetti B, Scheres SHW, Goedert M (2018) Structures of filaments from Pick\u2019s disease reveal a novel tau protein fold. Nature 561:137\u2013140","journal-title":"Nature"},{"key":"2028_CR211","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1056\/NEJMra1311488","volume":"372","author":"A Fanciulli","year":"2015","unstructured":"Fanciulli A, Wenning GK (2015) Multiple-system atrophy. N Engl J Med 372:249\u2013263","journal-title":"N Engl J Med"},{"key":"2028_CR212","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/nan.12501","volume":"45","author":"YY Fathy","year":"2019","unstructured":"Fathy YY, Jonker AJ, Oudejans E, de Jong FJJ, van Dam AW, Rozemuller AJM, van de Berg WDJ (2019) Differential insular cortex subregional vulnerability to alpha-synuclein pathology in Parkinson\u2019s disease and dementia with Lewy bodies. Neuropathol Appl Neurobiol 45:262\u2013277","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR213","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/35006074","volume":"404","author":"MB Feany","year":"2000","unstructured":"Feany MB, Bender WW (2000) A Drosophila model of Parkinson\u2019s disease. Nature 404:394\u2013398","journal-title":"Nature"},{"key":"2028_CR214","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.parkreldis.2015.11.005","volume":"22","author":"M Federoff","year":"2016","unstructured":"Federoff M, Price TR, Sailer A, Scholz S, Hernandez D, Nicolas A, Singleton AB, Nalls M, Houlden H (2016) Genome-wide estimate of the heritability of multiple system atrophy. Parkinsonism Relat Disord 22:35\u201341","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR215","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2016.03.012","volume":"27","author":"VD Felice","year":"2016","unstructured":"Felice VD, Quigley EM, Sullivan AM, O\u2019Keeffe GW, O\u2019Mahony SM (2016) Microbiota-gut-brain signalling in Parkinson\u2019s disease: Implications for non-motor symptoms. Parkinsonism Relat Disord 27:1\u20138","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR216","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00401-011-0833-z","volume":"121","author":"L Fellner","year":"2011","unstructured":"Fellner L, Jellinger KA, Wenning GK, Stefanova N (2011) Glial dysfunction in the pathogenesis of alpha-synucleinopathies: emerging concepts. Acta Neuropathol 121:675\u2013693","journal-title":"Acta Neuropathol"},{"key":"2028_CR217","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/7854_2013_269","volume":"22","author":"L Fellner","year":"2015","unstructured":"Fellner L, Wenning GK, Stefanova N (2015) Models of multiple system atrophy. Curr Top Behav Neurosci 22:369\u2013393","journal-title":"Curr Top Behav Neurosci"},{"key":"2028_CR218","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12868-018-0431-2","volume":"19","author":"L Fellner","year":"2018","unstructured":"Fellner L, Buchinger E, Brueck D, Irschick R, Wenning GK, Stefanova N (2018) Limited effects of dysfunctional macroautophagy on the accumulation of extracellularly derived alpha-synuclein in oligodendroglia: implications for MSA pathogenesis. BMC Neurosci 19:32","journal-title":"BMC Neurosci"},{"key":"2028_CR219","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/brain\/awx118","volume":"140","author":"SM Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB (2017) Clinical criteria for subtyping Parkinson\u2019s disease: biomarkers and longitudinal progression. Brain 140:1959\u20131976","journal-title":"Brain"},{"key":"2028_CR220","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10286-013-0216-8","volume":"24","author":"MC Ferguson","year":"2014","unstructured":"Ferguson MC, Garland EM, Hedges L, Womack-Nunley B, Hamid R, Phillips JA 3rd, Shibao CA, Raj SR, Biaggioni I, Robertson D (2014) SHC2 gene copy number in multiple system atrophy (MSA). Clin Auton Res 24:25\u201330","journal-title":"Clin Auton Res"},{"key":"2028_CR221","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jalz.2017.09.014","volume":"14","author":"TJ Ferman","year":"2018","unstructured":"Ferman TJ, Aoki N, Crook JE, Murray ME, Graff-Radford NR, van Gerpen JA, Uitti RJ, Wszolek ZK, Graff-Radford J, Pedraza O, Kantarci K, Boeve BF, Dickson DW (2018) The limbic and neocortical contribution of alpha-synuclein, tau, and amyloid beta to disease duration in dementia with Lewy bodies. Alzheimers Dement 14:330\u2013339","journal-title":"Alzheimers Dement"},{"key":"2028_CR222","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12864-018-4804-9","volume":"19","author":"R Ferrari","year":"2018","unstructured":"Ferrari R, Kia DA, Tomkins JE, Hardy J, Wood NW, Lovering RC, Lewis PA, Manzoni C (2018) Stratification of candidate genes for Parkinson\u2019s disease using weighted protein-protein interaction network analysis. BMC Genom 19:452","journal-title":"BMC Genom"},{"key":"2028_CR223","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fncel.2018.00247","volume":"12","author":"SA Ferreira","year":"2018","unstructured":"Ferreira SA, Romero-Ramos M (2018) Microglia response during Parkinson\u2019s disease: alpha-synuclein intervention. Front Cell Neurosci 12:247","journal-title":"Front Cell Neurosci"},{"key":"2028_CR224","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pneurobio.2018.07.004","volume":"169","author":"I Ferrer","year":"2018","unstructured":"Ferrer I (2018) Oligodendrogliopathy in neurodegenerative diseases with abnormal protein aggregates: the forgotten partner. Prog Neurobiol 169:24\u201354","journal-title":"Prog Neurobiol"},{"key":"2028_CR225","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/NEN.0000000000000030","volume":"73","author":"I Ferrer","year":"2014","unstructured":"Ferrer I, Lopez-Gonzalez I, Carmona M, Arregui L, Dalfo E, Torrejon-Escribano B, Diehl R, Kovacs GG (2014) Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression. J Neuropathol Exp Neurol 73:81\u201397","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR226","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fnagi.2019.00112","volume":"11","author":"I Ferrer","year":"2019","unstructured":"Ferrer I, Aguil\u00f3 Garc\u00eda M, Carmona M, Andr\u00e9s-Benito P, Torrej\u00f3n-Escribano B, Garcia-Esparcia P, del Rio JA (2019) Involvement of oligodendrocytes in tau seeding and spreading in tauopathies. Front Aging Neurosci 11:112","journal-title":"Front Aging Neurosci"},{"key":"2028_CR227","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrneurol.2016.200","volume":"13","author":"DH Ffytche","year":"2017","unstructured":"Ffytche DH, Creese B, Politis M, Chaudhuri KR, Weintraub D, Ballard C, Aarsland D (2017) The psychosis spectrum in Parkinson disease. Nat Rev Neurol 13:81\u201395","journal-title":"Nat Rev Neurol"},{"key":"2028_CR228","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10571-019-00649-9","volume":"39","author":"A Filippini","year":"2019","unstructured":"Filippini A, Gennarelli M, Russo I (2019) Alpha-synuclein and glia in Parkinson\u2019s disease: a beneficial or a detrimental duet for the endo-lysosomal system? Cell Mol Neurobiol 39:161\u2013168","journal-title":"Cell Mol Neurobiol"},{"key":"2028_CR229","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fnins.2019.00369","volume":"13","author":"E Fitzgerald","year":"2019","unstructured":"Fitzgerald E, Murphy S, Martinson HA (2019) Alpha-synuclein pathology and the role of the microbiota in Parkinson\u2019s disease. Front Neurosci 13:369","journal-title":"Front Neurosci"},{"key":"2028_CR230","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1093\/brain\/awt172","volume":"136","author":"BW Fling","year":"2013","unstructured":"Fling BW, Cohen RG, Mancini M, Nutt JG, Fair DA, Horak FB (2013) Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait. Brain 136:2405\u20132418","journal-title":"Brain"},{"key":"2028_CR231","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11910-018-0835-5","volume":"18","author":"C Foguem","year":"2018","unstructured":"Foguem C, Manckoundia P (2018) Lewy body disease: clinical and pathological \u201coverlap syndrome\u201d between synucleinopathies (Parkinson disease) and tauopathies (Alzheimer disease). Curr Neurol Neurosci Rep 18:24","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2028_CR232","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/HTR.0000000000000027","volume":"29","author":"R Formisano","year":"2014","unstructured":"Formisano R, Zasler ND (2014) Posttraumatic parkinsonism. J Head Trauma Rehabil 29:387\u2013390","journal-title":"J Head Trauma Rehabil"},{"key":"2028_CR233","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","volume":"55","author":"LS Forno","year":"1996","unstructured":"Forno LS (1996) Neuropathology of Parkinson\u2019s disease. J Neuropathol Exp Neurol 55:259\u2013272","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR234","first-page":"217","volume":"69","author":"LS Forno","year":"1996","unstructured":"Forno LS, DeLanney LE, Irwin I, Langston JW (1996) Electron microscopy of Lewy bodies in the amygdala-parahippocampal region. Comparison with inclusion bodies in the MPTP-treated squirrel monkey. Adv Neurol 69:217\u2013228","journal-title":"Adv Neurol"},{"key":"2028_CR235","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/brain\/awx328","volume":"141","author":"SL Forrest","year":"2018","unstructured":"Forrest SL, Kril JJ, Stevens CH, Kwok JB, Hallupp M, Kim WS, Huang Y, McGinley CV, Werka H, Kiernan MC, Gotz J, Spillantini MG, Hodges JR, Ittner LM, Halliday GM (2018) Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies. Brain 141:521\u2013534","journal-title":"Brain"},{"key":"2028_CR236","doi-asserted-by":"publisher","first-page":"e2472","DOI":"10.1212\/WNL.0000000000007530","volume":"92","author":"SL Forrest","year":"2019","unstructured":"Forrest SL, Crockford DR, Sizemova A, McCann H, Shepherd CE, McGeachie AB, Affleck AJ, Carew-Jones F, Bartley L, Kwok JB, Kim WS, Jary E, Tan RH, McGinley CV, Piguet O, Hodges JR, Kril JJ, Halliday GM (2019a) Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration. Neurology 92:e2472\u2013e2482","journal-title":"Neurology"},{"key":"2028_CR237","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.dadm.2018.12.001","volume":"11","author":"SL Forrest","year":"2019","unstructured":"Forrest SL, Halliday GM, McCann H, McGeachie AB, McGinley CV, Hodges JR, Piguet O, Kwok JB, Spillantini MG, Kril JJ (2019b) Heritability in frontotemporal tauopathies. Alzheimers Dement (Amst) 11:115\u2013124","journal-title":"Alzheimers Dement (Amst)"},{"key":"2028_CR238","doi-asserted-by":"publisher","first-page":"6559","DOI":"10.1038\/s41598-019-42902-7","volume":"9","author":"SC Foti","year":"2019","unstructured":"Foti SC, Hargreaves I, Carrington S, Kiely AP, Houlden H, Holton JL (2019) Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson\u2019s disease. Sci Rep 9:6559","journal-title":"Sci Rep"},{"issue":"Suppl 17","key":"2028_CR239","doi-asserted-by":"publisher","first-page":"S351","DOI":"10.1002\/mds.21683","volume":"22","author":"PT Francis","year":"2007","unstructured":"Francis PT, Perry EK (2007) Cholinergic and other neurotransmitter mechanisms in Parkinson\u2019s disease, Parkinson\u2019s disease dementia, and dementia with Lewy bodies. Mov Disord 22(Suppl 17):S351\u2013S357","journal-title":"Mov Disord"},{"key":"2028_CR240","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/mds.25049","volume":"27","author":"E Franquet","year":"2012","unstructured":"Franquet E, Salvado-Figueres M, Lorenzo-Bosquet C, Cuberas-Borros G, Rovira A, Castell-Conesa J, Hernandez-Vara J (2012) Nigrostriatal pathway dysfunction in a methanol-induced delayed dystonia-parkinsonism. Mov Disord 27:1220\u20131221","journal-title":"Mov Disord"},{"key":"2028_CR241","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1111\/j.1460-9568.2009.06990.x","volume":"30","author":"PS Freestone","year":"2009","unstructured":"Freestone PS, Chung KK, Guatteo E, Mercuri NB, Nicholson LF, Lipski J (2009) Acute action of rotenone on nigral dopaminergic neurons\u2014involvement of reactive oxygen species and disruption of Ca homeostasis. Eur J Neurosci 30:1849\u20131859","journal-title":"Eur J Neurosci"},{"key":"2028_CR242","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fnagi.2018.00099","volume":"10","author":"IT French","year":"2018","unstructured":"French IT, Muthusamy KA (2018) A review of the pedunculopontine nucleus in Parkinson\u2019s disease. Front Aging Neurosci 10:99","journal-title":"Front Aging Neurosci"},{"key":"2028_CR243","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23747","volume":"72","author":"EC Freundt","year":"2012","unstructured":"Freundt EC, Maynard N, Clancy EK, Roy S, Bousset L, Sourigues Y, Covert M, Melki R, Kirkegaard K, Brahic M (2012) Neuron-to-neuron transmission of alpha-synuclein fibrils through axonal transport. Ann Neurol 72:517\u2013524","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"2028_CR244","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/j.parkreldis.2017.07.013","volume":"46","author":"JH Friedman","year":"2018","unstructured":"Friedman JH (2018) Dementia with Lewy bodies and Parkinson\u2019s disease dementia become the same disease. Parkinsonism Relat Disord 46(Suppl 1):S6\u2013S9","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR245","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neurobiolaging.2009.05.019","volume":"32","author":"R Frigerio","year":"2011","unstructured":"Frigerio R, Fujishiro H, Ahn TB, Josephs KA, Maraganore DM, Delledonne A, Parisi JE, Klos KJ, Boeve BF, Dickson DW, Ahlskog JE (2011) Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies? Neurobiol Aging 32:857\u2013863","journal-title":"Neurobiol Aging"},{"key":"2028_CR246","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.parkreldis.2008.04.038","volume":"15","author":"PG Frisina","year":"2009","unstructured":"Frisina PG, Haroutunian V, Libow LS (2009) The neuropathological basis for depression in Parkinson\u2019s disease. Parkinsonism Relat Disord 15:144\u2013148","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 1","key":"2028_CR247","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/S1353-8020(13)70010-5","volume":"20","author":"S Fujioka","year":"2014","unstructured":"Fujioka S, Ogaki K, Tacik PM, Uitti RJ, Ross OA, Wszolek ZK (2014a) Update on novel familial forms of Parkinson\u2019s disease and multiple system atrophy. Parkinsonism Relat Disord 20(Suppl 1):S29\u2013S34","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR248","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000354975","volume":"13","author":"S Fujioka","year":"2014","unstructured":"Fujioka S, Van Gerpen JA, Uitti RJ, Dickson DW, Wszolek ZK (2014b) Familial progressive supranuclear palsy: a literature review. Neurodegener Dis 13:180\u2013182","journal-title":"Neurodegener Dis"},{"key":"2028_CR249","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/NEN.0b013e31817d7a1d","volume":"67","author":"H Fujishiro","year":"2008","unstructured":"Fujishiro H, Ferman TJ, Boeve BF, Smith GE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Knopman DS, Petersen RC, Parisi JE, Dickson DW (2008a) Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol 67:649\u2013656","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR250","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00401-008-0383-1","volume":"116","author":"H Fujishiro","year":"2008","unstructured":"Fujishiro H, Tsuboi Y, Lin WL, Uchikado H, Dickson DW (2008b) Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer\u2019s disease with amygdala Lewy bodies. Acta Neuropathol 116:17\u201324","journal-title":"Acta Neuropathol"},{"key":"2028_CR251","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neulet.2010.09.036","volume":"486","author":"H Fujishiro","year":"2010","unstructured":"Fujishiro H, Iseki E, Higashi S, Kasanuki K, Murayama N, Togo T, Katsuse O, Uchikado H, Aoki N, Kosaka K, Arai H, Sato K (2010) Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia. Neurosci Lett 486:19\u201323","journal-title":"Neurosci Lett"},{"key":"2028_CR252","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neuint.2019.01.024","volume":"125","author":"F Fujiyama","year":"2019","unstructured":"Fujiyama F, Unzai T, Karube F (2019) Thalamostriatal projections and striosome-matrix compartments. Neurochem Int 125:67\u201373","journal-title":"Neurochem Int"},{"issue":"Suppl 2","key":"2028_CR253","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3233\/JAD-2011-110182","volume":"24","author":"BS Gadad","year":"2011","unstructured":"Gadad BS, Britton GB, Rao KS (2011) Targeting oligomers in neurodegenerative disorders: lessons from alpha-synuclein, tau, and amyloid-beta peptide. J Alzheimers Dis 24(Suppl 2):223\u2013232","journal-title":"J Alzheimers Dis"},{"key":"2028_CR254","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0014-4886(03)00004-9","volume":"181","author":"WP Gai","year":"2003","unstructured":"Gai WP, Pountney DL, Power JH, Li QX, Culvenor JG, McLean CA, Jensen PH, Blumbergs PC (2003) Alpha-synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy. Exp Neurol 181:68\u201378","journal-title":"Exp Neurol"},{"key":"2028_CR255","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neubiorev.2019.04.002","volume":"102","author":"CPC Galts","year":"2019","unstructured":"Galts CPC, Bettio LEB, Jewett DC, Yang CC, Brocardo PS, Rodrigues ALS, Thacker JS, Gil-Mohapel J (2019) Depression in neurodegenerative diseases: common mechanisms and current treatment options. Neurosci Biobehav Rev 102:56\u201384","journal-title":"Neurosci Biobehav Rev"},{"key":"2028_CR906","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3233\/JAD-181298","volume":"69","author":"M Gallucci","year":"2019","unstructured":"Gallucci M, Dell\u2019Acqua C, Boccaletto F, Fenoglio C, Galimberti D, Di Battista ME (2019) Overlap between frontotemporal dementia and dementia with Lewy bodies: a Treviso Dementia (TREDEM) registry case report. J Alzheimers Dis 69:839\u2013847","journal-title":"J Alzheimers Dis"},{"key":"2028_CR256","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/cns.12634","volume":"23","author":"LL Gao","year":"2017","unstructured":"Gao LL, Zhang JR, Chan P, Wu T (2017) Levodopa effect on basal ganglia motor circuit in Parkinson\u2019s disease. CNS Neurosci Ther 23:76\u201386","journal-title":"CNS Neurosci Ther"},{"key":"2028_CR257","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/ana.21288","volume":"63","author":"DM Gash","year":"2008","unstructured":"Gash DM, Rutland K, Hudson NL, Sullivan PG, Bing G, Cass WA, Pandya JD, Liu M, Choi DY, Hunter RL, Gerhardt GA, Smith CD, Slevin JT, Prince TS (2008) Trichloroethylene: parkinsonism and complex 1 mitochondrial neurotoxicity. Ann Neurol 63:184\u2013192","journal-title":"Ann Neurol"},{"key":"2028_CR258","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/mds.23637","volume":"26","author":"T Gasser","year":"2011","unstructured":"Gasser T, Hardy J, Mizuno Y (2011) Milestones in PD genetics. Mov Disord 26:1042\u20131048","journal-title":"Mov Disord"},{"key":"2028_CR259","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1111\/febs.14393","volume":"285","author":"ME Gegg","year":"2018","unstructured":"Gegg ME, Schapira AHV (2018) The role of glucocerebrosidase in Parkinson disease pathogenesis. FEBS J 285:3591\u20133603","journal-title":"FEBS J"},{"key":"2028_CR260","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00702-019-01970-9","volume":"126","author":"FF Geibl","year":"2019","unstructured":"Geibl FF, Henrich MT, Oertel WH (2019) Mesencephalic and extramesencephalic dopaminergic systems in Parkinson\u2019s disease. J Neural Transm (Vienna) 126:377\u2013396","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR261","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.nbd.2016.06.004","volume":"94","author":"JT Geiger","year":"2016","unstructured":"Geiger JT, Ding J, Crain B, Pletnikova O, Letson C, Dawson TM, Rosenthal LS, Pantelyat A, Gibbs JR, Albert MS, Hernandez DG, Hillis AE, Stone DJ, Singleton AB, Hardy JA, Troncoso JC, Scholz SW (2016) Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies. Neurobiol Dis 94:55\u201362","journal-title":"Neurobiol Dis"},{"key":"2028_CR262","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/brain\/awy342","volume":"142","author":"E Gelpi","year":"2019","unstructured":"Gelpi E, Colom-Cadena M (2019) Oligomers: a hot topic for neurodegeneration and a note of caution for experimental models. Brain 142:228\u2013230","journal-title":"Brain"},{"key":"2028_CR263","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/mds.25776","volume":"29","author":"E Gelpi","year":"2014","unstructured":"Gelpi E, Navarro-Otano J, Tolosa E, Gaig C, Compta Y, Rey MJ, Marti MJ, Hernandez I, Valldeoriola F, Rene R, Ribalta T (2014) Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord 29:1010\u20131018","journal-title":"Mov Disord"},{"key":"2028_CR264","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.gene.2019.02.026","volume":"697","author":"G George","year":"2019","unstructured":"George G, Valiya Parambath S, Lokappa SB, Varkey J (2019) Construction of Parkinson\u2019s disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes. Gene 697:67\u201377","journal-title":"Gene"},{"key":"2028_CR265","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13024-018-0245-9","volume":"13","author":"JE Gerson","year":"2018","unstructured":"Gerson JE, Farmer KM, Henson N, Castillo-Carranza DL, Carretero Murillo M, Sengupta U, Barrett A, Kayed R (2018) Tau oligomers mediate alpha-synuclein toxicity and can be targeted by immunotherapy. Mol Neurodegener 13:13","journal-title":"Mol Neurodegener"},{"key":"2028_CR266","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.1002.1011","author":"H Geut","year":"2019","unstructured":"Geut H, Vergouw LJM, Galis Y, Ingrassia A, de Jong FJ, Quadri M, Bonifati V, Lemstra AW, Rozemuller AJM, van de Berg WDJ (2019) Neuropathological and genetic characteristics of a post-mortem series of cases with dementia with Lewy bodies clinically suspected of Creutzfeldt-Jakob\u2019s disease. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.1002.1011","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR267","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s13760-018-0937-5","volume":"118","author":"F Ghazi Sherbaf","year":"2018","unstructured":"Ghazi Sherbaf F, Same K, Aarabi MH (2018) High angular resolution diffusion imaging correlates of depression in Parkinson\u2019s disease: a connectometry study. Acta Neurol Belg 118:573\u2013579","journal-title":"Acta Neurol Belg"},{"key":"2028_CR269","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/9781444341256.ch14","volume-title":"Neurodegeneration: the molecular pathology of dementia and movement disorders","author":"B Ghetti","year":"2011","unstructured":"Ghetti B, Wszolek ZK, Boeve BF, Spina S, Goedert M (2011) Frontotemporal dementia and parkinsonism linked to chromosome 17. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 110\u2013134","edition":"2"},{"key":"2028_CR270","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fneur.2018.00295","volume":"9","author":"V Ghiglieri","year":"2018","unstructured":"Ghiglieri V, Calabrese V, Calabresi P (2018) Alpha-synuclein: from early synaptic dysfunction to neurodegeneration. Front Neurol 9:295","journal-title":"Front Neurol"},{"key":"2028_CR271","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1001\/jamaneurol.2018.2505","volume":"76","author":"GS Gibbons","year":"2019","unstructured":"Gibbons GS, Lee VMY, Trojanowski JQ (2019) Mechanisms of cell-to-cell transmission of pathological tau: a review. JAMA Neurol 76:101\u2013108","journal-title":"JAMA Neurol"},{"key":"2028_CR272","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fneur.2018.00455","volume":"9","author":"N Giguere","year":"2018","unstructured":"Giguere N, Burke Nanni S, Trudeau LE (2018) On cell loss and selective vulnerability of neuronal populations in Parkinson\u2019s disease. Front Neurol 9:455","journal-title":"Front Neurol"},{"key":"2028_CR273","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jocn.2018.10.024","volume":"58","author":"MJ Gil","year":"2018","unstructured":"Gil MJ, Manzano MS, Cuadrado ML, Fernandez C, Gomez E, Matesanz C, Calero M, Rabano A (2018a) Frontotemporal lobar degeneration: Study of a clinicopathological cohort. J Clin Neurosci 58:172\u2013180","journal-title":"J Clin Neurosci"},{"key":"2028_CR274","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3233\/JAD-171115","volume":"63","author":"MJ Gil","year":"2018","unstructured":"Gil MJ, Manzano MS, Cuadrado ML, Fernandez C, Gomez E, Matesanz C, Calero M, Rabano A (2018b) Argyrophilic grain pathology in frontotemporal lobar degeneration: demographic, clinical, neuropathological, and genetic features. J Alzheimers Dis 63:1109\u20131117","journal-title":"J Alzheimers Dis"},{"key":"2028_CR275","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670\u2013676","journal-title":"Neurology"},{"key":"2028_CR276","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/15563658508990635","volume":"23","author":"MD Ginsberg","year":"1985","unstructured":"Ginsberg MD (1985) Carbon monoxide intoxication: clinical features, neuropathology and mechanisms of injury. J Toxicol Clin Toxicol 23:281\u2013288","journal-title":"J Toxicol Clin Toxicol"},{"key":"2028_CR277","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1002\/jcp.27330","volume":"234","author":"R Godini","year":"2019","unstructured":"Godini R, Fallahi H, Ebrahimie E (2019) A comparative system-level analysis of the neurodegenerative diseases. J Cell Physiol 234:5215\u20135229","journal-title":"J Cell Physiol"},{"key":"2028_CR278","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev-neuro-072116-031153","volume":"40","author":"M Goedert","year":"2017","unstructured":"Goedert M, Eisenberg DS, Crowther RA (2017a) Propagation of tau aggregates and neurodegeneration. Annu Rev Neurosci 40:189\u2013210","journal-title":"Annu Rev Neurosci"},{"key":"2028_CR279","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.3233\/JPD-179005","volume":"7","author":"M Goedert","year":"2017","unstructured":"Goedert M, Jakes R, Spillantini MG (2017b) The synucleinopathies: twenty years on. J Parkinsons Dis 7:S51\u2013S69","journal-title":"J Parkinsons Dis"},{"key":"2028_CR280","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/brain\/aww230","volume":"140","author":"M Goedert","year":"2017","unstructured":"Goedert M, Masuda-Suzukake M, Falcon B (2017c) Like prions: the propagation of aggregated tau and alpha-synuclein in neurodegeneration. Brain 140:266\u2013278","journal-title":"Brain"},{"key":"2028_CR281","doi-asserted-by":"publisher","DOI":"10.1101\/sqb.2018.1183.037580","author":"M Goedert","year":"2019","unstructured":"Goedert M, Falcon B, Zhang W, Ghetti B, Scheres SHW (2019) Distinct conformers of assembled tau in Alzheimer\u2019s and Pick\u2019s diseases. Cold Spring Harb Symp Quant Biol. https:\/\/doi.org\/10.1101\/sqb.2018.1183.037580","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"Suppl 2","key":"2028_CR282","first-page":"S81","volume":"64","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Emre M, Dubois B (2008) Parkinson\u2019s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol 64(Suppl 2):S81\u2013S92","journal-title":"Ann Neurol"},{"key":"2028_CR283","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-12019-11515-12034","author":"G Gomez","year":"2019","unstructured":"Gomez G, Escande MV, Suarez LM, Rela L, Belforte JE, Moratalla R, Murer MG, Gershanik OS, Taravini IRE (2019) Changes in dendritic spine density and inhibitory perisomatic connectivity onto medium spiny neurons in l-dopa-induced dyskinesia. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-12019-11515-12034","journal-title":"Mol Neurobiol"},{"key":"2028_CR284","first-page":"324521","volume":"2012","author":"P Gomez-Suaga","year":"2012","unstructured":"Gomez-Suaga P, Fdez E, Blanca Ramirez M, Hilfiker S (2012) A link between autophagy and the pathophysiology of LRRK2 in Parkinson\u2019s disease. Parkinsons Dis 2012:324521","journal-title":"Parkinsons Dis"},{"key":"2028_CR285","first-page":"435","volume":"22","author":"SN Gomperts","year":"2016","unstructured":"Gomperts SN (2016) Lewy body dementias: dementia with Lewy bodies and Parkinson disease dementia. Continuum (Minneap Minn) 22:435\u2013463","journal-title":"Continuum (Minneap Minn)"},{"key":"2028_CR286","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14721","author":"N Gonzalez","year":"2019","unstructured":"Gonzalez N, Arcos-Lopez T, Konig A, Quintanar L, Menacho Marquez M, Outeiro TF, Fernandez CO (2019) Effects of alpha-synuclein posttranslational modifications on metal binding. J Neurochem. https:\/\/doi.org\/10.1111\/jnc.14721","journal-title":"J Neurochem"},{"key":"2028_CR287","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-pathmechdis-012418-012936","volume":"14","author":"J Gotz","year":"2019","unstructured":"Gotz J, Halliday G, Nisbet RM (2019) Molecular pathogenesis of the tauopathies. Annu Rev Pathol 14:239\u2013261","journal-title":"Annu Rev Pathol"},{"key":"2028_CR288","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/CBO9780511977749.024","volume-title":"Uncommon causes of movement disorders","author":"D Grabli","year":"2011","unstructured":"Grabli D, Aur\u00e9 K, Vidailhet M, Roze E (2011) Movement disorders in neurometabolic diseases. In: G\u00e1lvez-Jim\u00e9nez N, Tuite P (eds) Uncommon causes of movement disorders. Cambridge University Press, Cambridge, pp 245\u2013257"},{"key":"2028_CR289","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/mds.22658","volume":"24","author":"R Grant","year":"2009","unstructured":"Grant R, Graus F (2009) Paraneoplastic movement disorders. Mov Disord 24:1715\u20131724","journal-title":"Mov Disord"},{"key":"2028_CR290","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neurobiolaging.2008.03.015","volume":"31","author":"S Greffard","year":"2010","unstructured":"Greffard S, Verny M, Bonnet AM, Seilhean D, Hauw JJ, Duyckaerts C (2010) A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death. Neurobiol Aging 31:99\u2013103","journal-title":"Neurobiol Aging"},{"key":"2028_CR291","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40478-017-0439-3","volume":"5","author":"J Grigoletto","year":"2017","unstructured":"Grigoletto J, Pukass K, Gamliel A, Davidi D, Katz-Brull R, Richter-Landsberg C, Sharon R (2017) Higher levels of myelin phospholipids in brains of neuronal alpha-synuclein transgenic mice precede myelin loss. Acta Neuropathol Commun 5:37","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR292","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27666","author":"MJ Grimm","year":"2019","unstructured":"Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Colosimo C, van Eimeren T, Kassubek J, Levin J, Meissner WG, Nilsson C, Oertel WH, Piot I, Poewe W, Wenning GK, Boxer A, Golbe LI, Josephs KA, Litvan I, Morris HR, Whitwell JL, Compta Y, Corvol JC, Lang AE, Rowe JB, Hoglinger GU (2019) How to apply the Movement Disorder Society criteria for diagnosis of progressive supranuclear palsy. Mov Disord. https:\/\/doi.org\/10.1002\/mds.27666","journal-title":"Mov Disord"},{"key":"2028_CR293","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00441-017-2775-9","volume":"373","author":"V Grozdanov","year":"2018","unstructured":"Grozdanov V, Danzer KM (2018) Release and uptake of pathologic alpha-synuclein. Cell Tissue Res 373:175\u2013182","journal-title":"Cell Tissue Res"},{"key":"2028_CR294","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12640-017-9843-5","volume":"33","author":"E Grunblatt","year":"2018","unstructured":"Grunblatt E, Ruder J, Monoranu CM, Riederer P, Youdim MB, Mandel SA (2018) Differential alterations in metabolism and proteolysis-related proteins in human Parkinson\u2019s disease substantia nigra. Neurotox Res 33:560\u2013568","journal-title":"Neurotox Res"},{"key":"2028_CR295","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neurobiolaging.2018.11.013","volume":"75","author":"X Guan","year":"2019","unstructured":"Guan X, Zhang Y, Wei H, Guo T, Zeng Q, Zhou C, Wang J, Gao T, Xuan M, Gu Q, Xu X, Huang P, Pu J, Zhang B, Liu C, Zhang M (2019) Iron-related nigral degeneration influences functional topology mediated by striatal dysfunction in Parkinson\u2019s disease. Neurobiol Aging 75:83\u201397","journal-title":"Neurobiol Aging"},{"key":"2028_CR296","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","volume":"17","author":"R Guerreiro","year":"2018","unstructured":"Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD, Shepherd CE, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Bras J (2018) Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17:64\u201374","journal-title":"Lancet Neurol"},{"key":"2028_CR297","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12035-012-8328-z","volume":"47","author":"E Guerrero","year":"2013","unstructured":"Guerrero E, Vasudevaraju P, Hegde ML, Britton GB, Rao KS (2013) Recent advances in alpha-synuclein functions, advanced glycation, and toxicity: implications for Parkinson\u2019s disease. Mol Neurobiol 47:525\u2013536","journal-title":"Mol Neurobiol"},{"key":"2028_CR298","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuint.2017.01.004","volume":"104","author":"SJ Guiney","year":"2017","unstructured":"Guiney SJ, Adlard PA, Bush AI, Finkelstein DI, Ayton S (2017) Ferroptosis and cell death mechanisms in Parkinson\u2019s disease. Neurochem Int 104:34\u201348","journal-title":"Neurochem Int"},{"key":"2028_CR299","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.nbd.2018.09.015","volume":"121","author":"AL Gundner","year":"2019","unstructured":"Gundner AL, Duran-Pacheco G, Zimmermann S, Ruf I, Moors T, Baumann K, Jagasia R, van de Berg WDJ, Kremer T (2019) Path mediation analysis reveals GBA impacts Lewy body disease status by increasing alpha-synuclein levels. Neurobiol Dis 121:205\u2013213","journal-title":"Neurobiol Dis"},{"key":"2028_CR300","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.3457","volume":"20","author":"JL Guo","year":"2014","unstructured":"Guo JL, Lee VM (2014) Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med 20:130\u2013138","journal-title":"Nat Med"},{"key":"2028_CR301","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s12311-019-01019-3","volume":"18","author":"C Habas","year":"2019","unstructured":"Habas C, Manto M, Cabaraux P (2019) The cerebellar thalamus. Cerebellum 18:635\u2013648","journal-title":"Cerebellum"},{"key":"2028_CR302","doi-asserted-by":"crossref","first-page":"7","DOI":"10.31887\/DCNS.2016.18.1\/shaber","volume":"18","author":"SN Haber","year":"2016","unstructured":"Haber SN (2016) Corticostriatal circuitry. Dialogues Clin Neurosci 18:7\u201321","journal-title":"Dialogues Clin Neurosci"},{"key":"2028_CR303","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.irn.2018.09.009","volume":"144","author":"JM Hall","year":"2019","unstructured":"Hall JM, Lewis SJG (2019) Neural correlates of cognitive impairment in Parkinson\u2019s disease: a review of structural MRI findings. Int Rev Neurobiol 144:1\u201328","journal-title":"Int Rev Neurobiol"},{"key":"2028_CR304","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.parkreldis.2014.02.028","volume":"20","author":"JM Hall","year":"2014","unstructured":"Hall JM, Shine JM, Walton CC, Gilat M, Kamsma YP, Naismith SL, Lewis SJ (2014) Early phenotypic differences between Parkinson\u2019s disease patients with and without freezing of gait. Parkinsonism Relat Disord 20:604\u2013607","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR305","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1749-6632.2009.05118.x","volume":"1184","author":"GM Halliday","year":"2010","unstructured":"Halliday GM, McCann H (2010) The progression of pathology in Parkinson\u2019s disease. Ann N Y Acad Sci 1184:188\u2013195","journal-title":"Ann N Y Acad Sci"},{"key":"2028_CR306","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","volume":"115","author":"G Halliday","year":"2008","unstructured":"Halliday G, Hely M, Reid W, Morris J (2008) The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease. Acta Neuropathol 115:409\u2013415","journal-title":"Acta Neuropathol"},{"key":"2028_CR307","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/mds.22481","volume":"24","author":"G Halliday","year":"2009","unstructured":"Halliday G, Herrero MT, Murphy K, McCann H, Ros-Bernal F, Barcia C, Mori H, Blesa FJ, Obeso JA (2009) No Lewy pathology in monkeys with over 10\u00a0years of severe MPTP parkinsonism. Mov Disord 24:1519\u20131523","journal-title":"Mov Disord"},{"key":"2028_CR308","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00702-011-0641-6","volume":"118","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Song YJ, Harding AJ (2011) Striatal beta-amyloid in dementia with Lewy bodies but not Parkinson\u2019s disease. J Neural Transm 118:713\u2013719","journal-title":"J Neural Transm"},{"key":"2028_CR309","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1586\/ern.12.47","volume":"12","author":"G Halliday","year":"2012","unstructured":"Halliday G, McCann H, Shepherd C (2012) Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson\u2019s disease? Expert Rev Neurother 12:673\u2013686","journal-title":"Expert Rev Neurother"},{"key":"2028_CR310","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/mds.25857","volume":"29","author":"GM Halliday","year":"2014","unstructured":"Halliday GM, Leverenz JB, Schneider JS, Adler CH (2014) The neurobiological basis of cognitive impairment in Parkinson\u2019s disease. Mov Disord 29:634\u2013650","journal-title":"Mov Disord"},{"key":"2028_CR311","doi-asserted-by":"publisher","first-page":"428","DOI":"10.4172\/2161-0460.1000428","volume":"8","author":"M Hamed","year":"2018","unstructured":"Hamed M, Schraml F, Wilson J, Galvin J, Sabbagh MN (2018) Occipital and cingulate hypometabolism are significantly under-reported on 18-fluorodeoxyglucose positron emission tomography scans of patients with Lewy body dementia. J Alzheimers Dis Parkinsonism 8:428","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"2028_CR312","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1136\/jnnp.64.5.653","volume":"64","author":"LA Hansen","year":"1998","unstructured":"Hansen LA, Daniel SE, Wilcock GK, Love S (1998) Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer\u2019s disease and dementia. J Neurol Neurosurg Psychiatry 64:653\u2013656","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2028_CR313","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/nan.12554","volume":"11","author":"D Hansen","year":"2019","unstructured":"Hansen D, Ling H, Lashley T, Holton JL, Warner TT (2019) Clinical, neuropathological and genetic features of Lewy body dementias. Neuropathol Appl Neurobiol 11:78. https:\/\/doi.org\/10.1111\/nan.12554","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR314","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00415-018-8923-7","volume":"265","author":"K Hara","year":"2018","unstructured":"Hara K, Watanabe H, Bagarinao E, Kawabata K, Yoneyama N, Ohdake R, Imai K, Masuda M, Yokoi T, Ogura A, Tsuboi T, Ito M, Atsuta N, Niwa H, Taoka T, Maesawa S, Naganawa S, Katsuno M, Sobue G (2018) Corpus callosal involvement is correlated with cognitive impairment in multiple system atrophy. J Neurol 265:2079\u20132087","journal-title":"J Neurol"},{"key":"2028_CR315","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1093\/brain\/awf251","volume":"125","author":"AJ Harding","year":"2002","unstructured":"Harding AJ, Stimson E, Henderson JM, Halliday GM (2002) Clinical correlates of selective pathology in the amygdala of patients with Parkinson\u2019s disease. Brain 125:2431\u20132445","journal-title":"Brain"},{"key":"2028_CR316","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ana.21425","volume":"64","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle F, Morita M, Nakano I, Oda T, Tsuchiya K, Akiyama H (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64:60\u201370","journal-title":"Ann Neurol"},{"key":"2028_CR317","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3389\/fnins.2017.00751","volume":"11","author":"Y Hata","year":"2018","unstructured":"Hata Y, Ma N, Yoneda M, Morimoto S, Okano H, Murayama S, Kawanishi S, Kuzuhara S, Kokubo Y (2018) Nitrative stress and tau accumulation in amyotrophic lateral sclerosis\/parkinsonism-dementia complex (ALS\/PDC) in the Kii Peninsula, Japan. Front Neurosci 11:751","journal-title":"Front Neurosci"},{"key":"2028_CR318","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00702-013-1039-4","volume":"120","author":"H Hayakawa","year":"2013","unstructured":"Hayakawa H, Nagai M, Kawanami A, Nakata Y, Nihira T, Ogino M, Takada M, Saido T, Takano J, Saegusa M, Mikami T, Hamada J, Nishiyama K, Mochizuki H, Mizuno Y (2013) Loss of DARPP-32 and calbindin in multiple system atrophy. J Neural Transm 120:1689\u20131698","journal-title":"J Neural Transm"},{"key":"2028_CR319","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1212\/WNL.0000000000001078","volume":"83","author":"MG Heckman","year":"2014","unstructured":"Heckman MG, Schottlaender L, Soto-Ortolaza AI, Diehl NN, Rayaprolu S, Ogaki K, Fujioka S, Murray ME, Cheshire WP, Uitti RJ, Wszolek ZK, Farrer MJ, Sailer A, Singleton AB, Chinnery PF, Keogh MJ, Gentleman SM, Holton JL, Aoife K, Mann DM, Al-Sarraj S, Troakes C, Dickson DW, Houlden H, Ross OA (2014) LRRK2 exonic variants and risk of multiple system atrophy. Neurology 83:2256\u20132261","journal-title":"Neurology"},{"key":"2028_CR320","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.0250","author":"MG Heckman","year":"2019","unstructured":"Heckman MG, Brennan RR, Labbe C, Soto AI, Koga S, DeTure MA, Murray ME, Petersen RC, Boeve BF, van Gerpen JA, Uitti RJ, Wszolek ZK, Rademakers R, Dickson DW, Ross OA (2019) Association of MAPT subhaplotypes with risk of progressive supranuclear palsy and severity of tau pathology. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2019.0250","journal-title":"JAMA Neurol"},{"key":"2028_CR321","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/ejn.13196","volume":"43","author":"DJ Hegeman","year":"2016","unstructured":"Hegeman DJ, Hong ES, Hernandez VM, Chan CS (2016) The external globus pallidus: progress and perspectives. Eur J Neurosci 43:1239\u20131265","journal-title":"Eur J Neurosci"},{"key":"2028_CR322","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13195-014-0091-0","volume":"7","author":"C Heitz","year":"2015","unstructured":"Heitz C, Noblet V, Cretin B, Philippi N, Kremer L, Stackfleth M, Hubele F, Armspach JP, Namer I, Blanc F (2015) Neural correlates of visual hallucinations in dementia with Lewy bodies. Alzheimers Res Ther 7:6","journal-title":"Alzheimers Res Ther"},{"key":"2028_CR323","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/mds.27224","volume":"33","author":"RC Helmich","year":"2018","unstructured":"Helmich RC (2018) The cerebral basis of Parkinsonian tremor: a network perspective. Mov Disord 33:219\u2013231","journal-title":"Mov Disord"},{"key":"2028_CR917","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ana.22361","volume":"69","author":"RC Helmich","year":"2011","unstructured":"Helmich RC, Janssen MJ, Oyen WJ, Bloem BR, Toni I (2011) Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor. Ann Neurol 69:269\u2013281","journal-title":"Ann Neurol"},{"key":"2028_CR324","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord 23:837\u2013844","journal-title":"Mov Disord"},{"key":"2028_CR907","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134316","author":"MX Henderson","year":"2019","unstructured":"Henderson MX, Trojanowski JQ, Lee VM (2019) \u03b1-Synuclein pathology in Parkinson's disease and related alpha-synucleinopathies. Neurosci Lett. https:\/\/doi.org\/10.1016\/j.neulet.2019.134316","journal-title":"Neurosci Lett"},{"key":"2028_CR325","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/jnen\/nlw070","volume":"75","author":"DH Hepp","year":"2016","unstructured":"Hepp DH, Vergoossen DL, Huisman E, Lemstra AW, Berendse HW, Rozemuller AJ, Foncke EM, van de Berg WD (2016) Distribution and load of amyloid-beta pathology in Parkinson disease and dementia with Lewy bodies. J Neuropathol Exp Neurol 75:936\u2013945","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR326","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/mds.27562","volume":"34","author":"A Heras-Garvin","year":"2019","unstructured":"Heras-Garvin A, Weckbecker D, Ryazanov S, Leonov A, Griesinger C, Giese A, Wenning GK, Stefanova N (2019) Anle138b modulates alpha-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy. Mov Disord 34:255\u2013263","journal-title":"Mov Disord"},{"key":"2028_CR327","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neulet.2005.07.044","volume":"389","author":"D Hernandez","year":"2005","unstructured":"Hernandez D, Paisan Ruiz C, Crawley A, Malkani R, Werner J, Gwinn-Hardy K, Dickson D, Wavrant Devrieze F, Hardy J, Singleton A (2005) The dardarin G 2019 S mutation is a common cause of Parkinson\u2019s disease but not other neurodegenerative diseases. Neurosci Lett 389:137\u2013139","journal-title":"Neurosci Lett"},{"key":"2028_CR328","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1093\/brain\/awv096","volume":"138","author":"DM Herz","year":"2015","unstructured":"Herz DM, Haagensen BN, Christensen MS, Madsen KH, Rowe JB, Lokkegaard A, Siebner HR (2015) Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans. Brain 138:1658\u20131666","journal-title":"Brain"},{"key":"2028_CR329","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00429-017-1584-y","volume":"223","author":"A Hintzen","year":"2018","unstructured":"Hintzen A, Pelzer EA, Tittgemeyer M (2018) Thalamic interactions of cerebellum and basal ganglia. Brain Struct Funct 223:569\u2013587","journal-title":"Brain Struct Funct"},{"key":"2028_CR330","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/mds.25032","volume":"28","author":"EC Hirsch","year":"2013","unstructured":"Hirsch EC, Jenner P, Przedborski S (2013) Pathogenesis of Parkinson\u2019s disease. Mov Disord 28:24\u201330","journal-title":"Mov Disord"},{"key":"2028_CR331","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/bpa.12678","volume":"29","author":"A Hoffmann","year":"2019","unstructured":"Hoffmann A, Ettle B, Battis K, Reiprich S, Schlachetzki JCM, Masliah E, Wegner M, Kuhlmann T, Riemenschneider MJ, Winkler J (2019) Oligodendroglial a-synucleinopathy-driven neuroinflammation in multiple system atrophy. Brain Pathol 29:380\u2013396","journal-title":"Brain Pathol"},{"key":"2028_CR332","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mdc3.12582","volume":"5","author":"GU Hoglinger","year":"2018","unstructured":"Hoglinger GU (2018) Is it useful to classify progressive supranuclear palsy and corticobasal degeneration as different disorders? No. Mov Disord Clin Pract 5:141\u2013144","journal-title":"Mov Disord Clin Pract"},{"key":"2028_CR333","doi-asserted-by":"crossref","unstructured":"Hoglinger GU, Oertel WH, Hirsch EC (2006) The rotenone model of parkinsonism\u2014the 5\u00a0years inspection. J Neural Transm Suppl (70):269\u2013272","DOI":"10.1007\/978-3-211-45295-0_41"},{"key":"2028_CR334","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ng.859","volume":"43","author":"GU Hoglinger","year":"2011","unstructured":"Hoglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, Hurtig HI, Gross RG, Maetzler W, Goldwurm S, Tolosa E, Borroni B, Pastor P, Cantwell LB, Han MR, Dillman A, van der Brug MP, Gibbs JR, Cookson MR, Hernandez DG, Singleton AB, Farrer MJ, Yu CE, Golbe LI, Revesz T, Hardy J, Lees AJ, Devlin B, Hakonarson H, Muller U, Schellenberg GD (2011) Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 43:699\u2013705","journal-title":"Nat Genet"},{"key":"2028_CR335","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU Hoglinger","year":"2018","unstructured":"Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Muller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I (2018) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853\u2013864","journal-title":"Mov Disord"},{"key":"2028_CR336","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T, Wang ZY, Roybon L, Melki R, Li JY (2014) Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 128:805\u2013820","journal-title":"Acta Neuropathol"},{"key":"2028_CR337","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/9781444341256.ch24","volume-title":"Neurodegeneration: the molecular pathology of dementia and movement disorders","author":"JL Holton","year":"2011","unstructured":"Holton JL, Lees AL, Revesz T (2011) Multiple system atrophy. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 242\u2013252","edition":"2"},{"key":"2028_CR338","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/neup.12289","volume":"36","author":"T Homma","year":"2016","unstructured":"Homma T, Mochizuki Y, Komori T, Isozaki E (2016) Frequent globular neuronal cytoplasmic inclusions in the medial temporal region as a possible characteristic feature in multiple system atrophy with dementia. Neuropathology 36:421\u2013431","journal-title":"Neuropathology"},{"issue":"Suppl 2","key":"2028_CR339","doi-asserted-by":"publisher","first-page":"S551","DOI":"10.3233\/JAD-2010-100354","volume":"20","author":"MP Horowitz","year":"2010","unstructured":"Horowitz MP, Greenamyre JT (2010) Mitochondrial iron metabolism and its role in neurodegeneration. J Alzheimers Dis 20(Suppl 2):S551\u2013S568","journal-title":"J Alzheimers Dis"},{"key":"2028_CR340","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1750-3639.2012.00611.x","volume":"23","author":"J Horvath","year":"2013","unstructured":"Horvath J, Burkhard PR, Bouras C, Kovari E (2013a) Etiologies of parkinsonism in a century-long autopsy-based cohort. Brain Pathol 23:28\u201333","journal-title":"Brain Pathol"},{"key":"2028_CR341","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.parkreldis.2013.05.010","volume":"19","author":"J Horvath","year":"2013","unstructured":"Horvath J, Herrmann FR, Burkhard PR, Bouras C, Kovari E (2013b) Neuropathology of dementia in a large cohort of patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 19:864\u2013868 (discussion 864)","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR342","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00401-012-1013-5","volume":"124","author":"H Houlden","year":"2012","unstructured":"Houlden H, Singleton AB (2012) The genetics and neuropathology of Parkinson\u2019s disease. Acta Neuropathol 124:325\u2013338","journal-title":"Acta Neuropathol"},{"key":"2028_CR343","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1212\/WNL.56.12.1702","volume":"56","author":"H Houlden","year":"2001","unstructured":"Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, Adamson J, Lees AJ, Rossor MN, Quinn NP, Kertesz A, Khan MN, Hardy J, Lantos PL, St George-Hyslop P, Munoz DG, Mann D, Lang AE, Bergeron C, Bigio EH, Litvan I, Bhatia KP, Dickson D, Wood NW, Hutton M (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56:1702\u20131706","journal-title":"Neurology"},{"key":"2028_CR344","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00401-019-01993-2","volume":"137","author":"D Hu","year":"2019","unstructured":"Hu D, Sun X, Liao X, Zhang X, Zarabi S, Schimmer A, Hong Y, Ford C, Luo Y, Qi X (2019) Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity. Acta Neuropathol 137:939\u2013960","journal-title":"Acta Neuropathol"},{"key":"2028_CR345","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fnins.2019.00028","volume":"13","author":"M Huang","year":"2019","unstructured":"Huang M, Wang B, Li X, Fu C, Wang C, Kang X (2019) Alpha-synuclein: a multifunctional player in exocytosis, endocytosis, and vesicle recycling. Front Neurosci 13:28","journal-title":"Front Neurosci"},{"key":"2028_CR346","doi-asserted-by":"crossref","unstructured":"Hwang J, Bank AM, Mortazavi F, Oakley DH, Frosch MP, Schmahmann JD (2019) Spinal cord a-synuclein deposition associated with myoclonus in patients with MSA-C. Neurology (accepted paper)","DOI":"10.1212\/WNL.0000000000007949"},{"key":"2028_CR347","doi-asserted-by":"publisher","first-page":"E1206","DOI":"10.1073\/pnas.1524128113","volume":"113","author":"M Iljina","year":"2016","unstructured":"Iljina M, Garcia GA, Horrocks MH, Tosatto L, Choi ML, Ganzinger KA, Abramov AY, Gandhi S, Wood NW, Cremades N, Dobson CM, Knowles TP, Klenerman D (2016) Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading. Proc Natl Acad Sci USA 113:E1206\u2013E1215","journal-title":"Proc Natl Acad Sci USA"},{"key":"2028_CR348","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fneur.2018.00103","volume":"9","author":"P Imbriani","year":"2018","unstructured":"Imbriani P, Schirinzi T, Meringolo M, Mercuri NB, Pisani A (2018) Centrality of early synaptopathy in Parkinson\u2019s disease. Front Neurol 9:103","journal-title":"Front Neurol"},{"key":"2028_CR349","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3233\/JPD-181360","volume":"8","author":"R Inzelberg","year":"2018","unstructured":"Inzelberg R, Estrada-Cuzcano A, Laitman Y, De Vriendt E, Friedman E, Jordanova A (2018) Kufor\u2013Rakeb syndrome\/PARK9: one novel and one possible recurring Ashkenazi ATP13A2 mutation. J Parkinsons Dis 8:399\u2013403","journal-title":"J Parkinsons Dis"},{"key":"2028_CR350","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1136\/jnnp-2011-301068","volume":"83","author":"V Iodice","year":"2012","unstructured":"Iodice V, Lipp A, Ahlskog JE, Sandroni P, Fealey RD, Parisi JE, Matsumoto JY, Benarroch EE, Kimpinski K, Singer W, Gehrking TL, Gehrking JA, Sletten DM, Schmeichel AM, Bower JH, Gilman S, Figueroa J, Low PA (2012) Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests. J Neurol Neurosurg Psychiatry 83:453\u2013459","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2028_CR351","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0460.1000444","author":"DJ Irwin","year":"2018","unstructured":"Irwin DJ, Hurtig HI (2018) The contribution of tau, amyloid-beta and alpha-synuclein pathology to dementia in Lewy body disorders. J Alzheimers Dis Parkinsonism. https:\/\/doi.org\/10.4172\/2161-0460.1000444","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"2028_CR352","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jamaneurol.2013.1933","volume":"70","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Abrams JY, Schonberger LB, Leschek EW, Mills JL, Lee VM, Trojanowski JQ (2013a) Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol 70:462\u2013468","journal-title":"JAMA Neurol"},{"key":"2028_CR353","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ajpath.2013.04.025","volume":"183","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Cohen TJ, Grossman M, Arnold SE, McCarty-Wood E, Van Deerlin VM, Lee VM, Trojanowski JQ (2013b) Acetylated tau neuropathology in sporadic and hereditary tauopathies. Am J Pathol 183:344\u2013351","journal-title":"Am J Pathol"},{"key":"2028_CR354","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549","volume":"14","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Lee VM, Trojanowski JQ (2013c) Parkinson\u2019s disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies. Nat Rev Neurosci 14:626\u2013636","journal-title":"Nat Rev Neurosci"},{"key":"2028_CR355","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00401-014-1380-1","volume":"129","author":"DJ Irwin","year":"2015","unstructured":"Irwin DJ, Cairns NJ, Grossman M, McMillan CT, Lee EB, Van Deerlin VM, Lee VM, Trojanowski JQ (2015) Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine. Acta Neuropathol 129:469\u2013491","journal-title":"Acta Neuropathol"},{"key":"2028_CR356","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ana.24559","volume":"79","author":"DJ Irwin","year":"2016","unstructured":"Irwin DJ, Brettschneider J, McMillan CT, Cooper F, Olm C, Arnold SE, Van Deerlin VM, Seeley WW, Miller BL, Lee EB, Lee VM, Grossman M, Trojanowski JQ (2016) Deep clinical and neuropathological phenotyping of Pick disease. Ann Neurol 79:272\u2013287","journal-title":"Ann Neurol"},{"issue":"2","key":"2028_CR357","first-page":"A58","volume":"26","author":"M Ishiyama","year":"2006","unstructured":"Ishiyama M, Yagishita S, Hasegawa K, Yokoyama T (2006) Ultrastructural study (tEM and sEM) of cortical Lewy bodies (abstract). Neuropathol 26(2):A58","journal-title":"Neuropathol"},{"key":"2028_CR358","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00401-008-0378-y","volume":"115","author":"K Ito","year":"2008","unstructured":"Ito K, Arai K, Yoshiyama Y, Kashiwado K, Sakakibara Y, Hattori T (2008) Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy. Acta Neuropathol 115:623\u2013628","journal-title":"Acta Neuropathol"},{"key":"2028_CR359","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/jnen\/62.7.791","volume":"62","author":"N Itoh","year":"2003","unstructured":"Itoh N, Ishiguro K, Arai H, Kokubo Y, Sasaki R, Narita Y, Kuzuhara S (2003) Biochemical and ultrastructural study of neurofibrillary tangles in amyotrophic lateral sclerosis\/parkinsonism-dementia complex in the Kii peninsula of Japan. J Neuropathol Exp Neurol 62:791\u2013798","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR360","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.bbapap.2018.10.006","volume":"1867","author":"A Iyer","year":"2019","unstructured":"Iyer A, Claessens M (2019) Disruptive membrane interactions of alpha-synuclein aggregates. Biochim Biophys Acta Proteins Proteom 1867:468\u2013482","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"2028_CR361","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/ana.25308","volume":"84","author":"E Jabbari","year":"2018","unstructured":"Jabbari E, Woodside J, Tan MMX, Shoai M, Pittman A, Ferrari R, Mok KY, Zhang D, Reynolds RH, de Silva R, Grimm MJ, Respondek G, Muller U, Al-Sarraj S, Gentleman SM, Lees AJ, Warner TT, Hardy J, Revesz T, Hoglinger GU, Holton JL, Ryten M, Morris HR (2018) Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype. Ann Neurol 84:485\u2013496","journal-title":"Ann Neurol"},{"key":"2028_CR362","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s12035-012-8318-1","volume":"46","author":"E Janda","year":"2012","unstructured":"Janda E, Isidoro C, Carresi C, Mollace V (2012) Defective autophagy in Parkinson\u2019s disease: role of oxidative stress. Mol Neurobiol 46:639\u2013661","journal-title":"Mol Neurobiol"},{"key":"2028_CR363","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00702-003-0824-x","volume":"110","author":"KA Jellinger","year":"2003","unstructured":"Jellinger KA (2003) Prevalence of vascular lesions in dementia with Lewy bodies. A postmortem study. J Neural Transm (Vienna) 110:771\u2013778","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR364","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00702-004-0138-7","volume":"111","author":"KA Jellinger","year":"2004","unstructured":"Jellinger KA (2004) Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm 111:1219\u20131235","journal-title":"J Neural Transm"},{"key":"2028_CR365","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.parkreldis.2005.09.001","volume":"12","author":"KA Jellinger","year":"2006","unstructured":"Jellinger KA (2006) Pathological substrate of dementia in Parkinson\u2019s disease\u2013its relation to DLB and DLBD. Parkinsonism Relat Disord 12:119\u2013120","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR366","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2217\/14750708.5.2.237","volume":"5","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA (2008a) Vascular parkinsonism. Therapy 5:237\u2013255","journal-title":"Therapy"},{"key":"2028_CR367","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000121388","volume":"5","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA (2008b) Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegener Dis 5:339\u2013346","journal-title":"Neurodegener Dis"},{"key":"2028_CR368","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.bbadis.2008.07.006","volume":"1792","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA (2009a) A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim Biophys Acta 1792:730\u2013740","journal-title":"Biochim Biophys Acta"},{"key":"2028_CR369","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000197890","volume":"24","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA (2009b) Significance of brain lesions in Parkinson disease dementia and Lewy body dementia. Front Neurol Neurosci 24:114\u2013125","journal-title":"Front Neurol Neurosci"},{"key":"2028_CR370","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/9781444341256.ch19","volume-title":"Neurodegeneration: the molecular pathology of dementia and movement disorders","author":"KA Jellinger","year":"2011","unstructured":"Jellinger KA (2011) Postencephalitic Parkinsonism. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 179\u2013187","edition":"2"},{"key":"2028_CR371","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2478\/s13380-012-0013-1","volume":"3","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012a) The role of alpha-synuclein in neurodegeneration\u2014an update. Transl Neurosci 3:75\u2013122","journal-title":"Transl Neurosci"},{"key":"2028_CR372","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mds.23795","volume":"27","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012b) Neuropathology of sporadic Parkinson\u2019s disease: evaluation and changes of concepts. Mov Disord 27:8\u201330","journal-title":"Mov Disord"},{"key":"2028_CR373","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1039\/9781849737357-00175","volume-title":"Emerging drugs and targets for Parkinson\u2019s disease","author":"KA Jellinger","year":"2013","unstructured":"Jellinger KA (2013a) Synuclein and Parkinson\u2019s disease: an update. In: Martinez A, Gil C (eds) Emerging drugs and targets for Parkinson\u2019s disease. The Royal Society of Chemistry, London, pp 175\u2013214"},{"key":"2028_CR374","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00702-012-0771-5","volume":"120","author":"KA Jellinger","year":"2013","unstructured":"Jellinger KA (2013b) Mild cognitive impairment in Parkinson disease: heterogenous mechanisms. J Neural Transm (Vienna) 120:157\u2013167","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR375","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-3-7091-0687-7_3","volume-title":"Multiple system atrophy","author":"KA Jellinger","year":"2014","unstructured":"Jellinger KA (2014) Neuropathology. In: Wenning GK, Fanciulli A (eds) Multiple system atrophy. Springer, Vienna, pp 17\u201355"},{"key":"2028_CR376","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00702-015-1405-5","volume":"122","author":"KA Jellinger","year":"2015","unstructured":"Jellinger KA (2015) Neuropathobiology of non-motor symptoms in Parkinson disease. J Neural Transm (Vienna) 122:1429\u20131440","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR377","first-page":"e840","volume-title":"Youmans Neurological surgery","author":"KA Jellinger","year":"2016","unstructured":"Jellinger KA (2016) Neuropathology of movement disorders, vol 1. In: Winn HR (ed) Youmans Neurological surgery, 7th edn. Elsevier-Saunders, Philadelphia, pp e840\u2013e880","edition":"7"},{"key":"2028_CR378","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-3-7091-1628-9_5","volume-title":"Movement disorders curricula","author":"KA Jellinger","year":"2017","unstructured":"Jellinger KA (2017a) Neuropathology of movement disorders. In: Falup-Pecurariu C, Ferreira J, Martinez-Martin P, Chaudhuri KR (eds) Movement disorders curricula. Springer, Wien, pp 43\u201348"},{"key":"2028_CR379","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/bs.irn.2017.05.005","volume":"133","author":"KA Jellinger","year":"2017","unstructured":"Jellinger KA (2017b) Neuropathology of nonmotor symptoms of Parkinson\u2019s disease. Int Rev Neurobiol 133:13\u201362","journal-title":"Int Rev Neurobiol"},{"key":"2028_CR380","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3233\/JAD-170397","volume":"62","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA (2018a) Multiple system atrophy: an oligodendroglioneural synucleinopathy. J Alzheimers Dis 62:1141\u20131179","journal-title":"J Alzheimers Dis"},{"key":"2028_CR381","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00702-017-1821-9","volume":"125","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA (2018b) Dementia with Lewy bodies and Parkinson\u2019s disease-dementia: current concepts and controversies. J Neural Transm (Vienna) 125:615\u2013650","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR382","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1002\/mds.27567","volume":"33","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA (2018c) Young-onset multiple system atrophy. Mov Disord 33:1974\u20131975","journal-title":"Mov Disord"},{"key":"2028_CR383","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00702-018-1898-9","volume":"126","author":"KA Jellinger","year":"2019","unstructured":"Jellinger KA (2019) Is Braak staging valid for all types of Parkinson\u2019s disease? J Neural Transm (Vienna) 126:423\u2013431","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR384","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00401-006-0088-2","volume":"112","author":"KA Jellinger","year":"2006","unstructured":"Jellinger KA, Attems J (2006) Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathol 112:253\u2013260","journal-title":"Acta Neuropathol"},{"key":"2028_CR385","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00401-008-0347-5","volume":"115","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA, Attems J (2008) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol 115:127\u2013136","journal-title":"Acta Neuropathol"},{"key":"2028_CR386","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12916-018-1016-8","volume":"16","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA, Korczyn AD (2018) Are dementia with Lewy bodies and Parkinson\u2019s disease dementia the same disease? BMC Med 16:34","journal-title":"BMC Med"},{"key":"2028_CR387","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00401-010-0672-3","volume":"119","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA, Lantos PL (2010) Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update. Acta Neuropathol 119:657\u2013667","journal-title":"Acta Neuropathol"},{"key":"2028_CR388","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00702-016-1545-2","volume":"123","author":"KA Jellinger","year":"2016","unstructured":"Jellinger KA, Wenning GK (2016) Multiple system atrophy: pathogenic mechanisms and biomarkers. J Neural Transm (Vienna) 123:555\u2013572","journal-title":"J Neural Transm (Vienna)"},{"issue":"Suppl 12","key":"2028_CR389","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1002\/mds.20537","volume":"20","author":"KA Jellinger","year":"2005","unstructured":"Jellinger KA, Seppi K, Wenning GK (2005) Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 20(Suppl 12):S29\u2013S36","journal-title":"Mov Disord"},{"key":"2028_CR390","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-017-1788-5","volume":"135","author":"P Jiang","year":"2018","unstructured":"Jiang P, Dickson DW (2018) Parkinson\u2019s disease: experimental models and reality. Acta Neuropathol 135:13\u201332","journal-title":"Acta Neuropathol"},{"key":"2028_CR391","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00401-016-1542-4","volume":"132","author":"P Jiang","year":"2016","unstructured":"Jiang P, Gan M, Yen SH, Moussaud S, McLean PJ, Dickson DW (2016) Proaggregant nuclear factor(s) trigger rapid formation of alpha-synuclein aggregates in apoptotic neurons. Acta Neuropathol 132:77\u201391","journal-title":"Acta Neuropathol"},{"key":"2028_CR908","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tins.2018.09.007","volume":"42","author":"ME Johnson","year":"2019","unstructured":"Johnson ME, Stecher B, Labrie V, Brundin L, Brundin P (2019) Triggers, facilitators, and aggravators: redefining Parkinson\u2019s disease pathogenesis. Trends Neurosci 42:4\u201313","journal-title":"Trends Neurosci"},{"key":"2028_CR392","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jns.2017.12.018","volume":"385","author":"H Joki","year":"2018","unstructured":"Joki H, Higashiyama Y, Nakae Y, Kugimoto C, Doi H, Kimura K, Kishida H, Ueda N, Nakano T, Takahashi T, Koyano S, Takeuchi H, Tanaka F (2018) White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson\u2019s disease with dementia, and Alzheimer\u2019s disease. J Neurol Sci 385:99\u2013104","journal-title":"J Neurol Sci"},{"key":"2028_CR393","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1001\/archneur.59.10.1597","volume":"59","author":"KA Josephs","year":"2002","unstructured":"Josephs KA, Ishizawa T, Tsuboi Y, Cookson N, Dickson DW (2002) A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy. Arch Neurol 59:1597\u20131601","journal-title":"Arch Neurol"},{"key":"2028_CR394","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-00019-02012-00700","author":"WH Jost","year":"2019","unstructured":"Jost WH, Lingor P, Tonges L, Schwarz J, Buhmann C, Kassubek J, Schrag A (2019) Dyskinesia in multiple system atrophy and progressive supranuclear palsy. J Neural Transm (Vienna). https:\/\/doi.org\/10.1007\/s00702-00019-02012-00700","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR395","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.parkreldis.2014.04.019","volume":"20","author":"J Joutsa","year":"2014","unstructured":"Joutsa J, Gardberg M, Roytta M, Kaasinen V (2014) Diagnostic accuracy of parkinsonism syndromes by general neurologists. Parkinsonism Relat Disord 20:840\u2013844","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR396","doi-asserted-by":"publisher","DOI":"10.7916\/d7918nv7919gz7919","author":"C Kaindlstorfer","year":"2013","unstructured":"Kaindlstorfer C, Granata R, Wenning GK (2013) Tremor in multiple system atrophy\u2014a review. Tremor Other Hyperkinet Mov (N Y). https:\/\/doi.org\/10.7916\/d7918nv7919gz7919","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"2028_CR397","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3233\/JAD-170601","volume":"61","author":"C Kaindlstorfer","year":"2018","unstructured":"Kaindlstorfer C, Jellinger KA, Eschlbock S, Stefanova N, Weiss G, Wenning GK (2018) The relevance of iron in the pathogenesis of multiple system atrophy: a viewpoint. J Alzheimers Dis 61:1253\u20131273","journal-title":"J Alzheimers Dis"},{"key":"2028_CR398","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00401-009-0597-x","volume":"118","author":"ME Kalaitzakis","year":"2009","unstructured":"Kalaitzakis ME, Pearce RK (2009) The morbid anatomy of dementia in Parkinson\u2019s disease. Acta Neuropathol 118:587\u2013598","journal-title":"Acta Neuropathol"},{"key":"2028_CR399","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.parkreldis.2008.05.007","volume":"15","author":"ME Kalaitzakis","year":"2009","unstructured":"Kalaitzakis ME, Christian LM, Moran LB, Graeber MB, Pearce RK, Gentleman SM (2009a) Dementia and visual hallucinations associated with limbic pathology in Parkinson\u2019s disease. Parkinsonism Relat Disord 15:196\u2013204","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR400","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neulet.2009.05.083","volume":"461","author":"ME Kalaitzakis","year":"2009","unstructured":"Kalaitzakis ME, Pearce RK, Gentleman SM (2009b) Clinical correlates of pathology in the claustrum in Parkinson\u2019s disease and dementia with Lewy bodies. Neurosci Lett 461:12\u201315","journal-title":"Neurosci Lett"},{"key":"2028_CR401","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.nbd.2010.10.005","volume":"41","author":"ME Kalaitzakis","year":"2011","unstructured":"Kalaitzakis ME, Walls AJ, Pearce RK, Gentleman SM (2011) Striatal Abeta peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes. Neurobiol Dis 41:377\u2013384","journal-title":"Neurobiol Dis"},{"key":"2028_CR402","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/WCO.0000000000000215","volume":"28","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Kalia SK (2015) Alpha-synuclein and Lewy pathology in Parkinson\u2019s disease. Curr Opin Neurol 28:375\u2013381","journal-title":"Curr Opin Neurol"},{"key":"2028_CR403","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386:896\u2013912","journal-title":"Lancet"},{"key":"2028_CR404","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat8407","author":"TI Kam","year":"2018","unstructured":"Kam TI, Mao X, Park H, Chou SC, Karuppagounder SS, Umanah GE, Yun SP, Brahmachari S, Panicker N, Chen R, Andrabi SA, Qi C, Poirier GG, Pletnikova O, Troncoso JC, Bekris LM, Leverenz JB, Pantelyat A, Ko HS, Rosenthal LS, Dawson TM, Dawson VL (2018) Poly(ADP-ribose) drives pathologic alpha-synuclein neurodegeneration in Parkinson\u2019s disease. Science. https:\/\/doi.org\/10.1126\/science.aat8407","journal-title":"Science"},{"key":"2028_CR405","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1176\/appi.ps.51.3.287","volume":"51","author":"J Kamin","year":"2000","unstructured":"Kamin J, Manwani S, Hughes D (2000) Emergency psychiatry: extrapyramidal side effects in the psychiatric emergency service. Psychiatr Serv 51:287\u2013289","journal-title":"Psychiatr Serv"},{"key":"2028_CR406","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1750-3639.2008.00140.x","volume":"18","author":"T Kanazawa","year":"2008","unstructured":"Kanazawa T, Uchihara T, Takahashi A, Nakamura A, Orimo S, Mizusawa H (2008) Three-layered structure shared between Lewy bodies and Lewy neurites\u2014three-dimensional reconstruction of triple-labeled sections. Brain Pathol 18:415\u2013422","journal-title":"Brain Pathol"},{"key":"2028_CR407","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1750-3639.2011.00509.x","volume":"22","author":"T Kanazawa","year":"2012","unstructured":"Kanazawa T, Adachi E, Orimo S, Nakamura A, Mizusawa H, Uchihara T (2012) Pale neurites, premature alpha-synuclein aggregates with centripetal extension from axon collaterals. Brain Pathol 22:67\u201378","journal-title":"Brain Pathol"},{"key":"2028_CR408","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13195-018-0350-6","volume":"10","author":"JPM Kane","year":"2018","unstructured":"Kane JPM, Surendranathan A, Bentley A, Barker SAH, Taylor JP, Thomas AJ, Allan LM, McNally RJ, James PW, McKeith IG, Burn DJ, O\u2019Brien JT (2018) Clinical prevalence of Lewy body dementia. Alzheimers Res Ther 10:19","journal-title":"Alzheimers Res Ther"},{"key":"2028_CR409","doi-asserted-by":"publisher","first-page":"e2015","DOI":"10.1212\/WNL.0000000000007373","volume":"92","author":"SW Kang","year":"2019","unstructured":"Kang SW, Jeon S, Yoo HS, Chung SJ, Lee PH, Sohn YH, Yun M, Evans AC, Ye BS (2019) Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction. Neurology 92:e2015\u2013e2026","journal-title":"Neurology"},{"key":"2028_CR410","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-41019-40195-z","author":"RJ Karpowicz Jr","year":"2019","unstructured":"Karpowicz RJ Jr, Trojanowski JQ, Lee VM (2019) Transmission of alpha-synuclein seeds in neurodegenerative disease: recent developments. Lab Investig. https:\/\/doi.org\/10.1038\/s41374-41019-40195-z","journal-title":"Lab Investig"},{"key":"2028_CR411","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/brain\/awq059","volume":"133","author":"PA Kempster","year":"2010","unstructured":"Kempster PA, O\u2019Sullivan SS, Holton JL, Revesz T, Lees AJ (2010) Relationships between age and late progression of Parkinson\u2019s disease: a clinico-pathological study. Brain 133:1755\u20131762","journal-title":"Brain"},{"key":"2028_CR412","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/mds.26797","volume":"31","author":"LR Kett","year":"2016","unstructured":"Kett LR, Dauer WT (2016) Endolysosomal dysfunction in Parkinson\u2019s disease: recent developments and future challenges. Mov Disord 31:1433\u20131443","journal-title":"Mov Disord"},{"key":"2028_CR413","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","volume":"125","author":"AP Kiely","year":"2013","unstructured":"Kiely AP, Asi YT, Kara E, Limousin P, Ling H, Lewis P, Proukakis C, Quinn N, Lees AJ, Hardy J, Revesz T, Houlden H, Holton JL (2013) Alpha-synucleinopathy associated with G51D SNCA mutation: a link between Parkinson\u2019s disease and multiple system atrophy? Acta Neuropathol 125:753\u2013769","journal-title":"Acta Neuropathol"},{"key":"2028_CR414","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-015-0038-3","volume":"10","author":"AP Kiely","year":"2015","unstructured":"Kiely AP, Ling H, Asi YT, Kara E, Proukakis C, Schapira AH, Morris HR, Roberts HC, Lubbe S, Limousin P, Lewis PA, Lees AJ, Quinn N, Hardy J, Love S, Revesz T, Houlden H, Holton JL (2015) Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation. Mol Neurodegener 10:41","journal-title":"Mol Neurodegener"},{"key":"2028_CR415","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/jnen\/nly035","volume":"77","author":"AP Kiely","year":"2018","unstructured":"Kiely AP, Murray CE, Foti SC, Benson BC, Courtney R, Strand C, Lashley T, Holton JL (2018) Immunohistochemical and molecular investigations show alteration in the inflammatory profile of multiple system atrophy brain. J Neuropathol Exp Neurol 77:598\u2013607","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR416","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/nan.12512","volume":"45","author":"AP Kiely","year":"2019","unstructured":"Kiely AP, Miners JS, Courtney R, Strand C, Love S, Holton JL (2019) Exploring the putative role of kallikrein-6, calpain-1 and cathepsin-D in the proteolytic degradation of alpha-synuclein in multiple system atrophy. Neuropathol Appl Neurobiol 45:347\u2013360","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR417","first-page":"1834","volume":"27","author":"HJ Kim","year":"2012","unstructured":"Kim HJ, Jeon BS (2012) Multiple system atrophy with prolonged survival. Mov Disord 27:1834","journal-title":"Mov Disord"},{"key":"2028_CR418","doi-asserted-by":"crossref","unstructured":"Ryu H-S, Oh M, Oh JS, Moon H, Park KW, Lee CS, You S, Kim M-J, Kim Y, J., Kim J, Kim KM, Kim JS, Chung SJ (2019) Distinct clinical features of predominant pre-synaptic and transsynaptic nigrostriatal dysfunction in multiple system atrophy. J Neurol Sci (accepted article)","DOI":"10.1016\/j.jns.2019.05.017"},{"key":"2028_CR909","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.neuroscience.2015.04.021","volume":"298","author":"U Keber","year":"2015","unstructured":"Keber U, Klietz M, Carlsson T, Oertel WH, Weihe E, Schafer MK, Hoglinger GU, Depboylu C (2015) Striatal tyrosine hydroxylase-positive neurons are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. Neuroscience 298:302\u2013317","journal-title":"Neuroscience"},{"key":"2028_CR419","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.2169\/internalmedicine.48.2415","volume":"48","author":"YD Kim","year":"2009","unstructured":"Kim YD, Kim JS, Lee ES, Yang DW, Lee KS, Kim YI (2009) Progressive \u201cvascular\u201d corticobasal syndrome due to bilateral ischemic hemispheric lesions. Intern Med 48:1699\u20131702","journal-title":"Intern Med"},{"key":"2028_CR420","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1159\/000430953","volume":"15","author":"JS Kim","year":"2015","unstructured":"Kim JS, Yang JJ, Lee DK, Lee JM, Youn J, Cho JW (2015) Cognitive impairment and its structural correlates in the parkinsonian subtype of multiple system atrophy. Neurodegener Dis 15:294\u2013300","journal-title":"Neurodegener Dis"},{"key":"2028_CR421","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1007\/s00415-018-9086-2","volume":"265","author":"EJ Kim","year":"2018","unstructured":"Kim EJ, Brown JA, Deng J, Hwang JL, Spina S, Miller ZA, DeMay MG, Valcour V, Karydas A, Ramos EM, Coppola G, Miller BL, Rosen HJ, Seeley WW, Grinberg LT (2018) Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series. J Neurol 265:2960\u20132971","journal-title":"J Neurol"},{"key":"2028_CR422","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1002\/mds.23305","volume":"25","author":"AE Kingsbury","year":"2010","unstructured":"Kingsbury AE, Bandopadhyay R, Silveira-Moriyama L, Ayling H, Kallis C, Sterlacci W, Maeir H, Poewe W, Lees AJ (2010) Brain stem pathology in Parkinson\u2019s disease: an evaluation of the Braak staging model. Mov Disord 25:2508\u20132515","journal-title":"Mov Disord"},{"key":"2028_CR423","first-page":"157","volume":"5","author":"A Kishore","year":"2014","unstructured":"Kishore A, Popa T (2014) Cerebellum in levodopa-induced dyskinesias: the unusual suspect in the motor network. Front Neurol 5:157","journal-title":"Front Neurol"},{"key":"2028_CR424","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-072116-031033","author":"A Klaus","year":"2019","unstructured":"Klaus A, da Silva JA, Costa RM (2019) What, if, and when to move: basal ganglia circuits and self-paced action initiation. Annu Rev Neurosci. https:\/\/doi.org\/10.1146\/annurev-neuro-072116-031033","journal-title":"Annu Rev Neurosci"},{"key":"2028_CR425","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1093\/brain\/awy147","volume":"141","author":"AD Klein","year":"2018","unstructured":"Klein AD, Mazzulli JR (2018) Is Parkinson\u2019s disease a lysosomal disorder? Brain 141:2255\u20132262","journal-title":"Brain"},{"key":"2028_CR426","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1002\/mds.26814","volume":"31","author":"C Klein","year":"2016","unstructured":"Klein C, Lochte T, Delamonte SM, Braenne I, Hicks AA, Zschiedrich-Jansen K, Simon DK, Friedman JH, Lohmann K (2016) PLA2G6 mutations and parkinsonism: long-term follow-up of clinical features and neuropathology. Mov Disord 31:1927\u20131929","journal-title":"Mov Disord"},{"key":"2028_CR427","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neuroscience.2016.06.017","volume":"331","author":"M Klietz","year":"2016","unstructured":"Klietz M, Keber U, Carlsson T, Chiu WH, Hoglinger GU, Weihe E, Schafer MK, Depboylu C (2016) l-DOPA-induced dyskinesia is associated with a deficient numerical downregulation of striatal tyrosine hydroxylase mRNA-expressing neurons. Neuroscience 331:120\u2013133","journal-title":"Neuroscience"},{"key":"2028_CR428","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00702-017-1692-0","volume":"124","author":"L Klingelhoefer","year":"2017","unstructured":"Klingelhoefer L, Reichmann H (2017) Parkinson\u2019s disease as a multisystem disorder. J Neural Transm (Vienna) 124:709\u2013713","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR429","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.expneurol.2017.07.020","volume":"298","author":"WKD Ko","year":"2017","unstructured":"Ko WKD, Bezard E (2017) Experimental animal models of Parkinson\u2019s disease: a transition from assessing symptomatology to alpha-synuclein targeted disease modification. Exp Neurol 298:172\u2013179","journal-title":"Exp Neurol"},{"key":"2028_CR430","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/jnnp-2017-315813","volume":"89","author":"S Koga","year":"2018","unstructured":"Koga S, Dickson DW (2018) Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy. J Neurol Neurosurg Psychiatry 89:175\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2028_CR431","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-018-1901-4","volume":"137","author":"S Koga","year":"2019","unstructured":"Koga S, Dickson DW (2019) \u201cMinimal change\u201d multiple system atrophy with limbic-predominant alpha-synuclein pathology. Acta Neuropathol 137:167\u2013169","journal-title":"Acta Neuropathol"},{"key":"2028_CR432","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/WNL.0000000000001807","volume":"85","author":"S Koga","year":"2015","unstructured":"Koga S, Aoki N, Uitti RJ, van Gerpen JA, Cheshire WP, Josephs KA, Wszolek ZK, Langston JW, Dickson DW (2015) When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology 85:404\u2013412","journal-title":"Neurology"},{"key":"2028_CR433","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/mds.26874","volume":"32","author":"S Koga","year":"2017","unstructured":"Koga S, Parks A, Uitti RJ, van Gerpen JA, Cheshire WP, Wszolek ZK, Dickson DW (2017a) Profile of cognitive impairment and underlying pathology in multiple system atrophy. Mov Disord 32:405\u2013413","journal-title":"Mov Disord"},{"key":"2028_CR910","doi-asserted-by":"crossref","unstructured":"Koga S, Roemer SF, Kasanuki K, Dickson DW (2019) Cerebrovascular pathology presenting as corticobasal syndrome: an autopsy case series of \u201cvascular CBS\u201d. Parkinsonism Relat Disord (in press)","DOI":"10.1016\/j.parkreldis.2019.09.001"},{"key":"2028_CR434","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/mds.26809","volume":"32","author":"S Koga","year":"2017","unstructured":"Koga S, Sanchez-Contreras M, Josephs KA, Uitti RJ, Graff-Radford N, van Gerpen JA, Cheshire WP, Wszolek ZK, Rademakers R, Dickson DW (2017b) Distribution and characteristics of transactive response DNA binding protein 43\u00a0kDa pathology in progressive supranuclear palsy. Mov Disord 32:246\u2013255","journal-title":"Mov Disord"},{"key":"2028_CR435","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-018-1878-z","volume":"136","author":"S Koga","year":"2018","unstructured":"Koga S, Kouri N, Walton RL, Ebbert MTW, Josephs KA, Litvan I, Graff-Radford N, Ahlskog JE, Uitti RJ, van Gerpen JA, Boeve BF, Parks A, Ross OA, Dickson DW (2018a) Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype. Acta Neuropathol 136:389\u2013404","journal-title":"Acta Neuropathol"},{"key":"2028_CR436","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/nan.12485","volume":"44","author":"S Koga","year":"2018","unstructured":"Koga S, Lin WL, Walton RL, Ross OA, Dickson DW (2018b) TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and alpha-synuclein in glial cytoplasmic inclusions. Neuropathol Appl Neurobiol 44:707\u2013721","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR437","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/NEN.0b013e31825b9680","volume":"71","author":"Y Kokubo","year":"2012","unstructured":"Kokubo Y, Taniguchi A, Hasegawa M, Hayakawa Y, Morimoto S, Yoneda M, Hirokawa Y, Shiraishi T, Saito Y, Murayama S, Kuzuhara S (2012) Alpha-synuclein pathology in the amyotrophic lateral sclerosis\/parkinsonism dementia complex in the Kii Peninsula, Japan. J Neuropathol Exp Neurol 71:625\u2013630","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR438","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/mds.21992","volume":"23","author":"M K\u00f6llensperger","year":"2008","unstructured":"K\u00f6llensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, Boesch S, Mueller J, Koukouni V, Quinn N, Pellecchia MT, Barone P, Schimke N, Dodel R, Oertel W, Dupont E, Ostergaard K, Daniels C, Deuschl G, Gurevich T, Giladi N, Coelho M, Sampaio C, Nilsson C, Widner H, Sorbo FD, Albanese A, Cardozo A, Tolosa E, Abele M, Klockgether T, Kamm C, Gasser T, Djaldetti R, Colosimo C, Meco G, Schrag A, Poewe W, Wenning GK (2008) Red flags for multiple system atrophy. Mov Disord 23:1093\u20131099","journal-title":"Mov Disord"},{"key":"2028_CR439","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.parkreldis.2017.06.004","volume":"41","author":"T Konno","year":"2017","unstructured":"Konno T, Ross OA, Teive HAG, Slawek J, Dickson DW, Wszolek ZK (2017) DCTN1-related neurodegeneration: Perry syndrome and beyond. Parkinsonism Relat Disord 41:14\u201324","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR440","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain 136:2419\u20132431","journal-title":"Brain"},{"key":"2028_CR441","first-page":"299","volume":"7","author":"K Kosaka","year":"1988","unstructured":"Kosaka K, Tsuchiya K, Yoshimura M (1988) Lewy body disease with and without dementia: a clinicopathological study of 35 cases. Clin Neuropathol 7:299\u2013305","journal-title":"Clin Neuropathol"},{"key":"2028_CR442","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.expneurol.2004.01.007","volume":"187","author":"PT Kotzbauer","year":"2004","unstructured":"Kotzbauer PT, Giasson BI, Kravitz AV, Golbe LI, Mark MH, Trojanowski JQ, Lee VM (2004) Fibrillization of alpha-synuclein and tau in familial Parkinson\u2019s disease caused by the A53T alpha-synuclein mutation. Exp Neurol 187:279\u2013288","journal-title":"Exp Neurol"},{"key":"2028_CR443","doi-asserted-by":"publisher","first-page":"3","DOI":"10.15586\/codonpublications.parkinsonsdisease.12018","volume-title":"Parkinson\u2019s disease: pathogenesis and clinical aspects","author":"A Kouli","year":"2018","unstructured":"Kouli A, Torsney KM, Kuan WL (2018) Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. In: Stoker TB, Greenland JC (eds) Parkinson\u2019s disease: pathogenesis and clinical aspects, 2019\/02\/01 edn. Codon Publications, Brisbane, pp 3\u201326. https:\/\/doi.org\/10.15586\/codonpublications.parkinsonsdisease.12018","edition":"2019\/02\/01"},{"key":"2028_CR444","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00401-013-1087-8","volume":"125","author":"N Kouri","year":"2013","unstructured":"Kouri N, Oshima K, Takahashi M, Murray ME, Ahmed Z, Parisi JE, Yen SH, Dickson DW (2013) Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD. Acta Neuropathol 125:741\u2013752","journal-title":"Acta Neuropathol"},{"key":"2028_CR445","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00401-013-1193-7","volume":"127","author":"N Kouri","year":"2014","unstructured":"Kouri N, Carlomagno Y, Baker M, Liesinger AM, Caselli RJ, Wszolek ZK, Petrucelli L, Boeve BF, Parisi JE, Josephs KA, Uitti RJ, Ross OA, Graff-Radford NR, DeTure MA, Dickson DW, Rademakers R (2014) Novel mutation in MAPT exon 13 (p. N410H) causes corticobasal degeneration. Acta Neuropathol 127:271\u2013282","journal-title":"Acta Neuropathol"},{"key":"2028_CR446","doi-asserted-by":"publisher","first-page":"7247","DOI":"10.1038\/ncomms8247","volume":"6","author":"N Kouri","year":"2015","unstructured":"Kouri N, Ross OA, Dombroski B, Younkin CS, Serie DJ, Soto-Ortolaza A, Baker M, Finch NC, Yoon H, Kim J, Fujioka S, McLean CA, Ghetti B, Spina S, Cantwell LB, Farlow MR, Grafman J, Huey ED, Ryung Han M, Beecher S, Geller ET, Kretzschmar HA, Roeber S, Gearing M, Juncos JL, Vonsattel JP, Van Deerlin VM, Grossman M, Hurtig HI, Gross RG, Arnold SE, Trojanowski JQ, Lee VM, Wenning GK, White CL, Hoglinger GU, Muller U, Devlin B, Golbe LI, Crook J, Parisi JE, Boeve BF, Josephs KA, Wszolek ZK, Uitti RJ, Graff-Radford NR, Litvan I, Younkin SG, Wang LS, Ertekin-Taner N, Rademakers R, Hakonarsen H, Schellenberg GD, Dickson DW (2015) Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy. Nat Commun 6:7247","journal-title":"Nat Commun"},{"key":"2028_CR447","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1365-2990.2012.01272.x","volume":"39","author":"GG Kovacs","year":"2013","unstructured":"Kovacs GG, Rozemuller AJ, van Swieten JC, Gelpi E, Majtenyi K, Al-Sarraj S, Troakes C, Bodi I, King A, Hortobagyi T, Esiri MM, Ansorge O, Giaccone G, Ferrer I, Arzberger T, Bogdanovic N, Nilsson T, Leisser I, Alafuzoff I, Ironside JW, Kretzschmar H, Budka H (2013) Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium. Neuropathol Appl Neurobiol 39:166\u2013178","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR448","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/jnen\/nlx007","volume":"76","author":"GG Kovacs","year":"2017","unstructured":"Kovacs GG, Robinson JL, Xie SX, Lee EB, Grossman M, Wolk DA, Irwin DJ, Weintraub D, Kim CF, Schuck T, Yousef A, Wagner ST, Suh E, Van Deerlin VM, Lee VM, Trojanowski JQ (2017) Evaluating the patterns of aging-related tau astrogliopathy unravels novel insights into brain aging and neurodegenerative diseases. J Neuropathol Exp Neurol 76:270\u2013288","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR449","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S0035-3787(07)78403-5","volume":"163","author":"A Kreisler","year":"2007","unstructured":"Kreisler A, Mastain B, Tison F, Fenelon G, Destee A (2007) Multi-infarct disorder presenting as corticobasal degeneration (DCB): vascular pseudo-corticobasal degeneration? Rev Neurol (Paris) 163:1191\u20131199","journal-title":"Rev Neurol (Paris)"},{"key":"2028_CR450","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40478-019-0703-9","volume":"7","author":"Z Krejciova","year":"2019","unstructured":"Krejciova Z, Carlson GA, Giles K, Prusiner SB (2019) Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human alpha-synuclein. Acta Neuropathol Commun 7:81","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR451","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrneurol.2017.26","volume":"13","author":"F Krismer","year":"2017","unstructured":"Krismer F, Wenning GK (2017) Multiple system atrophy: insights into a rare and debilitating movement disorder. Nat Rev Neurol 13:232\u2013243","journal-title":"Nat Rev Neurol"},{"key":"2028_CR452","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/B978-0-12-410502-7.00009-0","volume":"110","author":"MC Kruer","year":"2013","unstructured":"Kruer MC (2013) The neuropathology of neurodegeneration with brain iron accumulation. Int Rev Neurobiol 110:165\u2013194","journal-title":"Int Rev Neurobiol"},{"key":"2028_CR453","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/mds.27620","volume":"34","author":"D K\u00fcbler","year":"2019","unstructured":"K\u00fcbler D, Wachter T, Cabanel N, Su Z, Turkheimer FE, Dodel R, Brooks DJ, Oertel WH, Gerhard A (2019) Widespread microglial activation in multiple system atrophy. Mov Disord 34:564\u2013568","journal-title":"Mov Disord"},{"key":"2028_CR454","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.3390\/ijms19113573","volume":"19","author":"M Kujawska","year":"2018","unstructured":"Kujawska M, Jodynis-Liebert J (2018) What is the evidence that Parkinson\u2019s disease is a prion disorder, which originates in the gut? Int J Mol Sci 19:3573","journal-title":"Int J Mol Sci"},{"key":"2028_CR455","doi-asserted-by":"publisher","first-page":"223e1","DOI":"10.1016\/j.neurobiolaging.2018.10.019","volume":"75","author":"C Kun-Rodrigues","year":"2019","unstructured":"Kun-Rodrigues C, Orme T, Carmona S, Hernandez DG, Ross OA, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Guerreiro R, Bras J (2019) A comprehensive screening of copy number variability in dementia with Lewy bodies. Neurobiol Aging 75:223e1\u2013223e10","journal-title":"Neurobiol Aging"},{"key":"2028_CR456","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/jnen\/62.12.1241","volume":"62","author":"E Kuusisto","year":"2003","unstructured":"Kuusisto E, Parkkinen L, Alafuzoff I (2003) Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62:1241\u20131253","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR457","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/brain\/awz084","volume":"142","author":"N Kuzumaki","year":"2019","unstructured":"Kuzumaki N, Suda Y, Iwasawa C, Narita M, Sone T, Watanabe M, Maekawa A, Matsumoto T, Akamatsu W, Igarashi K, Tamura H, Takeshima H, Tawfik VL, Ushijima T, Hattori N, Okano H (2019) Cell-specific overexpression of COMT in dopaminergic neurons of Parkinson\u2019s disease. Brain 142:1675\u20131689","journal-title":"Brain"},{"key":"2028_CR458","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/brain\/awy318","volume":"142","author":"P La Vitola","year":"2019","unstructured":"La Vitola P, Beeg M, Balducci C, Santamaria G, Restelli E, Colombo L, Caldinelli L, Pollegioni L, Gobbi M, Chiesa R, Forloni G (2019) Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects. Brain 142:249\u2013254","journal-title":"Brain"},{"key":"2028_CR459","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jalz.2016.08.014","volume":"13","author":"B Lam","year":"2018","unstructured":"Lam B, Khan A, Keith J, Rogaeva E, Bilbao J, St George-Hyslop P, Ghani M, Freedman M, Stuss DT, Chow T, Black SE, Masellis M (2018) Characterizing familial corticobasal syndrome due to Alzheimer\u2019s disease pathology and PSEN1 mutations. Alzheimers Dement 13:520\u2013530","journal-title":"Alzheimers Dement"},{"key":"2028_CR460","doi-asserted-by":"publisher","first-page":"a009621","DOI":"10.1101\/cshperspect.a009621","volume":"2","author":"JL Lanciego","year":"2012","unstructured":"Lanciego JL, Luquin N, Obeso JA (2012) Functional neuroanatomy of the basal ganglia. Cold Spring Harb Perspect Med 2:a009621","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2028_CR461","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/ejn.14119","volume":"49","author":"EL Lane","year":"2019","unstructured":"Lane EL (2019) l-DOPA for Parkinson\u2019s disease-a bittersweet pill. Eur J Neurosci 49:384\u2013398","journal-title":"Eur J Neurosci"},{"key":"2028_CR462","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/mds.23609","volume":"26","author":"AE Lang","year":"2011","unstructured":"Lang AE (2011) A critical appraisal of the premotor symptoms of Parkinson\u2019s disease: potential usefulness in early diagnosis and design of neuroprotective trials. Mov Disord 26:775\u2013783","journal-title":"Mov Disord"},{"key":"2028_CR463","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","volume":"46","author":"JW Langston","year":"1999","unstructured":"Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46:598\u2013605","journal-title":"Ann Neurol"},{"key":"2028_CR464","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11910-017-0751-0","volume":"17","author":"B Laurens","year":"2017","unstructured":"Laurens B, Vergnet S, Lopez MC, Foubert-Samier A, Tison F, Fernagut PO, Meissner WG (2017) Multiple system atrophy\u2014state of the art. Curr Neurol Neurosci Rep 17:41","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2028_CR465","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41467-018-03111-4","volume":"9","author":"J Lautenschlager","year":"2018","unstructured":"Lautenschlager J, Stephens AD, Fusco G, Strohl F, Curry N, Zacharopoulou M, Michel CH, Laine R, Nespovitaya N, Fantham M, Pinotsi D, Zago W, Fraser P, Tandon A, St George-Hyslop P, Rees E, Phillips JJ, De Simone A, Kaminski CF, Schierle GSK (2018) C-terminal calcium binding of alpha-synuclein modulates synaptic vesicle interaction. Nat Commun 9:712","journal-title":"Nat Commun"},{"key":"2028_CR466","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3233\/JPD-140523","volume":"5","author":"M Lawton","year":"2015","unstructured":"Lawton M, Baig F, Rolinski M, Ruffman C, Nithi K, May MT, Ben-Shlomo Y, Hu MT (2015) Parkinson\u2019s disease subtypes in the Oxford Parkinson Disease Centre (OPDC) discovery cohort. J Parkinsons Dis 5:269\u2013279","journal-title":"J Parkinsons Dis"},{"key":"2028_CR467","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1136\/jnnp-2018-318337","volume":"89","author":"M Lawton","year":"2018","unstructured":"Lawton M, Ben-Shlomo Y, May MT, Baig F, Barber TR, Klein JC, Swallow DMA, Malek N, Grosset KA, Bajaj N, Barker RA, Williams N, Burn DJ, Foltynie T, Morris HR, Wood NW, Grosset DG, Hu MTM (2018) Developing and validating Parkinson\u2019s disease subtypes and their motor and cognitive progression. J Neurol Neurosurg Psychiatry 89:1279\u20131287","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2028_CR468","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fneur.2019.00074","volume":"10","author":"J-H Lee","year":"2019","unstructured":"Lee J-H, Lee M-S (2019) Iron accumulation in atypical parkinsonian syndromes: in vivo MRI evidences for distinctive patterns. Front Neurol 10:74. https:\/\/doi.org\/10.3389\/fneur.2019.00074","journal-title":"Front Neurol"},{"key":"2028_CR469","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/ene.12796","volume":"23","author":"MJ Lee","year":"2015","unstructured":"Lee MJ, Shin JH, Seoung JK, Lee JH, Yoon U, Oh JH, Jung DS, Kim EJ (2015) Cognitive impairments associated with morphological changes in cortical and subcortical structures in multiple system atrophy of the cerebellar type. Eur J Neurol 23:92\u2013100","journal-title":"Eur J Neurol"},{"key":"2028_CR470","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T (2009) Parkinson\u2019s disease. Lancet 373:2055\u20132066","journal-title":"Lancet"},{"key":"2028_CR471","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fnins.2019.00457","volume":"13","author":"S Lehtonen","year":"2019","unstructured":"Lehtonen S, Sonninen TM, Wojciechowski S, Goldsteins G, Koistinaho J (2019) Dysfunction of cellular proteostasis in Parkinson\u2019s disease. Front Neurosci 13:457","journal-title":"Front Neurosci"},{"key":"2028_CR472","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s12035-012-8267-8","volume":"47","author":"CM Lema Tom\u00e9","year":"2013","unstructured":"Lema Tom\u00e9 CM, Tyson T, Rey NL, Grathwohl S, Britschgi M, Brundin P (2013) Inflammation and alpha-synuclein\u2019s prion-like behavior in Parkinson\u2019s disease\u2014is there a link? Mol Neurobiol 47:561\u2013574","journal-title":"Mol Neurobiol"},{"key":"2028_CR473","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s00702-018-1891-3","volume":"125","author":"A Lenka","year":"2018","unstructured":"Lenka A, Ingalhalikar M, Shah A, Saini J, Arumugham SS, Hegde S, George L, Reddy V, Reddy YCJ, Yadav R, Pal PK (2018) Hippocampal subfield atrophy in patients with Parkinson\u2019s disease and psychosis. J Neural Transm (Vienna) 125:1361\u20131372","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR474","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1750-3639.2007.00048.x","volume":"17","author":"JB Leverenz","year":"2007","unstructured":"Leverenz JB, Umar I, Wang Q, Montine TJ, McMillan PJ, Tsuang DW, Jin J, Pan C, Shin J, Zhu D, Zhang J (2007) Proteomic identification of novel proteins in cortical lewy bodies. Brain Pathol 17:139\u2013145","journal-title":"Brain Pathol"},{"key":"2028_CR475","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1750-3639.2007.00117.x","volume":"18","author":"JB Leverenz","year":"2008","unstructured":"Leverenz JB, Hamilton R, Tsuang DW, Schantz A, Vavrek D, Larson EB, Kukull WA, Lopez O, Galasko D, Masliah E, Kaye J, Woltjer R, Clark C, Trojanowski JQ, Montine TJ (2008) Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol 18:220\u2013224","journal-title":"Brain Pathol"},{"key":"2028_CR476","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1365-2990.2012.01269.x","volume":"39","author":"A Li","year":"2013","unstructured":"Li A, Paudel R, Johnson R, Courtney R, Lees AJ, Holton JL, Hardy J, Revesz T, Houlden H (2013) Pantothenate kinase-associated neurodegeneration is not a synucleinopathy. Neuropathol Appl Neurobiol 39:121\u2013131","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR477","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1007\/s00415-018-8876-x","volume":"265","author":"M Li","year":"2018","unstructured":"Li M, Ma Q, Zhao X, Wang C, Wu H, Li J, Yang W (2018) Dilemma of multiple system atrophy and spinocerebellar ataxias. J Neurol 265:2764\u20132772","journal-title":"J Neurol"},{"key":"2028_CR478","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00401-019-01974-5","volume":"137","author":"X Li","year":"2019","unstructured":"Li X, Koudstaal W, Fletcher L, Costa M, van Winsen M, Siregar B, Inganas H, Kim J, Keogh E, Macedo J, Holland T, Perry S, Bard F, Hoozemans JJ, Goudsmit J, Apetri A, Pascual G (2019) Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology. Acta Neuropathol 137:825\u2013836","journal-title":"Acta Neuropathol"},{"key":"2028_CR479","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/pmic.201300342","volume":"14","author":"V Licker","year":"2014","unstructured":"Licker V, Turck N, Kovari E, Burkhardt K, Cote M, Surini-Demiri M, Lobrinus JA, Sanchez JC, Burkhard PR (2014) Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson\u2019s disease pathogenesis. Proteomics 14:784\u2013794","journal-title":"Proteomics"},{"key":"2028_CR480","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.mcp.2016.11.001","volume":"30","author":"CM Lill","year":"2016","unstructured":"Lill CM (2016) Genetics of Parkinson\u2019s disease. Mol Cell Probes 30:386\u2013396","journal-title":"Mol Cell Probes"},{"key":"2028_CR481","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fneur.2013.00033","volume":"4","author":"KL Lim","year":"2013","unstructured":"Lim KL, Zhang CW (2013) Molecular events underlying Parkinson\u2019s disease\u2014an interwoven tapestry. Front Neurol 4:33","journal-title":"Front Neurol"},{"key":"2028_CR482","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-00018-09100-00418","author":"EW Lim","year":"2018","unstructured":"Lim EW, Aarsland D, Ffytche D, Taddei RN, van Wamelen DJ, Wan YM, Tan EK, Ray Chaudhuri K (2018) Amyloid-beta and Parkinson\u2019s disease. J Neurol. https:\/\/doi.org\/10.1007\/s00415-00018-09100-00418","journal-title":"J Neurol"},{"key":"2028_CR483","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1021\/acschemneuro.8b00498","volume":"10","author":"VA Lima","year":"2019","unstructured":"Lima VA, do Nascimento LA, Eliezer D, Follmer C (2019) Role of Parkinson\u2019s disease-linked mutations and n-terminal acetylation on the oligomerization of alpha-synuclein induced by 3,4-dihydroxyphenylacetaldehyde. ACS Chem Neurosci 10:690\u2013703","journal-title":"ACS Chem Neurosci"},{"key":"2028_CR484","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3389\/fneur.2018.00857","volume":"9","author":"N Limphaibool","year":"2018","unstructured":"Limphaibool N, Iwanowski P, Holstad MJV, Perkowska K (2018) Parkinsonism in inherited metabolic disorders: key considerations and major features. Front Neurol 9:857","journal-title":"Front Neurol"},{"key":"2028_CR485","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jns.2019.02.021","volume":"399","author":"YW Lin","year":"2019","unstructured":"Lin YW, Truong D (2019) Diffuse Lewy body disease. J Neurol Sci 399:144\u2013150","journal-title":"J Neurol Sci"},{"key":"2028_CR486","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/mds.26138","volume":"30","author":"CH Lin","year":"2015","unstructured":"Lin CH, Tan EK, Yang CC, Yi Z, Wu RM (2015) COQ2 gene variants associate with cerebellar subtype of multiple system atrophy in Chinese. Mov Disord 30:436\u2013437","journal-title":"Mov Disord"},{"key":"2028_CR487","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.tem.2018.11.003","volume":"30","author":"G Lin","year":"2019","unstructured":"Lin G, Wang L, Marcogliese PC, Bellen HJ (2019) Sphingolipids in the pathogenesis of Parkinson\u2019s disease and parkinsonism. Trends Endocrinol Metab 30:106\u2013117","journal-title":"Trends Endocrinol Metab"},{"key":"2028_CR488","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/nan.12067","volume":"40","author":"H Ling","year":"2013","unstructured":"Ling H, Holton JL, Lees AJ, Revesz T (2013) TDP-43 pathology is present in most post-encephalitic parkinsonism brains (Scientific correspondence). Neuropathol Appl Neurobiol 40:654\u2013657","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR489","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/nan.12037","volume":"40","author":"H Ling","year":"2014","unstructured":"Ling H, de Silva R, Massey LA, Courtney R, Hondhamuni G, Bajaj N, Lowe J, Holton JL, Lees A, Revesz T (2014) Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant. Neuropathol Appl Neurobiol 40:149\u2013163","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR490","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/mds.26220","volume":"30","author":"H Ling","year":"2015","unstructured":"Ling H, Asi YT, Petrovic IN, Ahmed Z, Prashanth LK, Hazrati LN, Nishizawa M, Ozawa T, Lang A, Lees AJ, Revesz T, Holton JL (2015) Minimal change multiple system atrophy: an aggressive variant? Mov Disord 30:960\u2013967","journal-title":"Mov Disord"},{"key":"2028_CR491","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1093\/brain\/aww256","volume":"139","author":"H Ling","year":"2016","unstructured":"Ling H, Kovacs GG, Vonsattel JP, Davey K, Mok KY, Hardy J, Morris HR, Warner TT, Holton JL, Revesz T (2016) Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology. Brain 139:3237\u20133252","journal-title":"Brain"},{"key":"2028_CR492","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-017-1777-8","volume":"135","author":"A Lionnet","year":"2018","unstructured":"Lionnet A, Leclair-Visonneau L, Neunlist M, Murayama S, Takao M, Adler CH, Derkinderen P, Beach TG (2018) Does Parkinson\u2019s disease start in the gut? Acta Neuropathol 135:1\u201312","journal-title":"Acta Neuropathol"},{"key":"2028_CR493","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1471-4159.2009.06497.x","volume":"112","author":"M Liu","year":"2010","unstructured":"Liu M, Choi DY, Hunter RL, Pandya JD, Cass WA, Sullivan PG, Kim HC, Gash DM, Bing G (2010) Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats. J Neurochem 112:773\u2013783","journal-title":"J Neurochem"},{"key":"2028_CR494","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/nan.12513","volume":"44","author":"AKL Liu","year":"2018","unstructured":"Liu AKL, Lim EJ, Ahmed I, Chang RC, Pearce RKB, Gentleman SM (2018) Review: revisiting the human cholinergic nucleus of the diagonal band of Broca. Neuropathol Appl Neurobiol 44:647\u2013662","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR495","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40478-019-0717-3","volume":"7","author":"AKL Liu","year":"2019","unstructured":"Liu AKL, Chau TW, Lim EJ, Ahmed I, Chang RC, Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RKB (2019a) Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson\u2019s disease with cognitive decline. Acta Neuropathol Commun 7:61","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR496","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/hmg\/ddy365","volume":"28","author":"X Liu","year":"2019","unstructured":"Liu X, Hebron M, Shi W, Lonskaya I, Moussa CE (2019b) Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies. Hum Mol Genet 28:548\u2013560","journal-title":"Hum Mol Genet"},{"key":"2028_CR497","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2019.1005.1020","author":"JQ Liu","year":"2019","unstructured":"Liu JQ, Chu SF, Zhou X, Zhang DY, Chen NH (2019c) Role of chemokines in Parkinson\u2019s disease. Brain Res Bull. https:\/\/doi.org\/10.1016\/j.brainresbull.2019.1005.1020","journal-title":"Brain Res Bull"},{"key":"2028_CR498","doi-asserted-by":"publisher","first-page":"5012129","DOI":"10.1155\/2017\/5012129","volume":"2017","author":"F Longhena","year":"2017","unstructured":"Longhena F, Faustini G, Missale C, Pizzi M, Spano P, Bellucci A (2017) The contribution of alpha-synuclein spreading to Parkinson\u2019s disease synaptopathy. Neural Plast 2017:5012129","journal-title":"Neural Plast"},{"key":"2028_CR499","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/bpa.12587","volume":"28","author":"F Longhena","year":"2018","unstructured":"Longhena F, Faustini G, Varanita T, Zaltieri M, Porrini V, Tessari I, Poliani PL, Missale C, Borroni B, Padovani A, Bubacco L, Pizzi M, Spano P, Bellucci A (2018) Synapsin III is a key component of alpha-synuclein fibrils in Lewy bodies of PD brains. Brain Pathol 28:875\u2013888","journal-title":"Brain Pathol"},{"key":"2028_CR500","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.brainres.2018.09.032","volume":"1706","author":"KLR Lopez","year":"2019","unstructured":"Lopez KLR, Simpson JE, Watson LC, Mortiboys H, Hautbergue GM, Bandmann O, Highley JR (2019) TIGAR inclusion pathology is specific for Lewy body diseases. Brain Res 1706:218\u2013223","journal-title":"Brain Res"},{"key":"2028_CR501","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1750-1326-9-17","volume":"9","author":"X Lu","year":"2014","unstructured":"Lu X, Kim-Han JS, Harmon S, Sakiyama-Elbert SE, O\u2019Malley KL (2014) The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons. Mol Neurodegener 9:17","journal-title":"Mol Neurodegener"},{"key":"2028_CR502","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00415-013-7003-2","volume":"261","author":"S Lubbe","year":"2014","unstructured":"Lubbe S, Morris HR (2014) Recent advances in Parkinson\u2019s disease genetics. J Neurol 261:259\u2013266","journal-title":"J Neurol"},{"key":"2028_CR503","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","volume":"9","author":"MHR Ludtmann","year":"2018","unstructured":"Ludtmann MHR, Angelova PR, Horrocks MH, Choi ML, Rodrigues M, Baev AY, Berezhnov AV, Yao Z, Little D, Banushi B, Al-Menhali AS, Ranasinghe RT, Whiten DR, Yapom R, Dolt KS, Devine MJ, Gissen P, Kunath T, Jaganjac M, Pavlov EV, Klenerman D, Abramov AY, Gandhi S (2018) Alpha-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease. Nat Commun 9:2293","journal-title":"Nat Commun"},{"key":"2028_CR504","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/j.1750-3639.2012.00585.x","volume":"22","author":"L-F Lue","year":"2012","unstructured":"Lue L-F, Walker DG, Adler CH, Shill H, Tran H, Akiyama H, Sue LI, Caviness J, Sabbagh MN, Beach TG (2012) Biochemical increase in phosphorylated a-synuclein precedes histopathology of Lewy-type synucleinopathies. Brain Pathol 22:745\u2013756","journal-title":"Brain Pathol"},{"key":"2028_CR505","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.neurol.2018.08.004","volume":"174","author":"A Lunati","year":"2018","unstructured":"Lunati A, Lesage S, Brice A (2018) The genetic landscape of Parkinson\u2019s disease. Rev Neurol (Paris) 174:628\u2013643","journal-title":"Rev Neurol (Paris)"},{"key":"2028_CR506","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1021\/acschemneuro.8b00383","volume":"10","author":"LY Ma","year":"2019","unstructured":"Ma LY, Liu GL, Wang DX, Zhang MM, Kou WY, Feng T (2019) Alpha-synuclein in peripheral tissues in Parkinson\u2019s disease. ACS Chem Neurosci 10:812\u2013823","journal-title":"ACS Chem Neurosci"},{"key":"2028_CR507","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neurobiolaging.2018.04.014","volume":"69","author":"S Maeda","year":"2018","unstructured":"Maeda S, Sato Y, Takashima A (2018) Frontotemporal dementia with parkinsonism linked to chromosome-17 mutations enhance tau oligomer formation. Neurobiol Aging 69:26\u201332","journal-title":"Neurobiol Aging"},{"key":"2028_CR508","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10072-013-1458-x","volume":"35","author":"E Maffeo","year":"2014","unstructured":"Maffeo E, Montuschi A, Stura G, Giordana MT (2014) Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patients. Neurol Sci 35:523\u2013530","journal-title":"Neurol Sci"},{"key":"2028_CR509","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1093\/brain\/aww162","volume":"139","author":"A Maillet","year":"2016","unstructured":"Maillet A, Krack P, Lhommee E, Metereau E, Klinger H, Favre E, Le Bars D, Schmitt E, Bichon A, Pelissier P, Fraix V, Castrioto A, Sgambato-Faure V, Broussolle E, Tremblay L, Thobois S (2016) The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson\u2019s disease. Brain 139:2486\u20132502","journal-title":"Brain"},{"key":"2028_CR510","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40035-017-0099-z","volume":"6","author":"P Maiti","year":"2017","unstructured":"Maiti P, Manna J, Dunbar GL (2017) Current understanding of the molecular mechanisms in Parkinson\u2019s disease: targets for potential treatments. Transl Neurodegener 6:28","journal-title":"Transl Neurodegener"},{"key":"2028_CR511","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neurobiolaging.2018.09.004","volume":"73","author":"E Mak","year":"2019","unstructured":"Mak E, Donaghy PC, McKiernan E, Firbank MJ, Lloyd J, Petrides GS, Thomas AJ, O\u2019Brien JT (2019) Beta amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies. Neurobiol Aging 73:74\u201381","journal-title":"Neurobiol Aging"},{"key":"2028_CR512","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/mds.25470","volume":"28","author":"A Malandrini","year":"2013","unstructured":"Malandrini A, Rubegni A, Battisti C, Berti G, Federico A (2013) Electron-dense lamellated inclusions in 2 siblings with Kufor-Rakeb syndrome. Mov Disord 28:1751\u20131752","journal-title":"Mov Disord"},{"key":"2028_CR513","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40478-017-0451-7","volume":"5","author":"RJ Mandel","year":"2017","unstructured":"Mandel RJ, Marmion DJ, Kirik D, Chu Y, Heindel C, McCown T, Gray SJ, Kordower JH (2017) Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates. Acta Neuropathol Commun 5:47","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR514","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/hmg\/ddz005","volume":"28","author":"G Maor","year":"2019","unstructured":"Maor G, Rapaport D, Horowitz M (2019) The effect of mutant GBA1 on accumulation and aggregation of alpha-synuclein. Hum Mol Genet 28:1768\u20131781","journal-title":"Hum Mol Genet"},{"issue":"Suppl 1","key":"2028_CR515","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1002\/mds.22787","volume":"25","author":"K Marder","year":"2010","unstructured":"Marder K (2010) Cognitive impairment and dementia in Parkinson\u2019s disease. Mov Disord 25(Suppl 1):S110\u2013S116","journal-title":"Mov Disord"},{"key":"2028_CR516","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3233\/JAD-2010-1220","volume":"19","author":"WR Markesbery","year":"2010","unstructured":"Markesbery WR (2010) Neuropathologic alterations in mild cognitive impairment: a review. J Alzheimers Dis 19:221\u2013228","journal-title":"J Alzheimers Dis"},{"key":"2028_CR517","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/NEN.0b013e3181ac10a7","volume":"68","author":"WR Markesbery","year":"2009","unstructured":"Markesbery WR, Jicha GA, Liu H, Schmitt FA (2009) Lewy body pathology in normal elderly subjects. J Neuropathol Exp Neurol 68:816\u2013822","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR518","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00401-008-0372-4","volume":"116","author":"K Markopoulou","year":"2008","unstructured":"Markopoulou K, Dickson DW, McComb RD, Wszolek ZK, Katechalidou L, Avery L, Stansbury MS, Chase BA (2008) Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson\u2019s disease. Variability in familial Parkinson\u2019s disease. Acta Neuropathol 116:25\u201335","journal-title":"Acta Neuropathol"},{"key":"2028_CR519","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/mds.26614","volume":"31","author":"C Marras","year":"2016","unstructured":"Marras C, Alcalay RN, Caspell-Garcia C, Coffey C, Chan P, Duda JE, Facheris MF, Fernandez-Santiago R, Ruiz-Martinez J, Mestre T, Saunders-Pullman R, Pont-Sunyer C, Tolosa E, Waro B (2016) Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson\u2019s disease. Mov Disord 31:1192\u20131202","journal-title":"Mov Disord"},{"key":"2028_CR520","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/mds.27045","volume":"32","author":"C Marras","year":"2017","unstructured":"Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C (2017) Nomenclature of genetic movement disorders: recommendations of the International Parkinson and Movement Disorder Society task force. Mov Disord 32:724\u2013725","journal-title":"Mov Disord"},{"key":"2028_CR521","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","volume":"4","author":"C Marras","year":"2018","unstructured":"Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, Abbott RD, Savica R, Van Den Eeden SK, Willis AW, Tanner CM (2018) Prevalence of Parkinson\u2019s disease across North America. NPJ Parkinsons Dis 4:21","journal-title":"NPJ Parkinsons Dis"},{"key":"2028_CR911","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz1120","author":"A Martin-Bastida","year":"2019","unstructured":"Martin-Bastida A, Lao-Kaim NP, Roussakis AA, Searle GE, Xing Y, Gunn RN, Schwarz ST, Barker RA, Auer DP, Piccini P (2019) Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system. Brain. https:\/\/doi.org\/10.1093\/brain\/awz1120","journal-title":"Brain"},{"key":"2028_CR522","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40478-018-0578-1","volume":"6","author":"C Masaracchia","year":"2018","unstructured":"Masaracchia C, Hnida M, Gerhardt E, Lopes da Fonseca T, Villar-Pique A, Branco T, Stahlberg MA, Dean C, Fernandez CO, Milosevic I, Outeiro TF (2018) Membrane binding, internalization, and sorting of alpha-synuclein in the cell. Acta Neuropathol Commun 6:79","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR523","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1440-1789.2011.01222.x","volume":"32","author":"K Masui","year":"2012","unstructured":"Masui K, Nakata Y, Fujii N, Iwaki T (2012) Extensive distribution of glial cytoplasmic inclusions in an autopsied case of multiple system atrophy with a prolonged 18-year clinical course. Neuropathology 32:69\u201376","journal-title":"Neuropathology"},{"key":"2028_CR524","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0002-9440(10)65617-9","volume":"153","author":"A Matsuo","year":"1998","unstructured":"Matsuo A, Akiguchi I, Lee GC, McGeer EG, McGeer PL, Kimura J (1998) Myelin degeneration in multiple system atrophy detected by unique antibodies. Am J Pathol 153:735\u2013744","journal-title":"Am J Pathol"},{"key":"2028_CR525","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00234-008-0381-y","volume":"50","author":"E Matsusue","year":"2008","unstructured":"Matsusue E, Fujii S, Kanasaki Y, Sugihara S, Miyata H, Ohama E, Ogawa T (2008) Putaminal lesion in multiple system atrophy: postmortem MR-pathological correlations. Neuroradiology 50:559\u2013567","journal-title":"Neuroradiology"},{"key":"2028_CR912","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-00019-02014-y","author":"P Mavroeidi","year":"2019","unstructured":"Mavroeidi P, Arvanitaki F, Karakitsou AK, Vetsi M, Kloukina I, Zweckstetter M, Giller K, Becker S, Sorrentino ZA, Giasson BI, Jensen PH, Stefanis L, Xilouri M (2019) Endogenous oligodendroglial alpha-synuclein and TPPP\/p25alpha orchestrate alpha-synuclein pathology in experimental multiple system atrophy models. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-00019-02014-y","journal-title":"Acta Neuropathol"},{"key":"2028_CR526","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/bpa.12424","volume":"27","author":"KE McAleese","year":"2017","unstructured":"McAleese KE, Walker L, Erskine D, Thomas AJ, McKeith IG, Attems J (2017) TDP-43 pathology in Alzheimer\u2019s disease, dementia with Lewy bodies and ageing. Brain Pathol 27:472\u2013479","journal-title":"Brain Pathol"},{"key":"2028_CR527","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jneumeth.2016.03.016","volume":"266","author":"A McCormack","year":"2016","unstructured":"McCormack A, Chegeni N, Chegini F, Colella A, Power J, Keating D, Chataway T (2016) Purification of alpha-synuclein containing inclusions from human post mortem brain tissue. J Neurosci Methods 266:141\u2013150","journal-title":"J Neurosci Methods"},{"key":"2028_CR528","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s12640-019-00014-0","volume":"35","author":"A McCormack","year":"2019","unstructured":"McCormack A, Keating DJ, Chegeni N, Colella A, Wang JJ, Chataway T (2019) Abundance of synaptic vesicle-related proteins in alpha-synuclein-containing protein inclusions suggests a targeted formation mechanism. Neurotox Res 35:883\u2013897","journal-title":"Neurotox Res"},{"key":"2028_CR529","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.neuron.2019.03.004","volume":"101","author":"MM McGregor","year":"2019","unstructured":"McGregor MM, Nelson AB (2019) Circuit mechanisms of Parkinson\u2019s disease. Neuron 101:1042\u20131056","journal-title":"Neuron"},{"key":"2028_CR530","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/bpa.12248","volume":"25","author":"AC McKee","year":"2015","unstructured":"McKee AC, Stein TD, Kiernan PT, Alvarez VE (2015) The neuropathology of chronic traumatic encephalopathy. Brain Pathol 25:350\u2013364","journal-title":"Brain Pathol"},{"key":"2028_CR531","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/B978-0-444-63954-7.00028-8","volume":"158","author":"AC McKee","year":"2018","unstructured":"McKee AC, Abdolmohammadi B, Stein TD (2018) The neuropathology of chronic traumatic encephalopathy. Handb Clin Neurol 158:297\u2013307","journal-title":"Handb Clin Neurol"},{"key":"2028_CR532","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/jnnp.2007.134163","volume":"7","author":"I McKeith","year":"2007","unstructured":"McKeith I (2007) Dementia with Lewy bodies and Parkinson\u2019s disease with dementia: where two worlds collide. Pract Neurol 7:374\u2013382","journal-title":"Pract Neurol"},{"key":"2028_CR533","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863\u20131872","journal-title":"Neurology"},{"key":"2028_CR534","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O\u2019Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89:88\u2013100","journal-title":"Neurology"},{"key":"2028_CR535","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1474-4422(13)70057-7","volume":"12","author":"R Mehanna","year":"2013","unstructured":"Mehanna R, Jankovic J (2013) Movement disorders in cerebrovascular disease. Lancet Neurol 12:597\u2013608","journal-title":"Lancet Neurol"},{"key":"2028_CR536","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2019.1003.1001","author":"S Mehra","year":"2019","unstructured":"Mehra S, Sahay S, Maji SK (2019) Alpha-synuclein misfolding and aggregation: implications in Parkinson\u2019s disease pathogenesis. Biochim Biophys Acta Proteins Proteomics. https:\/\/doi.org\/10.1016\/j.bbapap.2019.1003.1001","journal-title":"Biochim Biophys Acta Proteins Proteomics"},{"key":"2028_CR537","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3389\/fneur.2019.00391","volume":"10","author":"TR Melzer","year":"2019","unstructured":"Melzer TR, Stark MR, Keenan RJ, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Grenfell S, Horne KL, Young BN, Pascoe MJ, Almuqbel MM, Wang J, Marsh SH, Miller DH, Dalrymple-Alford JC, Anderson TJ (2019) Beta amyloid deposition is not associated with cognitive impairment in Parkinson\u2019s disease. Front Neurol 10:391","journal-title":"Front Neurol"},{"key":"2028_CR538","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1002\/mds.26360","volume":"30","author":"CE Mendoza-Santiesteban","year":"2015","unstructured":"Mendoza-Santiesteban CE, Palma JA, Martinez J, Norcliffe-Kaufmann L, Hedges TR 3rd, Kaufmann H (2015) Progressive retinal structure abnormalities in multiple system atrophy. Mov Disord 30:1944\u20131953","journal-title":"Mov Disord"},{"key":"2028_CR539","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-018-1923-y","volume":"137","author":"K Mensikova","year":"2019","unstructured":"Mensikova K, Tuckova L, Kolarikova K, Bartonikova T, Vodicka R, Ehrmann J, Vrtel R, Prochazka M, Kanovsky P, Kovacs GG (2019) Atypical parkinsonism of progressive supranuclear palsy-parkinsonism (PSP-P) phenotype with rare variants in FBXO7 and VPS35 genes associated with Lewy body pathology. Acta Neuropathol 137:171\u2013173","journal-title":"Acta Neuropathol"},{"key":"2028_CR540","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JPD-2011-11023","volume":"1","author":"GE Meredith","year":"2011","unstructured":"Meredith GE, Rademacher DJ (2011) MPTP mouse models of Parkinson\u2019s disease: an update. J Parkinsons Dis 1:19\u201333","journal-title":"J Parkinsons Dis"},{"key":"2028_CR541","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","volume":"90","author":"PP Michel","year":"2016","unstructured":"Michel PP, Hirsch EC, Hunot S (2016) Understanding dopaminergic cell death pathways in Parkinson disease. Neuron 90:675\u2013691","journal-title":"Neuron"},{"key":"2028_CR542","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.3390\/ijms15034671","volume":"15","author":"A Mietelska-Porowska","year":"2014","unstructured":"Mietelska-Porowska A, Wasik U, Goras M, Filipek A, Niewiadomska G (2014) Tau protein modifications and interactions: their role in function and dysfunction. Int J Mol Sci 15:4671\u20134713","journal-title":"Int J Mol Sci"},{"key":"2028_CR543","doi-asserted-by":"publisher","DOI":"10.1007\/s11682-11018-19922-11680","author":"AS Mihaescu","year":"2018","unstructured":"Mihaescu AS, Masellis M, Graff-Guerrero A, Kim J, Criaud M, Cho SS, Ghadery C, Valli M, Strafella AP (2018) Brain degeneration in Parkinson\u2019s disease patients with cognitive decline: a coordinate-based meta-analysis. Brain Imaging Behav. https:\/\/doi.org\/10.1007\/s11682-11018-19922-11680","journal-title":"Brain Imaging Behav"},{"key":"2028_CR544","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s00702-018-1885-1","volume":"125","author":"M Mikasa","year":"2018","unstructured":"Mikasa M, Kanai K, Li Y, Yoshino H, Mogushi K, Hayashida A, Ikeda A, Kawajiri S, Okuma Y, Kashihara K, Sato T, Kondo H, Funayama M, Nishioka K, Hattori N (2018) COQ2 variants in Parkinson\u2019s disease and multiple system atrophy. J Neural Transm (Vienna) 125:937\u2013944","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR545","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00401-008-0439-2","volume":"116","author":"J Miklossy","year":"2008","unstructured":"Miklossy J, Steele JC, Yu S, McCall S, Sandberg G, McGeer EG, McGeer PL (2008) Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis\/parkinsonism-dementia complex of Guam (ALS\/PDC). Acta Neuropathol 116:625\u2013637","journal-title":"Acta Neuropathol"},{"key":"2028_CR546","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.nbd.2018.10.020","volume":"124","author":"L Milosevic","year":"2019","unstructured":"Milosevic L, Gramer R, Kim TH, Algarni M, Fasano A, Kalia SK, Hodaie M, Lozano AM, Popovic MR, Hutchison WD (2019) Modulation of inhibitory plasticity in basal ganglia output nuclei of patients with Parkinson\u2019s disease. Neurobiol Dis 124:46\u201356","journal-title":"Neurobiol Dis"},{"key":"2028_CR547","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/neup.12434","volume":"38","author":"M Mimuro","year":"2018","unstructured":"Mimuro M, Yoshida M, Kuzuhara S, Kokubo Y (2018) Amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Hohara focus of the Kii Peninsula: a multiple proteinopathy? Neuropathology 38:98\u2013107","journal-title":"Neuropathology"},{"key":"2028_CR548","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/jnen\/nlx049","volume":"76","author":"T Mishima","year":"2017","unstructured":"Mishima T, Koga S, Lin WL, Kasanuki K, Castanedes-Casey M, Wszolek ZK, Oh SJ, Tsuboi Y, Dickson DW (2017) Perry syndrome: a distinctive type of TDP-43 proteinopathy. J Neuropathol Exp Neurol 76:676\u2013682","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR549","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1136\/jnnp-2017-316864","volume":"89","author":"T Mishima","year":"2018","unstructured":"Mishima T, Fujioka S, Tomiyama H, Yabe I, Kurisaki R, Fujii N, Neshige R, Ross OA, Farrer MJ, Dickson DW, Wszolek ZK, Hattori N, Tsuboi Y (2018) Establishing diagnostic criteria for Perry syndrome. J Neurol Neurosurg Psychiatry 89:482\u2013487","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2028_CR550","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/acn3.185","volume":"2","author":"J Mitsui","year":"2015","unstructured":"Mitsui J, Matsukawa T, Sasaki H, Yabe I, Matsushima M, Durr A, Brice A, Takashima H, Kikuchi A, Aoki M, Ishiura H, Yasuda T, Date H, Ahsan B, Iwata A, Goto J, Ichikawa Y, Nakahara Y, Momose Y, Takahashi Y, Hara K, Kakita A, Yamada M, Takahashi H, Onodera O, Nishizawa M, Watanabe H, Ito M, Sobue G, Ishikawa K, Mizusawa H, Kanai K, Hattori T, Kuwabara S, Arai K, Koyano S, Kuroiwa Y, Hasegawa K, Yuasa T, Yasui K, Nakashima K, Ito H, Izumi Y, Kaji R, Kato T, Kusunoki S, Osaki Y, Horiuchi M, Kondo T, Murayama S, Hattori N, Yamamoto M, Murata M, Satake W, Toda T, Filla A, Klockgether T, Wullner U, Nicholson G, Gilman S, Tanner CM, Kukull WA, Stern MB, Lee VM, Trojanowski JQ, Masliah E, Low PA, Sandroni P, Ozelius LJ, Foroud T, Tsuji S (2015) Variants associated with Gaucher disease in multiple system atrophy. Ann Clin Transl Neurol 2:417\u2013426","journal-title":"Ann Clin Transl Neurol"},{"key":"2028_CR551","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.07.005","volume":"22","author":"Y Miyaji","year":"2013","unstructured":"Miyaji Y, Koyama K, Kurokawa T, Mitomi M, Suzuki Y, Kuroiwa Y (2013) Vascular corticobasal syndrome caused by unilateral internal carotid artery occlusion. J Stroke Cerebrovasc Dis 22:1193\u20131195","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2028_CR552","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/brain\/awp280","volume":"133","author":"J Molano","year":"2010","unstructured":"Molano J, Boeve B, Ferman T, Smith G, Parisi J, Dickson D, Knopman D, Graff-Radford N, Geda Y, Lucas J, Kantarci K, Shiung M, Jack C, Silber M, Pankratz VS, Petersen R (2010) Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. Brain 133:540\u2013556","journal-title":"Brain"},{"key":"2028_CR553","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.stemcr.2018.09.007","volume":"11","author":"G Monzio Compagnoni","year":"2018","unstructured":"Monzio Compagnoni G, Kleiner G, Samarani M, Aureli M, Faustini G, Bellucci A, Ronchi D, Bordoni A, Garbellini M, Salani S, Fortunato F, Frattini E, Abati E, Bergamini C, Fato R, Tabano S, Miozzo M, Serratto G, Passafaro M, Deleidi M, Silipigni R, Nizzardo M, Bresolin N, Comi GP, Corti S, Quinzii CM, Di Fonzo A (2018) Mitochondrial dysregulation and impaired autophagy in iPSC-derived dopaminergic neurons of multiple system atrophy. Stem Cell Rep 11:1185\u20131198","journal-title":"Stem Cell Rep"},{"key":"2028_CR554","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/nn.4641","volume":"20","author":"DE Mor","year":"2017","unstructured":"Mor DE, Tsika E, Mazzulli JR, Gould NS, Kim H, Daniels MJ, Doshi S, Gupta P, Grossman JL, Tan VX, Kalb RG, Caldwell KA, Caldwell GA, Wolfe JH, Ischiropoulos H (2017) Dopamine induces soluble alpha-synuclein oligomers and nigrostriatal degeneration. Nat Neurosci 20:1560\u20131568","journal-title":"Nat Neurosci"},{"key":"2028_CR555","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/mds.27607","volume":"34","author":"DE Mor","year":"2019","unstructured":"Mor DE, Daniels MJ, Ischiropoulos H (2019) The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration. Mov Disord 34:167\u2013179","journal-title":"Mov Disord"},{"key":"2028_CR556","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.25453","volume":"85","author":"S Morbelli","year":"2019","unstructured":"Morbelli S, Chincarini A, Brendel M, Rominger A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Garibotto V, Nicastro N, Frisoni GB, Lemstra AW, van der Zande J, Pilotto A, Padovani A, Garcia-Ptacek S, Savitcheva I, Ochoa-Figueroa MA, Davidsson A, Camacho V, Peira E, Arnaldi D, Bauckneht M, Pardini M, Sambuceti G, Aarsland D, Nobili F (2019) Metabolic patterns across core features in dementia with Lewy bodies. Ann Neurol 85:715\u2013725","journal-title":"Ann Neurol"},{"key":"2028_CR557","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s004010100443","volume":"103","author":"F Mori","year":"2002","unstructured":"Mori F, Inenaga C, Yoshimoto M, Umezu H, Tanaka R, Takahashi H, Wakabayashi K (2002) Alpha-synuclein immunoreactivity in normal and neoplastic Schwann cells. Acta Neuropathol 103:145\u2013151","journal-title":"Acta Neuropathol"},{"key":"2028_CR558","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/01.jnen.0000230520.47768.1a","volume":"65","author":"F Mori","year":"2006","unstructured":"Mori F, Nishie M, Kakita A, Yoshimoto M, Takahashi H, Wakabayashi K (2006) Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra. J Neuropathol Exp Neurol 65:808\u2013815","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR559","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fnana.2016.00109","volume":"10","author":"F Mori","year":"2016","unstructured":"Mori F, Okada KI, Nomura T, Kobayashi Y (2016) The pedunculopontine tegmental nucleus as a motor and cognitive interface between the cerebellum and basal ganglia. Front Neuroanat 10:109","journal-title":"Front Neuroanat"},{"key":"2028_CR560","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/bpa.12500","volume":"28","author":"S Morimoto","year":"2018","unstructured":"Morimoto S, Hatsuta H, Kokubo Y, Nakano Y, Hasegawa M, Yoneda M, Hirokawa Y, Kuzuhara S, Shiraishi T, Murayama S (2018) Unusual tau pathology of the cerebellum in patients with amyotrophic lateral sclerosis\/parkinsonism-dementia complex from the Kii Peninsula, Japan. Brain Pathol 28:287\u2013291","journal-title":"Brain Pathol"},{"key":"2028_CR561","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3389\/fncir.2018.00111","volume":"12","author":"K Morita","year":"2019","unstructured":"Morita K, Kawaguchi Y (2019) A dual role hypothesis of the cortico-basal-ganglia pathways: opponency and temporal difference through dopamine and adenosine. Front Neural Circuits 12:111","journal-title":"Front Neural Circuits"},{"key":"2028_CR562","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.26103","volume":"30","author":"EV Mosharov","year":"2015","unstructured":"Mosharov EV, Borgkvist A, Sulzer D (2015) Presynaptic effects of levodopa and their possible role in dyskinesia. Mov Disord 30:45\u201353","journal-title":"Mov Disord"},{"key":"2028_CR563","first-page":"1268","volume":"70","author":"V Moskvina","year":"2013","unstructured":"Moskvina V, Harold D, Russo G, Vedernikov A, Sharma M, Saad M, Holmans P, Bras JM, Bettella F, Keller MF, Nicolaou N, Simon-Sanchez J, Gibbs JR, Schulte C, Durr A, Guerreiro R, Hernandez D, Brice A, Stefansson H, Majamaa K, Gasser T, Heutink P, Wood N, Martinez M, Singleton AB, Nalls MA, Hardy J, Owen MJ, O\u2019Donovan MC, Williams J, Morris HR, Williams NM (2013) Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk. JAMA Neurol 70:1268\u20131276","journal-title":"JAMA Neurol"},{"key":"2028_CR564","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1212115","volume":"369","author":"MSA-Research-Collaboration, Collaboration M-SAR","year":"2013","unstructured":"MSA-Research-Collaboration, Collaboration M-SAR (2013) Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med 369:233\u2013244","journal-title":"N Engl J Med"},{"key":"2028_CR565","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40478-017-0488-7","volume":"5","author":"A Mudher","year":"2017","unstructured":"Mudher A, Colin M, Dujardin S, Medina M, Dewachter I, Alavi Naini SM, Mandelkow EM, Mandelkow E, Buee L, Goedert M, Brion JP (2017) What is the evidence that tau pathology spreads through prion-like propagation? Acta Neuropathol Commun 5:99","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR566","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","volume":"21","author":"A Mulak","year":"2015","unstructured":"Mulak A, Bonaz B (2015) Brain-gut-microbiota axis in Parkinson\u2019s disease. World J Gastroenterol 21:10609\u201310620","journal-title":"World J Gastroenterol"},{"key":"2028_CR567","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.neurobiolaging.2013.03.016","volume":"34","author":"SK Muller","year":"2013","unstructured":"Muller SK, Bender A, Laub C, Hogen T, Schlaudraff F, Liss B, Klopstock T, Elstner M (2013) Lewy body pathology is associated with mitochondrial DNA damage in Parkinson\u2019s disease. Neurobiol Aging 34:2231\u20132233","journal-title":"Neurobiol Aging"},{"key":"2028_CR568","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s12035-013-8394-x","volume":"47","author":"S Mullin","year":"2013","unstructured":"Mullin S, Schapira A (2013) Alpha-synuclein and mitochondrial dysfunction in Parkinson\u2019s disease. Mol Neurobiol 47:587\u2013597","journal-title":"Mol Neurobiol"},{"key":"2028_CR569","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1111\/ene.13837","volume":"26","author":"S Mullin","year":"2019","unstructured":"Mullin S, Hughes D, Mehta A, Schapira AHV (2019) Neurological effects of glucocerebrosidase gene mutations. Eur J Neurol 26:e329\u2013e388","journal-title":"Eur J Neurol"},{"key":"2028_CR570","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0891-0618(00)00096-X","volume":"20","author":"G Munch","year":"2000","unstructured":"Munch G, Luth HJ, Wong A, Arendt T, Hirsch E, Ravid R, Riederer P (2000) Crosslinking of alpha-synuclein by advanced glycation endproducts\u2014an early pathophysiological step in Lewy body formation? J Chem Neuroanat 20:253\u2013257","journal-title":"J Chem Neuroanat"},{"key":"2028_CR571","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/9781444341256.ch16","volume-title":"Neurodegeneration: the molecular pathology of dementia and movement disorders","author":"DG Munoz","year":"2011","unstructured":"Munoz DG, Morris HR, Rossor M (2011) Pick\u2019s disease. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 156\u2013164","edition":"2"},{"key":"2028_CR572","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt231","volume":"6","author":"ME Murray","year":"2014","unstructured":"Murray ME, Kouri N, Lin WL, Jack CR Jr, Dickson DW, Vemuri P (2014) Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias. Alzheimers Res Ther 6:1","journal-title":"Alzheimers Res Ther"},{"key":"2028_CR573","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/13554794.2019.1604973","volume":"25","author":"G Naasan","year":"2019","unstructured":"Naasan G, Shany-Ur T, Sidhu M, Barton C, Ketelle R, Shdo SM, Kramer JH, Miller BL, Seeley WW (2019) Corticobasal syndrome with visual hallucinations and probable REM-sleep behavior disorder: an autopsied case report of a patient with CBD and LBD pathology. Neurocase 25:26\u201333","journal-title":"Neurocase"},{"key":"2028_CR574","doi-asserted-by":"publisher","first-page":"14215","DOI":"10.1038\/s41598-018-32573-1","volume":"8","author":"FK Nakamoto","year":"2018","unstructured":"Nakamoto FK, Okamoto S, Mitsui J, Sone T, Ishikawa M, Yamamoto Y, Kanegae Y, Nakatake Y, Imaizumi K, Ishiura H, Tsuji S, Okano H (2018) The pathogenesis linked to coenzyme Q10 insufficiency in iPSC-derived neurons from patients with multiple-system atrophy. Sci Rep 8:14215","journal-title":"Sci Rep"},{"key":"2028_CR575","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40478-015-0208-0","volume":"3","author":"K Nakamura","year":"2015","unstructured":"Nakamura K, Mori F, Kon T, Tanji K, Miki Y, Tomiyama M, Kurotaki H, Toyoshima Y, Kakita A, Takahashi H, Yamada M, Wakabayashi K (2015) Filamentous aggregations of phosphorylated alpha-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy. Acta Neuropathol Commun 3:29","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR576","doi-asserted-by":"publisher","first-page":"17186","DOI":"10.1523\/JNEUROSCI.2220-12.2012","volume":"32","author":"Y Nakata","year":"2012","unstructured":"Nakata Y, Yasuda T, Fukaya M, Yamamori S, Itakura M, Nihira T, Hayakawa H, Kawanami A, Kataoka M, Nagai M, Sakagami H, Takahashi M, Mizuno Y, Mochizuki H (2012) Accumulation of alpha-synuclein triggered by presynaptic dysfunction. J Neurosci 32:17186\u201317196","journal-title":"J Neurosci"},{"key":"2028_CR577","doi-asserted-by":"publisher","first-page":"11406","DOI":"10.1523\/JNEUROSCI.1230-17.2017","volume":"37","author":"S Narasimhan","year":"2017","unstructured":"Narasimhan S, Guo JL, Changolkar L, Stieber A, McBride JD, Silva LV, He Z, Zhang B, Gathagan RJ, Trojanowski JQ, Lee VMY (2017) Pathological tau strains from human brains recapitulate the diversity of tauopathies in nontransgenic mouse brain. J Neurosci 37:11406\u201311423","journal-title":"J Neurosci"},{"key":"2028_CR578","doi-asserted-by":"publisher","DOI":"10.1080\/10790268.10792018.11557863","author":"R Nardone","year":"2019","unstructured":"Nardone R, Holler Y, Brigo F, Versace V, Sebastianelli L, Florea C, Schwenker K, Golaszewski S, Saltuari L, Trinka E (2019) Spinal cord involvement in Lewy body-related alpha-synucleinopathies. J Spinal Cord Med. https:\/\/doi.org\/10.1080\/10790268.10792018.11557863","journal-title":"J Spinal Cord Med"},{"key":"2028_CR579","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12974-019-1477-5","volume":"16","author":"A Ndayisaba","year":"2019","unstructured":"Ndayisaba A, Jellinger K, Berger T, Wenning GK (2019) TNFalpha inhibitors as targets for protective therapies in MSA: a viewpoint. J Neuroinflamm 16:80","journal-title":"J Neuroinflamm"},{"key":"2028_CR580","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41380-018-0130-5","volume":"24","author":"S Nejad-Davarani","year":"2019","unstructured":"Nejad-Davarani S, Koeppe RA, Albin RL, Frey KA, Muller M, Bohnen NI (2019) Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [(18)F]-FEOBV. Mol Psychiatry 24:322\u2013327","journal-title":"Mol Psychiatry"},{"key":"2028_CR581","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/archneurol.2010.319","volume":"68","author":"A Nervi","year":"2011","unstructured":"Nervi A, Reitz C, Tang MX, Santana V, Piriz A, Reyes D, Lantigua R, Medrano M, Jimenez-Velazquez IZ, Lee JH, Mayeux R (2011) Familial aggregation of dementia with Lewy bodies. Arch Neurol 68:90\u201393","journal-title":"Arch Neurol"},{"key":"2028_CR582","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/nan.12526","volume":"45","author":"M Neumann","year":"2019","unstructured":"Neumann M, Mackenzie IRA (2019) Review: neuropathology of non-tau frontotemporal lobar degeneration. Neuropathol Appl Neurobiol 45:19\u201340","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR583","first-page":"2655","volume":"141","author":"WJ Neumann","year":"2018","unstructured":"Neumann WJ, Schroll H, de Almeida Marcelino AL, Horn A, Ewert S, Irmen F, Krause P, Schneider GH, Hamker F, Kuhn AA (2018) Functional segregation of basal ganglia pathways in Parkinson\u2019s disease. Brain 141:2655\u20132669","journal-title":"Brain"},{"key":"2028_CR913","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.tins.2018.11.001","volume":"42","author":"M Nguyen","year":"2019","unstructured":"Nguyen M, Wong YC, Ysselstein D, Severino A, Krainc D (2019) Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson\u2019s disease. Trends Neurosci 42:140\u2013149","journal-title":"Trends Neurosci"},{"key":"2028_CR584","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/ana.22221","volume":"68","author":"Z Ni","year":"2010","unstructured":"Ni Z, Pinto AD, Lang AE, Chen R (2010) Involvement of the cerebellothalamocortical pathway in Parkinson disease. Ann Neurol 68:816\u2013824","journal-title":"Ann Neurol"},{"key":"2028_CR585","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/nan.12229","volume":"41","author":"N Nishida","year":"2015","unstructured":"Nishida N, Yoshida K, Hata Y, Arai Y, Kinoshita K (2015) Pathological features of preclinical or early clinical stages of corticobasal degeneration: a comparison with advanced cases. Neuropathol Appl Neurobiol 41:893\u2013905","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR586","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40035-018-0128-6","volume":"7","author":"H Niu","year":"2018","unstructured":"Niu H, Shen L, Li T, Ren C, Ding S, Wang L, Zhang Z, Liu X, Zhang Q, Geng D, Wu X, Li H (2018) Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson\u2019s disease. Transl Neurodegener 7:25","journal-title":"Transl Neurodegener"},{"key":"2028_CR587","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.expneurol.2017.10.017","volume":"299","author":"N Nouraei","year":"2018","unstructured":"Nouraei N, Mason DM, Miner KM, Carcella MA, Bhatia TN, Dumm BK, Soni D, Johnson DA, Luk KC, Leak RK (2018) Critical appraisal of pathology transmission in the alpha-synuclein fibril model of Lewy body disorders. Exp Neurol 299:172\u2013196","journal-title":"Exp Neurol"},{"key":"2028_CR588","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1101\/cshperspect.a024109","volume":"8","author":"RL Nussbaum","year":"2018","unstructured":"Nussbaum RL (2018) Genetics of synucleinopathies. Cold Spring Harb Perspect Med 8:78. https:\/\/doi.org\/10.1101\/cshperspect.a024109","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2028_CR589","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/mds.26979","volume":"32","author":"C Nykjaer","year":"2017","unstructured":"Nykjaer C, Brudek T, Salvesen L, Pakkenberg B (2017) Changes in the cell population in brain white matter in multiple system atrophy. Mov Disord 32:1074\u20131082","journal-title":"Mov Disord"},{"key":"2028_CR590","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.27115","volume":"32","author":"JA Obeso","year":"2017","unstructured":"Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ (2017) Past, present, and future of Parkinson\u2019s disease: a special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord 32:1264\u20131310","journal-title":"Mov Disord"},{"key":"2028_CR591","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00401-012-0975-7","volume":"124","author":"S Odagiri","year":"2012","unstructured":"Odagiri S, Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K (2012) Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in alpha-synucleinopathy. Acta Neuropathol 124:173\u2013186","journal-title":"Acta Neuropathol"},{"key":"2028_CR592","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/mds.27297","volume":"33","author":"K Ogaki","year":"2018","unstructured":"Ogaki K, Martens YA, Heckman MG, Koga S, Labbe C, Lorenzo-Betancor O, Wernick AI, Walton RL, Soto AI, Vargas ER, Nielsen HM, Fujioka S, Kanekiyo T, Uitti RJ, van Gerpen JA, Cheshire WP, Wszolek ZK, Low PA, Singer W, Dickson DW, Bu G, Ross OA (2018) Multiple system atrophy and apolipoprotein E. Mov Disord 33:647\u2013650","journal-title":"Mov Disord"},{"key":"2028_CR593","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00401-009-0629-6","volume":"119","author":"M Oinas","year":"2010","unstructured":"Oinas M, Paetau A, Myllykangas L, Notkola IL, Kalimo H, Polvikoski T (2010) Alpha-synuclein pathology in the spinal cord autonomic nuclei associates with alpha-synuclein pathology in the brain: a population-based Vantaa 85+ study. Acta Neuropathol 119:715\u2013722","journal-title":"Acta Neuropathol"},{"key":"2028_CR594","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.parkreldis.2018.06.025","volume":"56","author":"GW O\u2019Keeffe","year":"2018","unstructured":"O\u2019Keeffe GW, Sullivan AM (2018) Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson\u2019s disease. Parkinsonism Relat Disord 56:9\u201315","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR914","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.13464","author":"J Olah","year":"2019","unstructured":"Olah J, Ovadi J (2019) Pharmacological targeting of alpha-synuclein and TPPP\/p25 in Parkinson\u2019s disease: challenges and opportunities in a Nutshell. FEBS Lett. https:\/\/doi.org\/10.1002\/1873-3468.13464","journal-title":"FEBS Lett"},{"key":"2028_CR595","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/14789450.2017.1304216","volume":"14","author":"J Olah","year":"2017","unstructured":"Olah J, Bertrand P, Ovadi J (2017) Role of the microtubule-associated TPPP\/p25 in Parkinson\u2019s and related diseases and its therapeutic potential. Expert Rev Proteom 14:301\u2013309","journal-title":"Expert Rev Proteom"},{"key":"2028_CR596","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1093\/brain\/awz104","volume":"142","author":"CW Olanow","year":"2019","unstructured":"Olanow CW, Savolainen M, Chu Y, Halliday GM, Kordower JH (2019) Temporal evolution of microglia and alpha-synuclein accumulation following foetal grafting in Parkinson\u2019s disease. Brain 142:1690\u20131700","journal-title":"Brain"},{"key":"2028_CR597","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jalz.2018.09.011","volume":"15","author":"K Oppedal","year":"2019","unstructured":"Oppedal K, Ferreira D, Cavallin L, Lemstra AW, Ten Kate M, Padovani A, Rektorova I, Bonanni L, Wahlund LO, Engedal K, Nobili F, Kramberger M, Taylor JP, Hort J, Snaedal J, Blanc F, Walker Z, Antonini A, Westman E, Aarsland D (2019) A signature pattern of cortical atrophy in dementia with Lewy bodies: a study on 333 patients from the European DLB consortium. Alzheimers Dement 15:400\u2013409","journal-title":"Alzheimers Dement"},{"key":"2028_CR598","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3233\/JPD-171092","volume":"7","author":"G O\u2019Regan","year":"2017","unstructured":"O\u2019Regan G, deSouza RM, Balestrino R, Schapira AH (2017) Glucocerebrosidase mutations in Parkinson disease. J Parkinsons Dis 7:411\u2013422","journal-title":"J Parkinsons Dis"},{"key":"2028_CR599","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/brain\/awm302","volume":"131","author":"S Orimo","year":"2008","unstructured":"Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, Takahashi H (2008) Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson\u2019s disease. Brain 131:642\u2013650","journal-title":"Brain"},{"key":"2028_CR600","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11910-018-0874-y","volume":"18","author":"T Orme","year":"2018","unstructured":"Orme T, Guerreiro R, Bras J (2018) The genetics of dementia with Lewy bodies: current understanding and future directions. Curr Neurol Neurosci Rep 18:67","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2028_CR601","doi-asserted-by":"publisher","first-page":"e12821","DOI":"10.1111\/acel.12821","volume":"17","author":"C Ortega-de San Luis","year":"2018","unstructured":"Ortega-de San Luis C, Sanchez-Garcia MA, Nieto-Gonzalez JL, Garcia-Junco-Clemente P, Montero-Sanchez A, Fernandez-Chacon R, Pascual A (2018) Substantia nigra dopaminergic neurons and striatal interneurons are engaged in three parallel but interdependent postnatal neurotrophic circuits. Aging Cell 17:e12821","journal-title":"Aging Cell"},{"key":"2028_CR602","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40478-018-0596-z","volume":"6","author":"I Ortuno-Lizaran","year":"2018","unstructured":"Ortuno-Lizaran I, Esquiva G, Beach TG, Serrano GE, Adler CH, Lax P, Cuenca N (2018) Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson\u2019s disease. Acta Neuropathol Commun 6:90","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR603","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1002\/mds.22826","volume":"24","author":"Y Osaki","year":"2009","unstructured":"Osaki Y, Ben-Shlomo Y, Lees AJ, Wenning GK, Quinn NP (2009) A validation exercise on the new consensus criteria for multiple system atrophy. Mov Disord 24:2272\u20132276","journal-title":"Mov Disord"},{"key":"2028_CR604","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/ene.13551","volume":"25","author":"R Ou","year":"2018","unstructured":"Ou R, Wei Q, Hou Y, Yuan X, Song W, Cao B, Liu H, Zhang L, Chen Y, Shang H (2018) Vascular risk factors and depression in Parkinson\u2019s disease. Eur J Neurol 25:637\u2013643","journal-title":"Eur J Neurol"},{"key":"2028_CR605","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/mds.25746","volume":"29","author":"H Ouchi","year":"2014","unstructured":"Ouchi H, Toyoshima Y, Tada M, Oyake M, Aida I, Tomita I, Satoh A, Tsujihata M, Takahashi H, Nishizawa M, Shimohata T (2014) Pathology and sensitivity of current clinical criteria in corticobasal syndrome. Mov Disord 29:238\u2013244","journal-title":"Mov Disord"},{"key":"2028_CR606","doi-asserted-by":"publisher","DOI":"10.1042\/BST20180466","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF, Harvey K, Dominguez-Meijide A, Gerhardt E (2019) LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders? Biochem Soc Trans. https:\/\/doi.org\/10.1042\/BST20180466","journal-title":"Biochem Soc Trans"},{"key":"2028_CR607","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, McKeith I (2019b) Dementia with Lewy bodies: an update and outlook. Mol Neurodegener 14:5","journal-title":"Mol Neurodegener"},{"key":"2028_CR608","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00401-017-1772-0","volume":"135","author":"C Overk","year":"2018","unstructured":"Overk C, Rockenstein E, Valera E, Stefanova N, Wenning G, Masliah E (2018) Multiple system atrophy: experimental models and reality. Acta Neuropathol 135:33\u201347","journal-title":"Acta Neuropathol"},{"key":"2028_CR609","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/9781444341256.ch18","volume-title":"Neurodegeneration: the molecular pathology of dementia and movement disorders","author":"K Oyanagi","year":"2011","unstructured":"Oyanagi K, Hashimoto T, Yamazaki M (2011) Parkinsonism-dementia complex of Guam. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 171\u2013178","edition":"2"},{"key":"2028_CR610","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00401-007-0254-1","volume":"114","author":"T Ozawa","year":"2007","unstructured":"Ozawa T (2007) Morphological substrate of autonomic failure and neurohormonal dysfunction in multiple system atrophy: impact on determining phenotype spectrum. Acta Neuropathol (Berl) 114:201\u2013211","journal-title":"Acta Neuropathol (Berl)"},{"key":"2028_CR611","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2183\/pjab.93.016","volume":"93","author":"T Ozawa","year":"2017","unstructured":"Ozawa T, Onodera O (2017) Multiple system atrophy: clinicopathological characteristics in Japanese patients. Proc Jpn Acad Ser B Phys Biol Sci 93:251\u2013258","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"2028_CR612","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00702-017-1823-7","volume":"125","author":"G Pagano","year":"2018","unstructured":"Pagano G, Niccolini F, Politis M (2018) The serotonergic system in Parkinson\u2019s patients with dyskinesia: evidence from imaging studies. J Neural Transm (Vienna) 125:1217\u20131223","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR613","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1002\/mds.23221","volume":"25","author":"C Paisan-Ruiz","year":"2010","unstructured":"Paisan-Ruiz C, Guevara R, Federoff M, Hanagasi H, Sina F, Elahi E, Schneider SA, Schwingenschuh P, Bajaj N, Emre M, Singleton AB, Hardy J, Bhatia KP, Brandner S, Lees AJ, Houlden H (2010) Early-onset l-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov Disord 25:1791\u20131800","journal-title":"Mov Disord"},{"key":"2028_CR614","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/brain\/awm318","volume":"131","author":"T Pan","year":"2008","unstructured":"Pan T, Kondo S, Le W, Jankovic J (2008) The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson\u2019s disease. Brain 131:1969\u20131978","journal-title":"Brain"},{"key":"2028_CR615","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.nbd.2018.04.020","volume":"122","author":"PY Pan","year":"2019","unstructured":"Pan PY, Zhu Y, Shen Y, Yue Z (2019) Crosstalk between presynaptic trafficking and autophagy in Parkinson\u2019s disease. Neurobiol Dis 122:64\u201371","journal-title":"Neurobiol Dis"},{"key":"2028_CR616","doi-asserted-by":"publisher","first-page":"e8762","DOI":"10.1371\/journal.pone.0008762","volume":"5","author":"F Pan-Montojo","year":"2010","unstructured":"Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H, Funk RH (2010) Progression of Parkinson\u2019s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 5:e8762","journal-title":"PLoS One"},{"key":"2028_CR617","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neuroscience.2018.04.003","volume":"405","author":"RC Paolicelli","year":"2019","unstructured":"Paolicelli RC, Bergamini G, Rajendran L (2019) Cell-to-cell communication by extracellular vesicles: focus on microglia. Neuroscience 405:148\u2013157","journal-title":"Neuroscience"},{"key":"2028_CR618","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/mds.26273","volume":"30","author":"SM Papa","year":"2015","unstructured":"Papa SM, Wichmann T (2015) Interaction between hyperdirect and indirect basal ganglia pathways. Mov Disord 30:909","journal-title":"Mov Disord"},{"key":"2028_CR619","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/mds.26243","volume":"30","author":"JS Park","year":"2015","unstructured":"Park JS, Blair NF, Sue CM (2015) The role of ATP13A2 in Parkinson\u2019s disease: clinical phenotypes and molecular mechanisms. Mov Disord 30:770\u2013779","journal-title":"Mov Disord"},{"key":"2028_CR620","doi-asserted-by":"publisher","first-page":"276","DOI":"10.5414\/NPP26276","volume":"26","author":"L Parkkinen","year":"2007","unstructured":"Parkkinen L, Hartikainen P, Alafuzoff I (2007) Abundant glial alpha-synuclein pathology in a case without overt clinical symptoms. Clin Neuropathol 26:276\u2013283","journal-title":"Clin Neuropathol"},{"key":"2028_CR621","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00401-008-0346-6","volume":"115","author":"L Parkkinen","year":"2008","unstructured":"Parkkinen L, Pirttila T, Alafuzoff I (2008) Applicability of current staging\/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol 115:399\u2013407","journal-title":"Acta Neuropathol"},{"key":"2028_CR622","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JPD-2011-11046","volume":"1","author":"L Parkkinen","year":"2011","unstructured":"Parkkinen L, O\u2019Sullivan SS, Collins C, Petrie A, Holton JL, Revesz T, Lees AJ (2011) Disentangling the relationship between Lewy bodies and nigral neuronal loss in Parkinson\u2019s disease. J Parkinsons Dis 1:277\u2013286","journal-title":"J Parkinsons Dis"},{"key":"2028_CR623","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/brain\/awx376","volume":"141","author":"J Pasquini","year":"2018","unstructured":"Pasquini J, Ceravolo R, Qamhawi Z, Lee JY, Deuschl G, Brooks DJ, Bonuccelli U, Pavese N (2018) Progression of tremor in early stages of Parkinson\u2019s disease: a clinical and neuroimaging study. Brain 141:811\u2013821","journal-title":"Brain"},{"key":"2028_CR624","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","volume":"50","author":"W Paulus","year":"1991","unstructured":"Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson\u2019s disease. J Neuropathol Exp Neurol 50:743\u2013755","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR625","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/mds.20289","volume":"20","author":"KM Pedersen","year":"2005","unstructured":"Pedersen KM, Marner L, Pakkenberg H, Pakkenberg B (2005) No global loss of neocortical neurons in parkinson\u2019s disease: a quantitative stereological study. Mov Disord 20:164\u2013171","journal-title":"Mov Disord"},{"key":"2028_CR626","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00441-018-2839-5","volume":"373","author":"W Peelaerts","year":"2018","unstructured":"Peelaerts W, Bousset L, Baekelandt V, Melki R (2018) a-Synuclein strains and seeding in Parkinson\u2019s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences. Cell Tissue Res 373:195\u2013212","journal-title":"Cell Tissue Res"},{"key":"2028_CR627","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00429-016-1223-z","volume":"222","author":"EA Pelzer","year":"2017","unstructured":"Pelzer EA, Melzer C, Timmermann L, von Cramon DY, Tittgemeyer M (2017) Basal ganglia and cerebellar interconnectivity within the human thalamus. Brain Struct Funct 222:381\u2013392","journal-title":"Brain Struct Funct"},{"key":"2028_CR628","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng C, Gathagan RJ, Covell DJ, Medellin C, Stieber A, Robinson JL, Zhang B, Pitkin RM, Olufemi MF, Luk KC, Trojanowski JQ, Lee VM (2018a) Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies. Nature 557:558\u2013563","journal-title":"Nature"},{"key":"2028_CR629","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.nbd.2017.07.018","volume":"109","author":"C Peng","year":"2018","unstructured":"Peng C, Gathagan RJ, Lee VM (2018b) Distinct alpha-synuclein strains and implications for heterogeneity among alpha-synucleinopathies. Neurobiol Dis 109:209\u2013218","journal-title":"Neurobiol Dis"},{"key":"2028_CR630","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/mds.26955","volume":"32","author":"XA Perez","year":"2017","unstructured":"Perez XA, Zhang D, Bordia T, Quik M (2017) Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice. Mov Disord 32:538\u2013548","journal-title":"Mov Disord"},{"key":"2028_CR631","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00702-018-1845-9","volume":"125","author":"XA Perez","year":"2018","unstructured":"Perez XA, Bordia T, Quik M (2018) The striatal cholinergic system in l-dopa-induced dyskinesias. J Neural Transm (Vienna) 125:1251\u20131262","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR632","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejphar.2017.05.042","volume":"817","author":"P Perez-Pardo","year":"2017","unstructured":"Perez-Pardo P, Kliest T, Dodiya HB, Broersen LM, Garssen J, Keshavarzian A, Kraneveld AD (2017) The gut-brain axis in Parkinson\u2019s disease: possibilities for food-based therapies. Eur J Pharmacol 817:86\u201395","journal-title":"Eur J Pharmacol"},{"key":"2028_CR633","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/nen.0b013e31812503cf","volume":"66","author":"DP Perl","year":"2007","unstructured":"Perl DP, Olanow CW (2007) The neuropathology of manganese-induced parkinsonism. J Neuropathol Exp Neurol 66:675\u2013682","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR634","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000356531","volume":"21","author":"N Pessoa Rocha","year":"2014","unstructured":"Pessoa Rocha N, Reis HJ, Vanden Berghe P, Cirillo C (2014) Depression and cognitive impairment in Parkinson\u2019s disease: a role for inflammation and immunomodulation? Neuroimmunomodulation 21:88\u201394","journal-title":"Neuroimmunomodulation"},{"key":"2028_CR635","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/archneur.63.5.665","volume":"63","author":"RC Petersen","year":"2006","unstructured":"Petersen RC, Parisi JE, Dickson DW, Johnson KA, Knopman DS, Boeve BF, Jicha GA, Ivnik RJ, Smith GE, Tangalos EG, Braak H, Kokmen E (2006) Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol 63:665\u2013672","journal-title":"Arch Neurol"},{"key":"2028_CR636","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/mds.25115","volume":"27","author":"IN Petrovic","year":"2012","unstructured":"Petrovic IN, Ling H, Asi Y, Ahmed Z, Kukkle PL, Hazrati LN, Lang AE, Revesz T, Holton JL, Lees AJ (2012) Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord 27:1186\u20131190","journal-title":"Mov Disord"},{"key":"2028_CR637","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.nbd.2007.10.001","volume":"29","author":"B Picconi","year":"2008","unstructured":"Picconi B, Paille V, Ghiglieri V, Bagetta V, Barone I, Lindgren HS, Bernardi G, Angela Cenci M, Calabresi P (2008) l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. Neurobiol Dis 29:327\u2013335","journal-title":"Neurobiol Dis"},{"key":"2028_CR638","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/mds.27506","volume":"33","author":"M Picillo","year":"2018","unstructured":"Picillo M, Lizarraga KJ, Friesen EL, Chau H, Zhang M, Sato C, Rooke G, Munhoz RP, Rogaeva E, Fraser PE, Kalia SK, Kalia LV (2018) Parkinsonism due to A53E alpha-synuclein gene mutation: clinical, genetic, epigenetic, and biochemical features. Mov Disord 33:1950\u20131955","journal-title":"Mov Disord"},{"key":"2028_CR639","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s10072-017-3099-y","volume":"38","author":"S Pietracupa","year":"2017","unstructured":"Pietracupa S, Martin-Bastida A, Piccini P (2017) Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review. Neurol Sci 38:2095\u20132101","journal-title":"Neurol Sci"},{"key":"2028_CR640","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/ana.25274","volume":"84","author":"L Pihlstrom","year":"2018","unstructured":"Pihlstrom L, Blauwendraat C, Cappelletti C, Berge-Seidl V, Langmyhr M, Henriksen SP, van de Berg WDJ, Gibbs JR, Cookson MR, Singleton AB, Nalls MA, Toft M (2018) A comprehensive analysis of SNCA-related genetic risk in sporadic Parkinson disease. Ann Neurol 84:117\u2013129","journal-title":"Ann Neurol"},{"key":"2028_CR641","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/hmg\/ddy326","volume":"28","author":"R Pinho","year":"2019","unstructured":"Pinho R, Paiva I, Jercic KG, Fonseca-Ornelas L, Gerhardt E, Fahlbusch C, Garcia-Esparcia P, Kerimoglu C, Pavlou MAS, Villar-Pique A, Szego E, Lopes da Fonseca T, Odoardi F, Soeroes S, Rego AC, Fischle W, Schwamborn JC, Meyer T, Kugler S, Ferrer I, Attems J, Fischer A, Becker S, Zweckstetter M, Borovecki F, Outeiro TF (2019) Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein. Hum Mol Genet 28:31\u201350","journal-title":"Hum Mol Genet"},{"key":"2028_CR642","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/jnnp-2011-301874","volume":"83","author":"M Poletti","year":"2012","unstructured":"Poletti M, Frosini D, Pagni C, Baldacci F, Nicoletti V, Tognoni G, Lucetti C, Del Dotto P, Ceravolo R, Bonuccelli U (2012) Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 83:601\u2013606","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2028_CR643","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JPD-171248","volume":"8","author":"NK Polinski","year":"2018","unstructured":"Polinski NK, Volpicelli-Daley LA, Sortwell CE, Luk KC, Cremades N, Gottler LM, Froula J, Duffy MF, Lee VMY, Martinez TN, Dave KD (2018) Best practices for generating and using alpha-synuclein pre-formed fibrils to model Parkinson\u2019s disease in rodents. J Parkinsons Dis 8:303\u2013322","journal-title":"J Parkinsons Dis"},{"key":"2028_CR644","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.nbd.2010.05.028","volume":"40","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Loane C, Kiferle L, Molloy S, Brooks DJ, Piccini P (2010) Staging of serotonergic dysfunction in Parkinson\u2019s disease: an in vivo 11C-DASB PET study. Neurobiol Dis 40:216\u2013221","journal-title":"Neurobiol Dis"},{"key":"2028_CR645","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1172\/JCI71640","volume":"124","author":"M Politis","year":"2014","unstructured":"Politis M, Wu K, Loane C, Brooks DJ, Kiferle L, Turkheimer FE, Bain P, Molloy S, Piccini P (2014) Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson\u2019s disease patients. J Clin Investig 124:1340\u20131349","journal-title":"J Clin Investig"},{"key":"2028_CR646","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"2028_CR647","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/mds.26964","volume":"32","author":"C Pont-Sunyer","year":"2017","unstructured":"Pont-Sunyer C, Tolosa E, Caspell-Garcia C, Coffey C, Alcalay RN, Chan P, Duda JE, Facheris M, Fernandez-Santiago R, Marek K, Lomena F, Marras C, Mondragon E, Saunders-Pullman R, Waro B (2017) The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: clinical and imaging Studies. Mov Disord 32:726\u2013738","journal-title":"Mov Disord"},{"key":"2028_CR648","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1515\/revneuro-2017-0081","volume":"29","author":"K Poplawska-Domaszewicz","year":"2018","unstructured":"Poplawska-Domaszewicz K, Florczak-Wyspianska J, Kozubski W, Michalak S (2018) Paraneoplastic movement disorders. Rev Neurosci 29:745\u2013755","journal-title":"Rev Neurosci"},{"key":"2028_CR649","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fnins.2018.00161","volume":"12","author":"MR Post","year":"2018","unstructured":"Post MR, Lieberman OJ, Mosharov EV (2018) Can interactions between alpha-synuclein, dopamine and calcium explain selective neurodegeneration in Parkinson\u2019s disease? Front Neurosci 12:161","journal-title":"Front Neurosci"},{"key":"2028_CR650","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bpa.12344","volume":"27","author":"JH Power","year":"2017","unstructured":"Power JH, Barnes OL, Chegini F (2017) Lewy bodies and the mechanisms of neuronal cell death in Parkinson\u2019s disease and dementia with Lewy bodies. Brain Pathol 27:3\u201312","journal-title":"Brain Pathol"},{"key":"2028_CR651","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1096\/fj.201800148RRR","volume":"33","author":"V Prasad","year":"2019","unstructured":"Prasad V, Wasser Y, Hans F, Goswami A, Katona I, Outeiro TF, Kahle PJ, Schulz JB, Voigt A (2019) Monitoring alpha-synuclein multimerization in vivo. FASEB J 33:2116\u20132131","journal-title":"FASEB J"},{"key":"2028_CR652","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1073\/pnas.1713129115","volume":"115","author":"I Prots","year":"2018","unstructured":"Prots I, Grosch J, Brazdis RM, Simmnacher K, Veber V, Havlicek S, Hannappel C, Krach F, Krumbiegel M, Schutz O, Reis A, Wrasidlo W, Galasko DR, Groemer TW, Masliah E, Schlotzer-Schrehardt U, Xiang W, Winkler J, Winner B (2018) Alpha-synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies. Proc Natl Acad Sci USA 115:7813\u20137818","journal-title":"Proc Natl Acad Sci USA"},{"key":"2028_CR653","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.nbd.2018.02.019","volume":"114","author":"G Puska","year":"2018","unstructured":"Puska G, Lutz MI, Molnar K, Regelsberger G, Ricken G, Pirker W, Laszlo L, Kovacs GG (2018) Lysosomal response in relation to alpha-synuclein pathology differs between Parkinson\u2019s disease and multiple system atrophy. Neurobiol Dis 114:140\u2013152","journal-title":"Neurobiol Dis"},{"key":"2028_CR654","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/brain\/awv215","volume":"138","author":"Z Qamhawi","year":"2015","unstructured":"Qamhawi Z, Towey D, Shah B, Pagano G, Seibyl J, Marek K, Borghammer P, Brooks DJ, Pavese N (2015) Clinical correlates of raphe serotonergic dysfunction in early Parkinson\u2019s disease. Brain 138:2964\u20132973","journal-title":"Brain"},{"key":"2028_CR268","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1474-4422(18)30179-0","volume":"17","author":"M Quadri","year":"2018","unstructured":"Quadri M, Mandemakers W, Grochowska MM, Masius R, Geut H, Fabrizio E, Breedveld GJ, Kuipers D, Minneboo M, Vergouw LJM, Carreras Mascaro A, Yonova-Doing E, Simons E, Zhao T, Di Fonzo AB, Chang HC, Parchi P, Melis M, Correia Guedes L, Criscuolo C, Thomas A, Brouwer RWW, Heijsman D, Ingrassia AMT, Calandra Buonaura G, Rood JP, Capellari S, Rozemuller AJ, Sarchioto M, Fen Chien H, Vanacore N, Olgiati S, Wu-Chou YH, Yeh TH, Boon AJW, Hoogers SE, Ghazvini M, Ijpma AS, van Ijcken WFJ, Onofrj M, Barone P, Nicholl DJ, Puschmann A, De Mari M, Kievit AJ, Barbosa E, De Michele G, Majoor-Krakauer D, van Swieten JC, de Jong FJ, Ferreira JJ, Cossu G, Lu CS, Meco G, Cortelli P, van de Berg WDJ, Bonifati V (2018) LRP10 genetic variants in familial Parkinson\u2019s disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study. Lancet Neurol 17:597\u2013608","journal-title":"Lancet Neurol"},{"key":"2028_CR655","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.brainres.2012.04.018","volume":"1459","author":"JG Quinn","year":"2012","unstructured":"Quinn JG, Coulson DT, Brockbank S, Beyer N, Ravid R, Hellemans J, Irvine GB, Johnston JA (2012) Alpha-synuclein mRNA and soluble alpha-synuclein protein levels in post-mortem brain from patients with Parkinson\u2019s disease, dementia with Lewy bodies, and Alzheimer\u2019s disease. Brain Res 1459:71\u201380","journal-title":"Brain Res"},{"key":"2028_CR656","first-page":"81","volume":"371","author":"CM Quinzii","year":"2014","unstructured":"Quinzii CM, Hirano M, DiMauro S (2014) Mutant COQ2 in multiple-system atrophy. N Engl J Med 371:81\u201382","journal-title":"N Engl J Med"},{"key":"2028_CR657","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.neuro.2012.08.011","volume":"33","author":"BA Racette","year":"2012","unstructured":"Racette BA, Criswell SR, Lundin JI, Hobson A, Seixas N, Kotzbauer PT, Evanoff BA, Perlmutter JS, Zhang J, Sheppard L, Checkoway H (2012) Increased risk of parkinsonism associated with welding exposure. Neurotoxicology 33:1356\u20131361","journal-title":"Neurotoxicology"},{"key":"2028_CR658","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1212\/01.wnl.0000285082.18969.3a","volume":"70","author":"AH Rajput","year":"2008","unstructured":"Rajput AH, Sitte HH, Rajput A, Fenton ME, Pifl C, Hornykiewicz O (2008) Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation. Neurology 70:1403\u20131410","journal-title":"Neurology"},{"key":"2028_CR659","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/brain\/awx310","volume":"141","author":"NJ Ray","year":"2018","unstructured":"Ray NJ, Bradburn S, Murgatroyd C, Toseeb U, Mir P, Kountouriotis GK, Teipel SJ, Grothe MJ (2018) In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson\u2019s disease. Brain 141:165\u2013176","journal-title":"Brain"},{"key":"2028_CR660","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1001\/archneur.1968.00470310034003","volume":"18","author":"JJ Rebeiz","year":"1968","unstructured":"Rebeiz JJ, Kolodny EH, Richardson EP Jr (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18:20\u201333","journal-title":"Arch Neurol"},{"key":"2028_CR661","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.nbd.2018.11.012","volume":"124","author":"X Reed","year":"2019","unstructured":"Reed X, Bandres-Ciga S, Blauwendraat C, Cookson MR (2019) The role of monogenic genes in idiopathic Parkinson\u2019s disease. Neurobiol Dis 124:230\u2013239","journal-title":"Neurobiol Dis"},{"key":"2028_CR662","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/mds.22333","volume":"24","author":"K Reetz","year":"2009","unstructured":"Reetz K, Gaser C, Klein C, Hagenah J, Buchel C, Gottschalk S, Pramstaller PP, Siebner HR, Binkofski F (2009) Structural findings in the basal ganglia in genetically determined and idiopathic Parkinson\u2019s disease. Mov Disord 24:99\u2013103","journal-title":"Mov Disord"},{"key":"2028_CR663","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40478-017-0504-y","volume":"6","author":"V Refolo","year":"2018","unstructured":"Refolo V, Bez F, Polissidis A, Kuzdas-Wood D, Sturm E, Kamaratou M, Poewe W, Stefanis L, Angela Cenci M, Romero-Ramos M, Wenning GK, Stefanova N (2018) Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies. Acta Neuropathol Commun 6:2","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR664","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/mds.21803","volume":"23","author":"JS Reijnders","year":"2008","unstructured":"Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF (2008) A systematic review of prevalence studies of depression in Parkinson\u2019s disease. Mov Disord 23:183\u2013189 (quiz 313)","journal-title":"Mov Disord"},{"key":"2028_CR665","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.parkreldis.2017.12.030","volume":"49","author":"I Rektor","year":"2018","unstructured":"Rektor I, Bohnen NI, Korczyn AD, Gryb V, Kumar H, Kramberger MG, de Leeuw FE, Pirtosek Z, Rektorova I, Schlesinger I, Slawek J, Valkovic P, Vesely B (2018) An updated diagnostic approach to subtype definition of vascular parkinsonism\u2014recommendations from an expert working group. Parkinsonism Relat Disord 49:9\u201316","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR666","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3389\/fnins.2018.00996","volume":"12","author":"S Ren","year":"2019","unstructured":"Ren S, Zhang H, Zheng W, Liu M, Gao F, Wang Z, Chen Z (2019) Altered functional connectivity of cerebello-cortical circuit in multiple system atrophy (cerebellar-type). Front Neurosci 12:996","journal-title":"Front Neurosci"},{"key":"2028_CR667","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.27034","volume":"32","author":"G Respondek","year":"2017","unstructured":"Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, Muller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan I, Stamelou M, Hoglinger GU (2017) Which ante mortem clinical features predict progressive supranuclear palsy pathology? Mov Disord 32:995\u20131005","journal-title":"Mov Disord"},{"key":"2028_CR668","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.nbd.2016.12.013","volume":"109","author":"NL Rey","year":"2018","unstructured":"Rey NL, Wesson DW, Brundin P (2018) The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol Dis 109:226\u2013248","journal-title":"Neurobiol Dis"},{"key":"2028_CR669","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/glia.22611","volume":"62","author":"JF Reyes","year":"2014","unstructured":"Reyes JF, Rey NL, Bousset L, Melki R, Brundin P, Angot E (2014) Alpha-synuclein transfers from neurons to oligodendrocytes. Glia 62:387\u2013398","journal-title":"Glia"},{"key":"2028_CR670","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-00019-02007-x","author":"JF Reyes","year":"2019","unstructured":"Reyes JF, Sackmann C, Hoffmann A, Svenningsson P, Winkler J, Ingelsson M, Hallbeck M (2019) Binding of alpha-synuclein oligomers to Cx32 facilitates protein uptake and transfer in neurons and oligodendrocytes. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-00019-02007-x","journal-title":"Acta Neuropathol"},{"key":"2028_CR671","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41531-019-0076-6","volume":"5","author":"RH Reynolds","year":"2019","unstructured":"Reynolds RH, Botia J, Nalls MA, Hardy J, Gagliano Taliun SA, Ryten M (2019) Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson\u2019s disease heritability. NPJ Parkinsons Dis 5:6","journal-title":"NPJ Parkinsons Dis"},{"key":"2028_CR672","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fneur.2017.00037","volume":"8","author":"CD Rietdijk","year":"2017","unstructured":"Rietdijk CD, Perez-Pardo P, Garssen J, van Wezel RJ, Kraneveld AD (2017) Exploring Braak\u2019s hypothesis of Parkinson\u2019s disease. Front Neurol 8:37","journal-title":"Front Neurol"},{"key":"2028_CR673","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1212\/WNL.0000000000002350","volume":"86","author":"G Rizzo","year":"2016","unstructured":"Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G (2016) Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology 86:566\u2013576","journal-title":"Neurology"},{"key":"2028_CR674","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/jnnp-2017-316844","volume":"89","author":"G Rizzo","year":"2018","unstructured":"Rizzo G, Arcuti S, Copetti M, Alessandria M, Savica R, Fontana A, Liguori R, Logroscino G (2018) Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 89:358\u2013366","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2028_CR675","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00702-016-1552-3","volume":"123","author":"D Robakis","year":"2016","unstructured":"Robakis D, Cortes E, Clark LN, Vonsattel JP, Virmani T, Alcalay RN, Crary JF, Levy OA (2016) The effect of MAPT haplotype on neocortical Lewy body pathology in Parkinson disease. J Neural Transm (Vienna) 123:583\u2013588","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR676","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/biom5020282","volume":"5","author":"HL Roberts","year":"2015","unstructured":"Roberts HL, Brown DR (2015) Seeking a mechanism for the toxicity of oligomeric alpha-synuclein. Biomolecules 5:282\u2013305","journal-title":"Biomolecules"},{"key":"2028_CR677","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/brain\/awy146","volume":"141","author":"JL Robinson","year":"2018","unstructured":"Robinson JL, Lee EB, Xie SX, Rennert L, Suh E, Bredenberg C, Caswell C, Van Deerlin VM, Yan N, Yousef A, Hurtig HI, Siderowf A, Grossman M, McMillan CT, Miller B, Duda JE, Irwin DJ, Wolk D, Elman L, McCluskey L, Chen-Plotkin A, Weintraub D, Arnold SE, Brettschneider J, Lee VM, Trojanowski JQ (2018) Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain 141:2181\u20132193","journal-title":"Brain"},{"key":"2028_CR678","volume-title":"Lewy Bodies","author":"F Rocha Cabrero","year":"2019","unstructured":"Rocha Cabrero F, Morrison EH (2019) Lewy Bodies, 2019\/02\/07 edn. StatPearls Publishing, Treasure Island","edition":"2019\/02\/07"},{"key":"2028_CR679","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha EM, De Miranda B, Sanders LH (2018) Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Neurobiol Dis 109:249\u2013257","journal-title":"Neurobiol Dis"},{"key":"2028_CR680","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1093\/brain\/awu057","volume":"137","author":"E Rockenstein","year":"2014","unstructured":"Rockenstein E, Nuber S, Overk CR, Ubhi K, Mante M, Patrick C, Adame A, Trejo-Morales M, Gerez J, Picotti P, Jensen PH, Campioni S, Riek R, Winkler J, Gage HH, Winner B, Masliah E (2014) Accumulation of oligomer-prone a-synuclein exacerbates synaptic and neuronal degeneration in vivo. Brain 137:1496\u20131513","journal-title":"Brain"},{"key":"2028_CR681","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00401-015-1455-7","volume":"130","author":"Z Rohan","year":"2015","unstructured":"Rohan Z, Rahimi J, Weis S, Kapas I, Auff E, Mitrovic N, Liberski PP, Sikorska B, Matej R, Kovacs GG (2015) Screening for alpha-synuclein immunoreactive neuronal inclusions in the hippocampus allows identification of atypical MSA (FTLD-synuclein). Acta Neuropathol 130:299\u2013301","journal-title":"Acta Neuropathol"},{"key":"2028_CR682","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/jnen\/nlw087","volume":"75","author":"Z Rohan","year":"2016","unstructured":"Rohan Z, Milenkovic I, Lutz MI, Matej R, Kovacs GG (2016) Shared and distinct patterns of oligodendroglial response in alpha-synucleinopathies and tauopathies. J Neuropathol Exp Neurol 75:1100\u20131109","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR683","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/mdc3.12570","volume":"5","author":"M Rohani","year":"2017","unstructured":"Rohani M, Lang AE, Sina F, Elahi E, Fasano A, Hardy J, Bras J, Alavi A (2017) Action myoclonus and seizure in Kufor\u2013Rakeb syndrome. Mov Disord Clin Pract 5:195\u2013199","journal-title":"Mov Disord Clin Pract"},{"key":"2028_CR684","doi-asserted-by":"publisher","first-page":"213e1","DOI":"10.1016\/j.neurobiolaging.2016.05.022","volume":"45","author":"D Ronchi","year":"2016","unstructured":"Ronchi D, Di Biase E, Franco G, Melzi V, Del Sorbo F, Elia A, Barzaghi C, Garavaglia B, Bergamini C, Fato R, Mora G, Del Bo R, Fortunato F, Borellini L, Trezzi I, Compagnoni GM, Monfrini E, Frattini E, Bonato S, Cogiamanian F, Ardolino G, Priori A, Bresolin N, Corti S, Comi GP, Di Fonzo A (2016) Mutational analysis of COQ2 in patients with MSA in Italy. Neurobiol Aging 45:213e1\u2013213e2","journal-title":"Neurobiol Aging"},{"key":"2028_CR685","first-page":"469","volume-title":"Oxford textbook of old age psychiatry 2e","author":"A Rongve","year":"2013","unstructured":"Rongve A, Aarsland D (2013) Dementia in Parkinson\u2019s disease and dementia with Lewy bodies. In: Dening T, Thomas A (eds) Oxford textbook of old age psychiatry 2e. Oxford University Press, Oxford, pp 469\u2013478"},{"key":"2028_CR686","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11910-017-0737-y","volume":"17","author":"K Rosborough","year":"2017","unstructured":"Rosborough K, Patel N, Kalia LV (2017) Alpha-synuclein and parkinsonism: updates and future perspectives. Curr Neurol Neurosci Rep 17:31","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2028_CR687","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/JPD-171181","volume":"8","author":"K Rosqvist","year":"2018","unstructured":"Rosqvist K, Horne M, Hagell P, Iwarsson S, Nilsson MH, Odin P (2018) Levodopa effect and motor function in late stage Parkinson\u2019s disease. J Parkinsons Dis 8:59\u201370","journal-title":"J Parkinsons Dis"},{"key":"2028_CR688","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.neurobiolaging.2018.09.008","volume":"73","author":"U Rudakou","year":"2019","unstructured":"Rudakou U, Ouled Amar Bencheikh B, Ruskey JA, Krohn L, Laurent SB, Spiegelman D, Liong C, Fahn S, Waters C, Monchi O, Fon EA, Dauvilliers Y, Alcalay RN, Dupre N, Gan-Or Z (2019) Common and rare GCH1 variants are associated with Parkinson\u2019s disease. Neurobiol Aging 73:231","journal-title":"Neurobiol Aging"},{"key":"2028_CR689","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00401-008-0352-8","volume":"115","author":"G Rudow","year":"2008","unstructured":"Rudow G, O\u2019Brien R, Savonenko AV, Resnick SM, Zonderman AB, Pletnikova O, Marsh L, Dawson TM, Crain BJ, West MJ, Troncoso JC (2008) Morphometry of the human substantia nigra in ageing and Parkinson\u2019s disease. Acta Neuropathol 115:461\u2013470","journal-title":"Acta Neuropathol"},{"key":"2028_CR690","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1021\/acschemneuro.8b00579","volume":"10","author":"VC Ruf","year":"2019","unstructured":"Ruf VC, Nubling GS, Willikens S, Shi S, Schmidt F, Levin J, Botzel K, Kamp F, Giese A (2019) Different effects of alpha-synuclein mutants on lipid binding and aggregation detected by single molecule fluorescence spectroscopy and tht fluorescence-based measurements. ACS Chem Neurosci 10:1649\u20131659","journal-title":"ACS Chem Neurosci"},{"key":"2028_CR691","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00401-012-0991-7","volume":"123","author":"C Ruffmann","year":"2012","unstructured":"Ruffmann C, Zini M, Goldwurm S, Bramerio M, Spinello S, Rusconi D, Gambacorta M, Tagliavini F, Pezzoli G, Giaccone G (2012) Lewy body pathology and typical Parkinson disease in a patient with a heterozygous (R275\u00a0W) mutation in the Parkin gene (PARK2). Acta Neuropathol 123:901\u2013903","journal-title":"Acta Neuropathol"},{"key":"2028_CR692","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/nan.12294","volume":"42","author":"C Ruffmann","year":"2016","unstructured":"Ruffmann C, Calboli FC, Bravi I, Gveric D, Curry LK, de Smith A, Pavlou S, Buxton JL, Blakemore AI, Takousis P, Molloy S, Piccini P, Dexter DT, Roncaroli F, Gentleman SM, Middleton LT (2016) Cortical Lewy bodies and Abeta burden are associated with prevalence and timing of dementia in Lewy body diseases. Neuropathol Appl Neurobiol 42:436\u2013450","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR693","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.2174\/1570159X16666180222165418","volume":"16","author":"Q Rui","year":"2018","unstructured":"Rui Q, Ni H, Li D, Gao R, Chen G (2018) The role of LRRK2 in neurodegeneration of Parkinson disease. Curr Neuropharmacol 16:1348\u20131357","journal-title":"Curr Neuropharmacol"},{"key":"2028_CR694","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1002\/mds.27205","volume":"32","author":"JJ Rumpf","year":"2018","unstructured":"Rumpf JJ, Albers J, Fricke C, Mueller W, Classen J (2018) Structural abnormality of substantia nigra induced by methamphetamine abuse. Mov Disord 32:1784\u20131788","journal-title":"Mov Disord"},{"key":"2028_CR695","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0304-3940(00)01785-7","volume":"299","author":"C Russ","year":"2001","unstructured":"Russ C, Lovestone S, Baker M, Pickering-Brown SM, Andersen PM, Furlong R, Mann D, Powell JF (2001) The extended haplotype of the microtubule associated protein tau gene is not associated with Pick\u2019s disease. Neurosci Lett 299:156\u2013158","journal-title":"Neurosci Lett"},{"key":"2028_CR696","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1212\/WNL.0000000000003221","volume":"87","author":"A Sailer","year":"2016","unstructured":"Sailer A, Scholz SW, Nalls MA, Schulte C, Federoff M, Price TR, Lees A, Ross OA, Dickson DW, Mok K, Mencacci NE, Schottlaender L, Chelban V, Ling H, O\u2019Sullivan SS, Wood NW, Traynor BJ, Ferrucci L, Federoff HJ, Mhyre TR, Morris HR, Deuschl G, Quinn N, Widner H, Albanese A, Infante J, Bhatia KP, Poewe W, Oertel W, Hoglinger GU, Wullner U, Goldwurm S, Pellecchia MT, Ferreira J, Tolosa E, Bloem BR, Rascol O, Meissner WG, Hardy JA, Revesz T, Holton JL, Gasser T, Wenning GK, Singleton AB, Houlden H (2016) A genome-wide association study in multiple system atrophy. Neurology 87:1591\u20131598","journal-title":"Neurology"},{"key":"2028_CR697","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1440-1789.2008.00968.x","volume":"29","author":"R Sakamoto","year":"2009","unstructured":"Sakamoto R, Tsuchiya K, Yoshida R, Itoh Y, Furuta N, Kosuga A, Sugai Y, Mimura M (2009) Progressive supranuclear palsy combined with Alzheimer\u2019s disease: a clinicopathological study of two autopsy cases. Neuropathology 29:219\u2013229","journal-title":"Neuropathology"},{"key":"2028_CR698","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.nbd.2014.11.008","volume":"74","author":"L Salvesen","year":"2015","unstructured":"Salvesen L, Ullerup BH, Sunay FB, Brudek T, Lokkegaard A, Agander TK, Winge K, Pakkenberg B (2015) Changes in total cell numbers of the basal ganglia in patients with multiple system atrophy\u2014a stereological study. Neurobiol Dis 74:104\u2013113","journal-title":"Neurobiol Dis"},{"key":"2028_CR699","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.nbd.2018.11.001","volume":"124","author":"F Sampedro","year":"2019","unstructured":"Sampedro F, Marin-Lahoz J, Martinez-Horta S, Pagonabarraga J, Kulisevsky J (2019) Dopaminergic degeneration induces early posterior cortical thinning in Parkinson\u2019s disease. Neurobiol Dis 124:29\u201335","journal-title":"Neurobiol Dis"},{"key":"2028_CR700","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s40266-016-0416-8","volume":"33","author":"N Samudra","year":"2016","unstructured":"Samudra N, Patel N, Womack KB, Khemani P, Chitnis S (2016) Psychosis in Parkinson disease: a review of etiology, phenomenology, and management. Drugs Aging 33:855\u2013863","journal-title":"Drugs Aging"},{"key":"2028_CR701","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cger.2018.06.007","volume":"34","author":"AM Sanford","year":"2018","unstructured":"Sanford AM (2018) Lewy body dementia. Clin Geriatr Med 34:603\u2013615","journal-title":"Clin Geriatr Med"},{"key":"2028_CR702","doi-asserted-by":"publisher","first-page":"061","DOI":"10.23937\/2378-3001\/3\/6\/1061","volume":"3","author":"RM Santiago","year":"2016","unstructured":"Santiago RM, Vital MABF, Sato MDO, Adam GP (2016) Depression in Parkinson\u2019s disease is associated with a serotoninergic system change secondary to neuroinflammation. Int J Neurol Neurother 3:061","journal-title":"Int J Neurol Neurother"},{"key":"2028_CR703","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fnins.2019.00273","volume":"13","author":"J Sassone","year":"2019","unstructured":"Sassone J, Valtorta F, Ciammola A (2019) Early dyskinesias in Parkinson\u2019s disease patients with parkin mutation: a primary corticostriatal synaptopathy? Front Neurosci 13:273","journal-title":"Front Neurosci"},{"key":"2028_CR704","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/jamaneurol.2013.114","volume":"70","author":"R Savica","year":"2013","unstructured":"Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA (2013a) Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. JAMA Neurol 70:859\u2013866","journal-title":"JAMA Neurol"},{"key":"2028_CR705","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1001\/jamaneurol.2013.3579","volume":"70","author":"R Savica","year":"2013","unstructured":"Savica R, Grossardt BR, Bower JH, Boeve BF, Ahlskog JE, Rocca WA (2013b) Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol 70:1396\u20131402","journal-title":"JAMA Neurol"},{"key":"2028_CR706","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/ane.13028","volume":"139","author":"R Savica","year":"2019","unstructured":"Savica R, Beach TG, Hentz JG, Sabbagh MN, Serrano GE, Sue LI, Dugger BN, Shill HA, Driver-Dunckley E, Caviness JN, Mehta SH, Jacobson SA, Belden CM, Davis KJ, Zamrini E, Shprecher DR, Adler CH (2019) Lewy body pathology in Alzheimer\u2019s disease: a clinicopathological prospective study. Acta Neurol Scand 139:76\u201381","journal-title":"Acta Neurol Scand"},{"key":"2028_CR707","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:435\u2013450","journal-title":"Nat Rev Neurosci"},{"key":"2028_CR708","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2016.0202","author":"R Schmidt","year":"2017","unstructured":"Schmidt R, Berke JD (2017) A pause-then-cancel model of stopping: evidence from basal ganglia neurophysiology. Philos Trans R Soc Lond B Biol Sci. https:\/\/doi.org\/10.1098\/rstb.2016.0202","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2028_CR709","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/mds.27193","volume":"32","author":"SA Schneider","year":"2017","unstructured":"Schneider SA, Alcalay RN (2017) Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature. Mov Disord 32:1504\u20131523","journal-title":"Mov Disord"},{"key":"2028_CR710","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/mds.23295","volume":"26","author":"EC Schofield","year":"2011","unstructured":"Schofield EC, Hodges JR, Macdonald V, Cordato NJ, Kril JJ, Halliday GM (2011) Cortical atrophy differentiates Richardson\u2019s syndrome from the parkinsonian form of progressive supranuclear palsy. Mov Disord 26:256\u2013263","journal-title":"Mov Disord"},{"key":"2028_CR711","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/ana.21685","volume":"65","author":"SW Scholz","year":"2009","unstructured":"Scholz SW, Houlden H, Schulte C, Sharma M, Li A, Berg D, Melchers A, Paudel R, Gibbs JR, Simon-Sanchez J, Paisan-Ruiz C, Bras J, Ding J, Chen H, Traynor BJ, Arepalli S, Zonozi RR, Revesz T, Holton J, Wood N, Lees A, Oertel W, Wullner U, Goldwurm S, Pellecchia MT, Illig T, Riess O, Fernandez HH, Rodriguez RL, Okun MS, Poewe W, Wenning GK, Hardy JA, Singleton AB, Del Sorbo F, Schneider S, Bhatia KP, Gasser T (2009) SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 65:610\u2013614","journal-title":"Ann Neurol"},{"key":"2028_CR712","doi-asserted-by":"publisher","first-page":"e0149557","DOI":"10.1371\/journal.pone.0149557","volume":"11","author":"LV Schottlaender","year":"2016","unstructured":"Schottlaender LV, Bettencourt C, Kiely AP, Chalasani A, Neergheen V, Holton JL, Hargreaves I, Houlden H (2016) Coenzyme Q10 levels are decreased in the cerebellum of multiple-system atrophy patients. PLoS One 11:e0149557","journal-title":"PLoS One"},{"key":"2028_CR713","first-page":"67","volume":"4","author":"C Schulte","year":"2011","unstructured":"Schulte C, Gasser T (2011) Genetic basis of Parkinson\u2019s disease: inheritance, penetrance, and expression. Appl Clin Genet 4:67\u201380","journal-title":"Appl Clin Genet"},{"key":"2028_CR714","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/brain\/awy072","volume":"141","author":"J Schulz","year":"2018","unstructured":"Schulz J, Pagano G, Fernandez Bonfante JA, Wilson H, Politis M (2018) Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson\u2019s disease. Brain 141:1501\u20131516","journal-title":"Brain"},{"key":"2028_CR715","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/ana.25490","volume":"85","author":"J Schulz","year":"2019","unstructured":"Schulz J, Takousis P, Wohlers I, Itua IOG, Dobricic V, Rucker G, Binder H, Middleton L, Ioannidis JPA, Perneczky R, Bertram L, Lill CM (2019) Meta-analyses identify differentially expressed microRNAs in Parkinson\u2019s disease. Ann Neurol 85:835\u2013851","journal-title":"Ann Neurol"},{"key":"2028_CR716","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","volume":"120","author":"WJ Schulz-Schaeffer","year":"2010","unstructured":"Schulz-Schaeffer WJ (2010) The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia. Acta Neuropathol 120:131\u2013143","journal-title":"Acta Neuropathol"},{"key":"2028_CR717","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3390\/biom5031467","volume":"5","author":"WJ Schulz-Schaeffer","year":"2015","unstructured":"Schulz-Schaeffer WJ (2015) Is cell death primary or secondary in the pathophysiology of idiopathic Parkinson\u2019s disease? Biomolecules 5:1467\u20131479","journal-title":"Biomolecules"},{"key":"2028_CR718","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1093\/brain\/awz069","volume":"142","author":"J Schumacher","year":"2019","unstructured":"Schumacher J, Peraza LR, Firbank M, Thomas AJ, Kaiser M, Gallagher P, O\u2019Brien JT, Blamire AM, Taylor JP (2019) Dysfunctional brain dynamics and their origin in Lewy body dementia. Brain 142:1767\u20131782","journal-title":"Brain"},{"key":"2028_CR719","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/jnen\/nly024","volume":"77","author":"O Scudamore","year":"2018","unstructured":"Scudamore O, Ciossek T (2018) Increased oxidative stress exacerbates alpha-synuclein aggregation in vivo. J Neuropathol Exp Neurol 77:443\u2013453","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR720","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/ana.22078","volume":"67","author":"K Seidel","year":"2010","unstructured":"Seidel K, Schols L, Nuber S, Petrasch-Parwez E, Gierga K, Wszolek Z, Dickson D, Gai WP, Bornemann A, Riess O, Rami A, Den Dunnen WF, Deller T, Rub U, Kruger R (2010) First appraisal of brain pathology owing to A30P mutant alpha-synuclein. Ann Neurol 67:684\u2013689","journal-title":"Ann Neurol"},{"key":"2028_CR721","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/bpa.12168","volume":"25","author":"K Seidel","year":"2015","unstructured":"Seidel K, Mahlke J, Sonny S, Kr\u00fcger R, Heinsen H, Auburger G, Bouzrou M, Grinberg LT, Wicht H, Korf H-W, den Dunnen W, R\u00fcb U (2015) The brainstem pathologies of Parkinson\u2019s disease and dementia with Lewy bodies. Brain Pathol 25:121\u2013135","journal-title":"Brain Pathol"},{"key":"2028_CR722","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00401-019-01961-w","volume":"137","author":"H Sekiya","year":"2019","unstructured":"Sekiya H, Kowa H, Koga H, Takata M, Satake W, Futamura N, Funakawa I, Jinnai K, Takahashi M, Kondo T, Ueno Y, Kanagawa M, Kobayashi K, Toda T (2019) Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation. Acta Neuropathol 137:455\u2013466","journal-title":"Acta Neuropathol"},{"key":"2028_CR723","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/brain\/awp234","volume":"132","author":"M Selikhova","year":"2009","unstructured":"Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ (2009) A clinico-pathological study of subtypes in Parkinson\u2019s disease. Brain 132:2947\u20132957","journal-title":"Brain"},{"key":"2028_CR724","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s40336-019-00321-8","volume":"7","author":"S Sestini","year":"2019","unstructured":"Sestini S, Alongi P, Berti V, Calcagni ML, Cecchin D, Chiaravalloti A, Chincarini A, Cistaro A, Guerra UP, Pappat\u00e0 S, Tiraboschi P, Nobili F (2019) The role of molecular imaging in the frame of the revised dementia with Lewy body criteria. Clin Transl Imaging 7:83\u201398","journal-title":"Clin Transl Imaging"},{"key":"2028_CR725","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/mds.24045","volume":"27","author":"N Seto-Salvia","year":"2012","unstructured":"Seto-Salvia N, Pagonabarraga J, Houlden H, Pascual-Sedano B, Dols-Icardo O, Tucci A, Paisan-Ruiz C, Campolongo A, Anton-Aguirre S, Martin I, Munoz L, Bufill E, Vilageliu L, Grinberg D, Cozar M, Blesa R, Lleo A, Hardy J, Kulisevsky J, Clarimon J (2012) Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson\u2019s disease course. Mov Disord 27:393\u2013399","journal-title":"Mov Disord"},{"key":"2028_CR726","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1007\/s00330-018-5874-4","volume":"29","author":"A Shah","year":"2019","unstructured":"Shah A, Prasad S, Rastogi B, Dash S, Saini J, Pal PK, Ingalhalikar M (2019) Altered structural connectivity of the motor subnetwork in multiple system atrophy with cerebellar features. Eur Radiol 29:2783\u20132791","journal-title":"Eur Radiol"},{"key":"2028_CR727","doi-asserted-by":"publisher","DOI":"10.1101\/137976","author":"SH Shahmoradian","year":"2018","unstructured":"Shahmoradian SH, Lewis AJ, Genoud C, Graff-Meyer A, Hench J, Moors T, Schweighauser G, Wang J, Goldie KN, Suetterlin R, Castano-Diez D, Perez-Navarro P, Huisman E, Ipsen S, Ingrassia A, de Gier Y, Rozemuller AJM, Da Paepe A, Erny J, Staempfli A, Hoernschemeyer J, Grosserueschkamp F, Niedieker D, El-Mashtoly SF, Quadri M, van Ijcken WFJ, Bonifati V, Gerwert K, Bohrmann B, Frank S, Britschgi M, Stahlberg H, van de Berg W, Lauer ME (2018) Lewy pathology in Parkinson\u2019s disease consists of a crowded organellar, membranous medley (This article is a preprint and has not been peer-reviewed). bioRxiv. https:\/\/doi.org\/10.1101\/137976","journal-title":"bioRxiv"},{"key":"2028_CR728","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1056\/NEJMc1311763","volume":"371","author":"M Sharma","year":"2014","unstructured":"Sharma M, Wenning G, Kr\u00fcger R (2014) Mutant COQ2 in multiple-system atrophy. N Engl J Med 371:80\u201383","journal-title":"N Engl J Med"},{"key":"2028_CR729","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/mds.25792","volume":"29","author":"ME Sharp","year":"2014","unstructured":"Sharp ME, Marder KS, Cote L, Clark LN, Nichols WC, Vonsattel JP, Alcalay RN (2014) Parkinson\u2019s disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation. Mov Disord 29:566\u2013568","journal-title":"Mov Disord"},{"key":"2028_CR730","first-page":"513","volume":"67","author":"T Shimohata","year":"2015","unstructured":"Shimohata T, Aiba I, Nishizawa M (2015) Criteria for the diagnosis of corticobasal degeneration. Brain Nerve 67:513\u2013523","journal-title":"Brain Nerve"},{"key":"2028_CR731","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-017-0413-0","volume":"5","author":"A Shimozawa","year":"2017","unstructured":"Shimozawa A, Ono M, Takahara D, Tarutani A, Imura S, Masuda-Suzukake M, Higuchi M, Yanai K, Hisanaga SI, Hasegawa M (2017) Propagation of pathological alpha-synuclein in marmoset brain. Acta Neuropathol Commun 5:12","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR732","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1093\/brain\/awt272","volume":"136","author":"JM Shine","year":"2013","unstructured":"Shine JM, Matar E, Ward PB, Frank MJ, Moustafa AA, Pearson M, Naismith SL, Lewis SJ (2013) Freezing of gait in Parkinson\u2019s disease is associated with functional decoupling between the cognitive control network and the basal ganglia. Brain 136:3671\u20133681","journal-title":"Brain"},{"key":"2028_CR733","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1212\/WNL.0000000000006736","volume":"92","author":"H Shinotoh","year":"2019","unstructured":"Shinotoh H, Shimada H, Kokubo Y, Tagai K, Niwa F, Kitamura S, Endo H, Ono M, Kimura Y, Hirano S, Mimuro M, Ichise M, Sahara N, Zhang MR, Suhara T, Higuchi M (2019) Tau imaging detects distinctive distribution of tau pathology in ALS\/PDC on the Kii Peninsula. Neurology 92:e136\u2013e147","journal-title":"Neurology"},{"key":"2028_CR734","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/mds.26467","volume":"31","author":"UA Shuaib","year":"2016","unstructured":"Shuaib UA, Rajput AH, Robinson CA, Rajput A (2016) Neuroleptic-induced parkinsonism: clinicopathological study. Mov Disord 31:360\u2013365","journal-title":"Mov Disord"},{"key":"2028_CR735","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1471-4159.2010.07132.x","volume":"118","author":"J Sian-Hulsmann","year":"2011","unstructured":"Sian-Hulsmann J, Mandel S, Youdim MB, Riederer P (2011) The relevance of iron in the pathogenesis of Parkinson\u2019s disease. J Neurochem 118:939\u2013957","journal-title":"J Neurochem"},{"key":"2028_CR736","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2174\/1871527314666150317225659","volume":"14","author":"J Sian-Hulsmann","year":"2015","unstructured":"Sian-Hulsmann J, Monoranu C, Strobel S, Riederer P (2015) Lewy bodies: a spectator or salient killer? CNS Neurol Disord Drug Targets 14:947\u2013955","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2028_CR737","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00019052-200402000-00009","volume":"17","author":"I Sibon","year":"2004","unstructured":"Sibon I, Tison F (2004) Vascular Parkinsonism. Curr Opin Neurol 17:49\u201354","journal-title":"Curr Opin Neurol"},{"key":"2028_CR738","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","volume":"11","author":"E Sidransky","year":"2012","unstructured":"Sidransky E, Lopez G (2012) The link between the GBA gene and parkinsonism. Lancet Neurol 11:986\u2013998","journal-title":"Lancet Neurol"},{"key":"2028_CR739","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/mds.26051","volume":"29","author":"FJ Siepel","year":"2014","unstructured":"Siepel FJ, Bronnick KS, Booij J, Ravina BM, Lebedev AV, Pereira JB, Gruner R, Aarsland D (2014) Cognitive executive impairment and dopaminergic deficits in de novo Parkinson\u2019s disease. Mov Disord 29:1802\u20131808","journal-title":"Mov Disord"},{"key":"2028_CR740","doi-asserted-by":"publisher","first-page":"122","DOI":"10.12688\/f11000research.16524.12681","volume":"8","author":"K Simonyan","year":"2019","unstructured":"Simonyan K (2019) Recent advances in understanding the role of the basal ganglia [version 1; peer review: 2 approved]. F1000 Res 8:122. https:\/\/doi.org\/10.12688\/f11000research.16524.12681","journal-title":"F1000 Res"},{"key":"2028_CR741","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1093\/brain\/awx263","volume":"140","author":"K Simonyan","year":"2017","unstructured":"Simonyan K, Cho H, Hamzehei Sichani A, Rubien-Thomas E, Hallett M (2017) The direct basal ganglia pathway is hyperfunctional in focal dystonia. Brain 140:3179\u20133190","journal-title":"Brain"},{"key":"2028_CR742","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mds.25249","volume":"28","author":"AB Singleton","year":"2013","unstructured":"Singleton AB, Farrer MJ, Bonifati V (2013) The genetics of Parkinson\u2019s disease: progress and therapeutic implications. Mov Disord 28:14\u201323","journal-title":"Mov Disord"},{"key":"2028_CR743","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/mdc3.12481","volume":"4","author":"M Sklerov","year":"2017","unstructured":"Sklerov M, Kang UJ, Liong C, Clark L, Marder K, Pauciulo M, Nichols WC, Chung WK, Honig LS, Cortes E, Vonsattel JP, Alcalay RN (2017) Frequency of GBA variants in autopsy-proven multiple system atrophy. Mov Disord Clin Pract 4:574\u2013581","journal-title":"Mov Disord Clin Pract"},{"key":"2028_CR744","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3233\/JAD-170274","volume":"59","author":"RE Skogseth","year":"2017","unstructured":"Skogseth RE, Hortobagyi T, Soennesyn H, Chwiszczuk L, Ffytche D, Rongve A, Ballard C, Aarsland D (2017) Accuracy of clinical diagnosis of dementia with Lewy bodies versus neuropathology. J Alzheimers Dis 59:1139\u20131152","journal-title":"J Alzheimers Dis"},{"key":"2028_CR915","doi-asserted-by":"crossref","unstructured":"Smith C, Malek N, Grosset KA, Cullen B, Gentleman SM, Grosset DG (2019) The neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry (in press)","DOI":"10.1136\/jnnp-2019-321111"},{"key":"2028_CR745","doi-asserted-by":"publisher","first-page":"292","DOI":"10.5607\/en.2014.23.4.292","volume":"23","author":"D Snead","year":"2014","unstructured":"Snead D, Eliezer D (2014) Alpha-synuclein function and dysfunction on cellular membranes. Exp Neurobiol 23:292\u2013313","journal-title":"Exp Neurobiol"},{"key":"2028_CR746","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/ana.24778","volume":"80","author":"AH Snijders","year":"2016","unstructured":"Snijders AH, Takakusaki K, Debu B, Lozano AM, Krishna V, Fasano A, Aziz TZ, Papa SM, Factor SA, Hallett M (2016) Physiology of freezing of gait. Ann Neurol 80:644\u2013659","journal-title":"Ann Neurol"},{"key":"2028_CR747","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-00019-01977-00402","author":"ZA Sorrentino","year":"2019","unstructured":"Sorrentino ZA, Giasson BI, Chakrabarty P (2019) Alpha-synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-00019-01977-00402","journal-title":"Acta Neuropathol"},{"key":"2028_CR748","doi-asserted-by":"publisher","first-page":"101644","DOI":"10.1016\/j.nicl.2018.101644","volume":"21","author":"C Spay","year":"2018","unstructured":"Spay C, Meyer G, Welter ML, Lau B, Boulinguez P, Ballanger B (2018) Functional imaging correlates of akinesia in Parkinson\u2019s disease: still open issues. Neuroimage Clin 21:101644","journal-title":"Neuroimage Clin"},{"key":"2028_CR749","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","volume":"12","author":"MG Spillantini","year":"2013","unstructured":"Spillantini MG, Goedert M (2013) Tau pathology and neurodegeneration. Lancet Neurol 12:609\u2013622","journal-title":"Lancet Neurol"},{"key":"2028_CR750","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95:6469\u20136473","journal-title":"Proc Natl Acad Sci USA"},{"key":"2028_CR751","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz1122","author":"S Spina","year":"2019","unstructured":"Spina S, Brown JA, Deng J, Gardner RC, Nana AL, Hwang JL, Gaus SE, Huang EJ, Kramer JH, Rosen HJ, Kornak J, Neuhaus J, Miller BL, Grinberg LT, Boxer AL, Seeley WW (2019) Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies. Brain. https:\/\/doi.org\/10.1093\/brain\/awz1122","journal-title":"Brain"},{"key":"2028_CR752","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","volume":"134","author":"TL Spires-Jones","year":"2017","unstructured":"Spires-Jones TL, Attems J, Thal DR (2017) Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol 134:187\u2013205","journal-title":"Acta Neuropathol"},{"key":"2028_CR753","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1111\/ene.12086","volume":"20","author":"K Srulijes","year":"2013","unstructured":"Srulijes K, Hauser AK, Guella I, Asselta R, Brockmann K, Schulte C, Solda G, Cilia R, Maetzler W, Schols L, Wenning GK, Poewe W, Barone P, Wullner U, Oertel W, Berg D, Goldwurm S, Gasser T (2013) No association of GBA mutations and multiple system atrophy. Eur J Neurol 20:e61\u2013e62","journal-title":"Eur J Neurol"},{"key":"2028_CR754","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27701","author":"I Stankovic","year":"2019","unstructured":"Stankovic I, Quinn N, Vignatelli L, Antonini A, Berg D, Coon E, Cortelli P, Fanciulli A, Ferreira JJ, Freeman R, Halliday G, Hoglinger GU, Iodice V, Kaufmann H, Klockgether T, Kostic V, Krismer F, Lang A, Levin J, Low P, Mathias C, Meissner WG, Kaufmann LN, Palma JA, Panicker JN, Pellecchia MT, Sakakibara R, Schmahmann J, Scholz SW, Singer W, Stamelou M, Tolosa E, Tsuji S, Seppi K, Poewe W, Wenning GK (2019) A critique of the second consensus criteria for multiple system atrophy. Mov Disord. https:\/\/doi.org\/10.1002\/mds.27701","journal-title":"Mov Disord"},{"key":"2028_CR755","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1212\/01.wnl.0000312571.81091.26","volume":"70","author":"JC Steele","year":"2008","unstructured":"Steele JC, McGeer PL (2008) The ALS\/PDC syndrome of Guam and the cycad hypothesis. Neurology 70:1984\u20131990","journal-title":"Neurology"},{"key":"2028_CR756","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) Alpha-synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a009399","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2028_CR757","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14704","author":"L Stefanis","year":"2019","unstructured":"Stefanis L, Emmanouilidou E, Pantazopoulou M, Kirik D, Vekrellis K, Tofaris GK (2019) How is alpha-synuclein cleared from the cell? J Neurochem. https:\/\/doi.org\/10.1111\/jnc.14704","journal-title":"J Neurochem"},{"key":"2028_CR758","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-7091-0687-7_5","volume-title":"Multiple system atrophy","author":"N Stefanova","year":"2014","unstructured":"Stefanova N (2014) Animal models. In: Wenning GK, Fanciulli A (eds) Multiple system atrophy. Springer, Vienna, pp 83\u201396"},{"key":"2028_CR759","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12883-019-1270-1","volume":"19","author":"Z Stejskalova","year":"2019","unstructured":"Stejskalova Z, Rohan Z, Rusina R, Tesar A, Kukal J, Kovacs GG, Bartos A, Matej R (2019) Pyramidal system involvement in progressive supranuclear palsy\u2014a clinicopathological correlation. BMC Neurol 19:42","journal-title":"BMC Neurol"},{"key":"2028_CR760","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1074\/jbc.M117.815357","volume":"293","author":"KH Strang","year":"2018","unstructured":"Strang KH, Croft CL, Sorrentino ZA, Chakrabarty P, Golde TE, Giasson BI (2018) Distinct differences in prion-like seeding and aggregation between tau protein variants provide mechanistic insights into tauopathies. J Biol Chem 293:2408\u20132421","journal-title":"J Biol Chem"},{"key":"2028_CR761","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-41019-40197-x","author":"KH Strang","year":"2019","unstructured":"Strang KH, Golde TE, Giasson BI (2019) MAPT mutations, tauopathy, and mechanisms of neurodegeneration. Lab Invest. https:\/\/doi.org\/10.1038\/s41374-41019-40197-x","journal-title":"Lab Invest"},{"key":"2028_CR762","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.biopsych.2018.12.008","volume":"85","author":"Y Su","year":"2019","unstructured":"Su Y, Deng MF, Xiong W, Xie AJ, Guo J, Liang ZH, Hu B, Chen JG, Zhu X, Man HY, Lu Y, Liu D, Tang B, Zhu LQ (2019) MicroRNA-26a\/death-associated protein kinase 1 signaling induces synucleinopathy and dopaminergic neuron degeneration in Parkinson\u2019s disease. Biol Psychiatry 85:769\u2013781","journal-title":"Biol Psychiatry"},{"key":"2028_CR763","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mds.25095","volume":"28","author":"D Sulzer","year":"2013","unstructured":"Sulzer D, Surmeier DJ (2013) Neuronal vulnerability, pathogenesis, and Parkinson\u2019s disease. Mov Disord 28:41\u201350","journal-title":"Mov Disord"},{"key":"2028_CR764","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40478-015-0236-9","volume":"3","author":"H Sumikura","year":"2015","unstructured":"Sumikura H, Takao M, Hatsuta H, Ito S, Nakano Y, Uchino A, Nogami A, Saito Y, Mochizuki H, Murayama S (2015) Distribution of alpha-synuclein in the spinal cord and dorsal root ganglia in an autopsy cohort of elderly persons. Acta Neuropathol Commun 3:57","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR765","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jocn.2012.01.055","volume":"20","author":"QY Sun","year":"2013","unstructured":"Sun QY, Guo JF, Han WW, Zuo X, Wang L, Yao LY, Pan Q, Xia K, Yan XX, Tang BS (2013) Genetic association study of glucocerebrosidase gene L444P mutation in essential tremor and multiple system atrophy in mainland China. J Clin Neurosci 20:217\u2013219","journal-title":"J Clin Neurosci"},{"key":"2028_CR766","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3109\/00207454.2014.990013","volume":"125","author":"Z Sun","year":"2015","unstructured":"Sun Z, Xiang X, Tang B, Chen Z, Peng H, Xia K, Jiang H (2015) SNP rs11931074 of the SNCA gene may not be associated with multiple system atrophy in Chinese population. Int J Neurosci 125:612\u2013615","journal-title":"Int J Neurosci"},{"key":"2028_CR767","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1212\/NXG.0000000000000054","volume":"2","author":"Z Sun","year":"2016","unstructured":"Sun Z, Ohta Y, Yamashita T, Sato K, Takemoto M, Hishikawa N, Abe K (2016) New susceptible variant of COQ2 gene in Japanese patients with sporadic multiple system atrophy. Neurol Genet 2:e54","journal-title":"Neurol Genet"},{"key":"2028_CR768","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3389\/fnins.2018.00859","volume":"12","author":"Y Sun","year":"2018","unstructured":"Sun Y, Pham AN, Hare DJ, Waite TD (2018) Kinetic modeling of pH-dependent oxidation of dopamine by iron and its relevance to Parkinson\u2019s disease. Front Neurosci 12:859","journal-title":"Front Neurosci"},{"key":"2028_CR769","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0891988718813675","volume":"32","author":"R Sun","year":"2019","unstructured":"Sun R, Yang S, Zheng B, Liu J, Ma X (2019) Apolipoprotein E polymorphisms and Parkinson disease with or without dementia: a meta-analysis including 6453 participants. J Geriatr Psychiatry Neurol 32:3\u201315","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"2028_CR770","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/febs.14607","volume":"285","author":"DJ Surmeier","year":"2018","unstructured":"Surmeier DJ (2018) Determinants of dopaminergic neuron loss in Parkinson\u2019s disease. FEBS J 285:3657\u20133668","journal-title":"FEBS J"},{"key":"2028_CR771","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM (2017) Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci 18:101\u2013113","journal-title":"Nat Rev Neurosci"},{"key":"2028_CR772","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neunet.2018.10.003","volume":"109","author":"SM Suryanarayana","year":"2019","unstructured":"Suryanarayana SM, Hellgren Kotaleski J, Grillner S, Gurney KN (2019) Roles for globus pallidus externa revealed in a computational model of action selection in the basal ganglia. Neural Netw 109:113\u2013136","journal-title":"Neural Netw"},{"key":"2028_CR773","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24448","volume":"78","author":"E Svensson","year":"2015","unstructured":"Svensson E, Horvath-Puho E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, Sorensen HT (2015) Vagotomy and subsequent risk of Parkinson\u2019s disease. Ann Neurol 78:522\u2013529","journal-title":"Ann Neurol"},{"key":"2028_CR774","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13195-014-0077-y","volume":"6","author":"M Swirski","year":"2014","unstructured":"Swirski M, Miners JS, de Silva R, Lashley T, Ling H, Holton J, Revesz T, Love S (2014) Evaluating the relationship between amyloid-\u00df and a-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson\u2019s disease. Alzheimers Res Ther 6:77","journal-title":"Alzheimers Res Ther"},{"key":"2028_CR775","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/978-3-7091-1628-9_21","volume-title":"Movement disorders curricula","author":"P Taba","year":"2017","unstructured":"Taba P (2017) Toxic-induced parkinsonism. In: Falup-Pecurariu C, Ferreira J, Martinez-Martin P, Chaudhuri KR (eds) Movement disorders curricula. Springer, Wien, pp 225\u2013232"},{"key":"2028_CR776","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.parkreldis.2014.05.004","volume":"20","author":"P Tacik","year":"2014","unstructured":"Tacik P, Fiesel FC, Fujioka S, Ross OA, Pretelt F, Castaneda Cardona C, Kidd A, Hlavac M, Raizis A, Okun MS, Traynor S, Strongosky AJ, Springer W, Wszolek ZK (2014) Three families with Perry syndrome from distinct parts of the world. Parkinsonism Relat Disord 20:884\u2013888","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR777","doi-asserted-by":"publisher","first-page":"22913","DOI":"10.1038\/srep22913","volume":"6","author":"F Taghdiri","year":"2016","unstructured":"Taghdiri F, Sato C, Ghani M, Moreno D, Rogaeva E, Tartaglia MC (2016) Novel GRN mutations in patients with corticobasal syndrome. Sci Rep 6:22913","journal-title":"Sci Rep"},{"key":"2028_CR778","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JPD-150769","volume":"6","author":"P Tagliaferro","year":"2016","unstructured":"Tagliaferro P, Burke RE (2016) Retrograde axonal degeneration in Parkinson disease. J Parkinsons Dis 6:1\u201315","journal-title":"J Parkinsons Dis"},{"key":"2028_CR779","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12565-018-0464-8","volume":"94","author":"K Taguchi","year":"2019","unstructured":"Taguchi K, Watanabe Y, Tsujimura A, Tanaka M (2019) Expression of alpha-synuclein is regulated in a neuronal cell type-dependent manner. Anat Sci Int 94:11\u201322","journal-title":"Anat Sci Int"},{"key":"2028_CR780","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/brain\/aww080","volume":"139","author":"R Taipa","year":"2016","unstructured":"Taipa R, Pereira C, Reis I, Alonso I, Bastos-Lima A, Melo-Pires M, Magalhaes M (2016) DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology. Brain 139:1680\u20131687","journal-title":"Brain"},{"key":"2028_CR781","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40478-018-0617-y","volume":"6","author":"M Takanashi","year":"2018","unstructured":"Takanashi M, Funayama M, Matsuura E, Yoshino H, Li Y, Tsuyama S, Takashima H, Nishioka K, Hattori N (2018) Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations. Acta Neuropathol Commun 6:105","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR782","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00441-017-2712-y","volume":"373","author":"G Tamguney","year":"2018","unstructured":"Tamguney G, Korczyn AD (2018) A critical review of the prion hypothesis of human synucleinopathies. Cell Tissue Res 373:213\u2013220","journal-title":"Cell Tissue Res"},{"key":"2028_CR783","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28871","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji OR, Behnam M, Pourattar MA, Jafarpour H, Asemi Z (2019) Aquaporin 4: a key player in Parkinson\u2019s disease. J Cell Physiol. https:\/\/doi.org\/10.1002\/jcp.28871","journal-title":"J Cell Physiol"},{"key":"2028_CR784","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.bbadis.2019.02.013","volume":"1865","author":"G Tanaka","year":"2019","unstructured":"Tanaka G, Yamanaka T, Furukawa Y, Kajimura N, Mitsuoka K, Nukina N (2019) Sequence- and seed-structure-dependent polymorphic fibrils of alpha-synuclein. Biochim Biophys Acta Mol Basis Dis 1865:1410\u20131420","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2028_CR785","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00401-015-1503-3","volume":"131","author":"S Taniguchi-Watanabe","year":"2016","unstructured":"Taniguchi-Watanabe S, Arai T, Kametani F, Nonaka T, Masuda-Suzukake M, Tarutani A, Murayama S, Saito Y, Arima K, Yoshida M, Akiyama H, Robinson A, Mann DMA, Iwatsubo T, Hasegawa M (2016) Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau. Acta Neuropathol 131:267\u2013280","journal-title":"Acta Neuropathol"},{"key":"2028_CR786","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12728","author":"K Tanji","year":"2019","unstructured":"Tanji K, Miki Y, Mori F, Kon T, Kakita A, Takahashi H, Wakabayashi K (2019) Phosphorylated NUB1 distinguishes alpha-synuclein in Lewy bodies from that in glial cytoplasmic inclusions in multiple system atrophy. Brain Pathol. https:\/\/doi.org\/10.1111\/bpa.12728","journal-title":"Brain Pathol"},{"key":"2028_CR787","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s40478-016-0386-4","volume":"4","author":"M Tardivel","year":"2016","unstructured":"Tardivel M, Begard S, Bousset L, Dujardin S, Coens A, Melki R, Buee L, Colin M (2016) Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological tau protein assemblies. Acta Neuropathol Commun 4:117","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR788","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/NEN.0000000000000022","volume":"73","author":"S Tatsumi","year":"2014","unstructured":"Tatsumi S, Mimuro M, Iwasaki Y, Takahashi R, Kakita A, Takahashi H, Yoshida M (2014a) Argyrophilic grains are reliable disease-specific features of corticobasal degeneration. J Neuropathol Exp Neurol 73:30\u201338","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR789","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s40478-014-0161-3","volume":"2","author":"S Tatsumi","year":"2014","unstructured":"Tatsumi S, Uchihara T, Aiba I, Iwasaki Y, Mimuro M, Takahashi R, Yoshida M (2014b) Ultrastructural differences in pretangles between Alzheimer disease and corticobasal degeneration revealed by comparative light and electron microscopy. Acta Neuropathol Commun 2:161","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR790","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cell.2016.06.032","volume":"166","author":"F Tecuapetla","year":"2016","unstructured":"Tecuapetla F, Jin X, Lima SQ, Costa RM (2016) Complementary contributions of striatal projection pathways to action initiation and execution. Cell 166:703\u2013715","journal-title":"Cell"},{"key":"2028_CR791","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/01913123.2013.825689","volume":"38","author":"A Tercjak","year":"2014","unstructured":"Tercjak A, Bergareche A, Caballero C, Tunon T, Linazasoro G (2014) Lewy bodies under atomic force microscope. Ultrastruct Pathol 38:1\u20135","journal-title":"Ultrastruct Pathol"},{"key":"2028_CR792","doi-asserted-by":"publisher","first-page":"E8284","DOI":"10.1073\/pnas.1710442114","volume":"114","author":"P Thakur","year":"2017","unstructured":"Thakur P, Breger LS, Lundblad M, Wan OW, Mattsson B, Luk KC, Lee VMY, Trojanowski JQ, Bjorklund A (2017) Modeling Parkinson\u2019s disease pathology by combination of fibril seeds and alpha-synuclein overexpression in the rat brain. Proc Natl Acad Sci USA 114:E8284\u2013E8293","journal-title":"Proc Natl Acad Sci USA"},{"key":"2028_CR793","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00702-014-1360-6","volume":"122","author":"DR Thal","year":"2015","unstructured":"Thal DR, von Arnim CA, Griffin WS, Mrak RE, Walker L, Attems J, Arzberger T (2015) Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies. J Neural Transm (Vienna) 122:1007\u20131018","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR794","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jamaneurol.2013.6233","volume":"71","author":"MA Thenganatt","year":"2014","unstructured":"Thenganatt MA, Jankovic J (2014) Parkinson disease subtypes. JAMA Neurol 71:499\u2013504","journal-title":"JAMA Neurol"},{"key":"2028_CR795","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11910-017-0788-0","volume":"17","author":"S Thobois","year":"2017","unstructured":"Thobois S, Prange S, Sgambato-Faure V, Tremblay L, Broussolle E (2017) Imaging the etiology of apathy, anxiety, and depression in Parkinson\u2019s disease: implication for treatment. Curr Neurol Neurosci Rep 17:76","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2028_CR796","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13195-018-0356-0","volume":"10","author":"AJ Thomas","year":"2018","unstructured":"Thomas AJ, Mahin-Babaei F, Saidi M, Lett D, Taylor JP, Walker L, Attems J (2018) Improving the identification of dementia with Lewy bodies in the context of an Alzheimer\u2019s-type dementia. Alzheimers Res Ther 10:27","journal-title":"Alzheimers Res Ther"},{"key":"2028_CR797","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1017\/S0033291718000995","volume":"49","author":"AJ Thomas","year":"2019","unstructured":"Thomas AJ, Donaghy P, Roberts G, Colloby SJ, Barnett NA, Petrides G, Lloyd J, Olsen K, Taylor JP, McKeith I, O\u2019Brien JT (2019) Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies. Psychol Med 49:396\u2013402","journal-title":"Psychol Med"},{"key":"2028_CR798","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0000000000001204","volume":"84","author":"P Tiraboschi","year":"2015","unstructured":"Tiraboschi P, Attems J, Thomas A, Brown A, Jaros E, Lett DJ, Ossola M, Perry RH, Ramsay L, Walker L, McKeith IG (2015) Clinicians\u2019 ability to diagnose dementia with Lewy bodies is not affected by beta-amyloid load. Neurology 84:496\u2013499","journal-title":"Neurology"},{"key":"2028_CR799","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/bs.irn.2017.02.016","volume":"132","author":"N Titova","year":"2017","unstructured":"Titova N, Qamar MA, Chaudhuri KR (2017) The nonmotor features of Parkinson\u2019s disease. Int Rev Neurobiol 132:33\u201354","journal-title":"Int Rev Neurobiol"},{"key":"2028_CR800","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1750-3639.2002.tb00421.x","volume":"12","author":"T Togo","year":"2002","unstructured":"Togo T, Cookson N, Dickson DW (2002) Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E. Brain Pathol 12:45\u201352","journal-title":"Brain Pathol"},{"key":"2028_CR801","first-page":"1409","volume":"69","author":"M Tomiyama","year":"2017","unstructured":"Tomiyama M (2017) Symptoms and pathophysiology of dyskinesias. Brain Nerve 69:1409\u20131416","journal-title":"Brain Nerve"},{"key":"2028_CR802","first-page":"839","volume":"59","author":"H Tomiyama","year":"2007","unstructured":"Tomiyama H, Hatano T, Hattori N (2007) Clinical molecular genetics for PARK8 (LRRK2). Brain Nerve 59:839\u2013850","journal-title":"Brain Nerve"},{"key":"2028_CR803","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/brain\/awp282","volume":"133","author":"J Tong","year":"2010","unstructured":"Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y (2010) Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson\u2019s disease and progressive supranuclear palsy: a comparative investigation. Brain 133:172\u2013188","journal-title":"Brain"},{"key":"2028_CR804","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00702-018-1900-6","volume":"125","author":"TN Tran","year":"2018","unstructured":"Tran TN, Vo TNN, Frei K, Truong DD (2018) Levodopa-induced dyskinesia: clinical features, incidence, and risk factors. J Neural Transm (Vienna) 125:1109\u20131117","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR916","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13024-019-0314-8","volume":"14","author":"ME Tremblay","year":"2019","unstructured":"Tremblay ME, Cookson MR, Civiero L (2019) Glial phagocytic clearance in Parkinson\u2019s disease. Mol Neurodegener 14:16","journal-title":"Mol Neurodegener"},{"key":"2028_CR805","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1002\/mds.27527","volume":"33","author":"J Trinh","year":"2018","unstructured":"Trinh J, Zeldenrust FMJ, Huang J, Kasten M, Schaake S, Petkovic S, Madoev H, Grunewald A, Almuammar S, Konig IR, Lill CM, Lohmann K, Klein C, Marras C (2018) Genotype-phenotype relations for the Parkinson\u2019s disease genes SNCA, LRRK2, VPS35: MDSGene systematic review. Mov Disord 33:1857\u20131870","journal-title":"Mov Disord"},{"key":"2028_CR806","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2990.2007.00907.x","volume":"33","author":"JQ Trojanowski","year":"2007","unstructured":"Trojanowski JQ, Revesz T (2007) Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 33:615\u2013620","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR807","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.bbadis.2008.12.006","volume":"1792","author":"AH Tsang","year":"2009","unstructured":"Tsang AH, Chung KK (2009) Oxidative and nitrosative stress in Parkinson\u2019s disease. Biochim Biophys Acta 1792:643\u2013650","journal-title":"Biochim Biophys Acta"},{"key":"2028_CR808","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mito.2016.03.003","volume":"28","author":"C Tzoulis","year":"2016","unstructured":"Tzoulis C, Schwarzlmuller T, Biermann M, Haugarvoll K, Bindoff LA (2016) Mitochondrial DNA homeostasis is essential for nigrostriatal integrity. Mitochondrion 28:33\u201337","journal-title":"Mitochondrion"},{"key":"2028_CR809","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.1523\/JNEUROSCI.0567-10.2010","volume":"30","author":"K Ubhi","year":"2010","unstructured":"Ubhi K, Rockenstein E, Mante M, Inglis C, Adame A, Patrick C, Whitney K, Masliah E (2010) Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors. J Neurosci 30:6236\u20136246","journal-title":"J Neurosci"},{"key":"2028_CR810","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.tins.2011.08.003","volume":"34","author":"K Ubhi","year":"2011","unstructured":"Ubhi K, Low P, Masliah E (2011) Multiple system atrophy: a clinical and neuropathological perspective. Trends Neurosci 34:581\u2013590","journal-title":"Trends Neurosci"},{"key":"2028_CR811","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/neup.12108","volume":"34","author":"T Uchihara","year":"2014","unstructured":"Uchihara T (2014) Pretangles and neurofibrillary changes: Similarities and differences between AD and CBD based on molecular and morphological evolution. Neuropathology 34:571\u2013577","journal-title":"Neuropathology"},{"key":"2028_CR812","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/01.jnen.0000218449.17073.43","volume":"65","author":"H Uchikado","year":"2006","unstructured":"Uchikado H, DelleDonne A, Ahmed Z, Dickson DW (2006a) Lewy bodies in progressive supranuclear palsy represent an independent disease process. J Neuropathol Exp Neurol 65:387\u2013395","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR813","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","volume":"65","author":"H Uchikado","year":"2006","unstructured":"Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006b) Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65:685\u2013697","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR814","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13024-018-0257-5","volume":"13","author":"N Uemura","year":"2018","unstructured":"Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R (2018) Inoculation of alpha-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol Neurodegener 13:21","journal-title":"Mol Neurodegener"},{"key":"2028_CR815","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1212\/WNL.35.6.921","volume":"35","author":"RJ Uitti","year":"1985","unstructured":"Uitti RJ, Rajput AH, Ashenhurst EM, Rozdilsky B (1985) Cyanide-induced parkinsonism: a clinicopathologic report. Neurology 35:921\u2013925","journal-title":"Neurology"},{"key":"2028_CR816","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12531","author":"NN Vaikath","year":"2018","unstructured":"Vaikath NN, Erskine D, Morris CM, Majbour NK, Vekrellis K, Li JY, El-Agnaf OMA (2018) Heterogeneity in alpha-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer\u2019s disease. Neuropathol Appl Neurobiol. https:\/\/doi.org\/10.1111\/nan.12531","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR817","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.3390\/ijms19124129","volume":"19","author":"D Valdinocci","year":"2018","unstructured":"Valdinocci D, Radford RAW, Goulding M, Hayashi J, Chung RS, Pountney DL (2018) Extracellular Interactions of alpha-synuclein in multiple system atrophy. Int J Mol Sci 19:4129","journal-title":"Int J Mol Sci"},{"key":"2028_CR818","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fnmol.2017.00329","volume":"10","author":"E Valera","year":"2017","unstructured":"Valera E, Spencer B, Mott J, Trejo M, Adame A, Mante M, Rockenstein E, Troncoso JC, Beach TG, Masliah E, Desplats P (2017) MicroRNA-101 modulates autophagy and oligodendroglial alpha-synuclein accumulation in multiple system atrophy. Front Mol Neurosci 10:329","journal-title":"Front Mol Neurosci"},{"issue":"Suppl 1","key":"2028_CR819","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/S1353-8020(11)70011-6","volume":"18","author":"WD van de Berg","year":"2012","unstructured":"van de Berg WD, Hepp DH, Dijkstra AA, Rozemuller JA, Berendse HW, Foncke E (2012) Patterns of alpha-synuclein pathology in incidental cases and clinical subtypes of Parkinson\u2019s disease. Parkinsonism Relat Disord 18(Suppl 1):S28\u2013S30","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR820","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.nbd.2016.05.011","volume":"94","author":"B Van Do","year":"2016","unstructured":"Van Do B, Gouel F, Jonneaux A, Timmerman K, Gele P, Petrault M, Bastide M, Laloux C, Moreau C, Bordet R, Devos D, Devedjian JC (2016) Ferroptosis, a newly characterized form of cell death in Parkinson\u2019s disease that is regulated by PKC. Neurobiol Dis 94:169\u2013178","journal-title":"Neurobiol Dis"},{"key":"2028_CR821","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1750-3639.2007.00052.x","volume":"17","author":"J van Swieten","year":"2007","unstructured":"van Swieten J, Spillantini MG (2007) Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol 17:63\u201373","journal-title":"Brain Pathol"},{"key":"2028_CR822","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fnmol.2019.00107","volume":"12","author":"E Vasili","year":"2019","unstructured":"Vasili E, Dominguez-Meijide A, Outeiro TF (2019) Spreading of alpha-synuclein and tau: a systematic comparison of the mechanisms involved. Front Mol Neurosci 12:107","journal-title":"Front Mol Neurosci"},{"key":"2028_CR823","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.07.009","volume":"43","author":"LJM Vergouw","year":"2017","unstructured":"Vergouw LJM, van Steenoven I, van de Berg WDJ, Teunissen CE, van Swieten JC, Bonifati V, Lemstra AW, de Jong FJ (2017) An update on the genetics of dementia with Lewy bodies. Parkinsonism Relat Disord 43:1\u20138","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR824","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fneur.2018.00173","volume":"9","author":"BM Verheijen","year":"2018","unstructured":"Verheijen BM, Oyanagi K, van Leeuwen FW (2018) Dysfunction of protein quality control in parkinsonism\u2013dementia complex of Guam. Front Neurol 9:173","journal-title":"Front Neurol"},{"key":"2028_CR825","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neuint.2016.11.009","volume":"102","author":"Y Vermeiren","year":"2017","unstructured":"Vermeiren Y, De Deyn PP (2017) Targeting the norepinephrinergic system in Parkinson\u2019s disease and related disorders: the locus coeruleus story. Neurochem Int 102:22\u201332","journal-title":"Neurochem Int"},{"key":"2028_CR826","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.tig.2015.01.004","volume":"31","author":"A Verstraeten","year":"2015","unstructured":"Verstraeten A, Theuns J, Van Broeckhoven C (2015) Progress in unraveling the genetic etiology of Parkinson disease in a genomic era. Trends Genet 31:140\u2013149","journal-title":"Trends Genet"},{"key":"2028_CR827","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00401-018-01956-z","volume":"137","author":"L Veys","year":"2019","unstructured":"Veys L, Vandenabeele M, Ortuno-Lizaran I, Baekelandt V, Cuenca N, Moons L, De Groef L (2019) Retinal alpha-synuclein deposits in Parkinson\u2019s disease patients and animal models. Acta Neuropathol 137:379\u2013395","journal-title":"Acta Neuropathol"},{"key":"2028_CR828","volume-title":"Encephalitis lethargica: during and after the epidemic","year":"2011","unstructured":"Vilensky JA (ed) (2011) Encephalitis lethargica: during and after the epidemic. Oxford University Press, Oxford"},{"key":"2028_CR829","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/mds.26346","volume":"30","author":"T Virmani","year":"2015","unstructured":"Virmani T, Moskowitz CB, Vonsattel JP, Fahn S (2015) Clinicopathological characteristics of freezing of gait in autopsy-confirmed Parkinson\u2019s disease. Mov Disord 30:1874\u20131884","journal-title":"Mov Disord"},{"key":"2028_CR830","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.1003.1004","author":"F Vitale","year":"2018","unstructured":"Vitale F, Capozzo A, Mazzone P, Scarnati E (2018) Neurophysiology of the pedunculopontine tegmental nucleus. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2018.1003.1004","journal-title":"Neurobiol Dis"},{"key":"2028_CR831","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.nbd.2016.12.008","volume":"105","author":"LA Volpicelli-Daley","year":"2017","unstructured":"Volpicelli-Daley LA (2017) Effects of alpha-synuclein on axonal transport. Neurobiol Dis 105:321\u2013327","journal-title":"Neurobiol Dis"},{"key":"2028_CR832","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S1474-4422(15)00186-6","volume":"14","author":"M Volta","year":"2015","unstructured":"Volta M, Milnerwood AJ, Farrer MJ (2015) Insights from late-onset familial parkinsonism on the pathogenesis of idiopathic Parkinson\u2019s disease. Lancet Neurol 14:1054\u20131064","journal-title":"Lancet Neurol"},{"key":"2028_CR833","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S1474-4422(17)30004-2","volume":"16","author":"V Voon","year":"2017","unstructured":"Voon V, Napier TC, Frank MJ, Sgambato-Faure V, Grace AA, Rodriguez-Oroz M, Obeso J, Bezard E, Fernagut PO (2017) Impulse control disorders and levodopa-induced dyskinesias in Parkinson\u2019s disease: an update. Lancet Neurol 16:238\u2013250","journal-title":"Lancet Neurol"},{"key":"2028_CR834","doi-asserted-by":"publisher","first-page":"9","DOI":"10.17116\/patol20188049","volume":"80","author":"DN Voronkov","year":"2018","unstructured":"Voronkov DN, Salkov VN, Anufriev PL, Khudoerkov RM (2018) Lewy bodies in Parkinson\u2019s disease: histological, immunohistochemical, and interferometric examinations. Arkhiv Patologii 80:9\u201313","journal-title":"Arkhiv Patologii"},{"key":"2028_CR835","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/humu.21248","volume":"31","author":"GE Voutsinas","year":"2010","unstructured":"Voutsinas GE, Stavrou EF, Karousos G, Dasoula A, Papachatzopoulou A, Syrrou M, Verkerk AJ, van der Spek P, Patrinos GP, Stoger R, Athanassiadou A (2010) Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson disease. Hum Mutat 31:685\u2013691","journal-title":"Hum Mutat"},{"key":"2028_CR836","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/jnnp-2012-304811","volume":"85","author":"C Vriend","year":"2014","unstructured":"Vriend C, Raijmakers P, Veltman DJ, van Dijk KD, van der Werf YD, Foncke EM, Smit JH, Berendse HW, van den Heuvel OA (2014) Depressive symptoms in Parkinson\u2019s disease are related to reduced [123I]FP-CIT binding in the caudate nucleus. J Neurol Neurosurg Psychiatry 85:159\u2013164","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2028_CR837","first-page":"489","volume":"70","author":"K Wakabayashi","year":"2018","unstructured":"Wakabayashi K, Miki Y (2018) Multi-organ distribution of alpha-synuclein pathology in dementia with Lewy bodies. Brain Nerve 70:489\u2013500","journal-title":"Brain Nerve"},{"key":"2028_CR838","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00401-005-1029-1","volume":"110","author":"K Wakabayashi","year":"2005","unstructured":"Wakabayashi K, Mori F, Nishie M, Oyama Y, Kurihara A, Yoshimoto M, Kuroda N (2005) An autopsy case of early (\u201cminimal change\u201d) olivopontocerebellar atrophy (multiple system atrophy-cerebellar). Acta Neuropathol 110:185\u2013190","journal-title":"Acta Neuropathol"},{"key":"2028_CR839","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-010-0706-x","volume":"120","author":"K Wakabayashi","year":"2010","unstructured":"Wakabayashi K, Mori F, Tanji K, Orimo S, Takahashi H (2010) Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol 120:1\u201312","journal-title":"Acta Neuropathol"},{"key":"2028_CR840","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","volume":"47","author":"K Wakabayashi","year":"2013","unstructured":"Wakabayashi K, Tanji K, Odagiri S, Miki Y, Mori F, Takahashi H (2013) The Lewy body in Parkinson\u2019s disease and related neurodegenerative disorders. Mol Neurobiol 47:495\u2013508","journal-title":"Mol Neurobiol"},{"key":"2028_CR841","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.expneurol.2012.11.020","volume":"240","author":"DG Walker","year":"2013","unstructured":"Walker DG, Lue LF, Adler CH, Shill HA, Caviness JN, Sabbagh MN, Akiyama H, Serrano GE, Sue LI, Beach TG (2013) Changes in properties of serine 129 phosphorylated alpha-synuclein with progression of Lewy-type histopathology in human brains. Exp Neurol 240:190\u2013204","journal-title":"Exp Neurol"},{"key":"2028_CR842","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","volume":"129","author":"L Walker","year":"2015","unstructured":"Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby SJ, Jellinger K, Attems J (2015) Neuropathologically mixed Alzheimer\u2019s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol 129:729\u2013748","journal-title":"Acta Neuropathol"},{"key":"2028_CR843","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-016-0143-y","volume":"12","author":"Y Wang","year":"2017","unstructured":"Wang Y, Balaji V, Kaniyappan S, Kruger L, Irsen S, Tepper K, Chandupatla R, Maetzler W, Schneider A, Mandelkow E, Mandelkow EM (2017) The release and trans-synaptic transmission of Tau via exosomes. Mol Neurodegener 12:5","journal-title":"Mol Neurodegener"},{"key":"2028_CR844","doi-asserted-by":"publisher","first-page":"8211","DOI":"10.1523\/JNEUROSCI.1134-18.2018","volume":"38","author":"B Wang","year":"2018","unstructured":"Wang B, Underwood R, Kamath A, Britain C, McFerrin MB, McLean PJ, Volpicelli-Daley LA, Whitaker RH, Placzek WJ, Becker K, Ma J, Yacoubian TA (2018) 14-3-3 proteins reduce cell-to-cell transfer and propagation of pathogenic alpha-synuclein. J Neurosci 38:8211\u20138232","journal-title":"J Neurosci"},{"key":"2028_CR845","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40478-019-0696-4","volume":"7","author":"X Wang","year":"2019","unstructured":"Wang X, Becker K, Levine N, Zhang M, Lieberman AP, Moore DJ, Ma J (2019) Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration. Acta Neuropathol Commun 7:41","journal-title":"Acta Neuropathol Commun"},{"key":"2028_CR846","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000078505","volume":"23","author":"SC Waring","year":"2004","unstructured":"Waring SC, Esteban-Santillan C, Reed DM, Craig UK, Labarthe DR, Petersen RC, Kurland LT (2004) Incidence of amyotrophic lateral sclerosis and of the parkinsonism-dementia complex of Guam, 1950-1989. Neuroepidemiology 23:192\u2013200","journal-title":"Neuroepidemiology"},{"key":"2028_CR847","doi-asserted-by":"publisher","first-page":"457","DOI":"10.5692\/clinicalneurol.cn-000903","volume":"56","author":"H Watanabe","year":"2016","unstructured":"Watanabe H, Riku Y, Nakamura T, Hara K, Ito M, Hirayama M, Yoshida M, Katsuno M, Sobue G (2016) Expanding concept of clinical conditions and symptoms in multiple system atrophy. Rinsho Shinkeigaku 56:457\u2013464","journal-title":"Rinsho Shinkeigaku"},{"key":"2028_CR848","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbr.2018.03.011","volume":"347","author":"L Wei","year":"2018","unstructured":"Wei L, Hu X, Yuan Y, Liu W, Chen H (2018) Abnormal ventral tegmental area-anterior cingulate cortex connectivity in Parkinson\u2019s disease with depression. Behav Brain Res 347:132\u2013139","journal-title":"Behav Brain Res"},{"key":"2028_CR849","doi-asserted-by":"publisher","first-page":"17336","DOI":"10.1074\/jbc.RA118.005316","volume":"293","author":"HA Weismiller","year":"2018","unstructured":"Weismiller HA, Murphy R, Wei G, Ma B, Nussinov R, Margittai M (2018) Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms. J Biol Chem 293:17336\u201317348","journal-title":"J Biol Chem"},{"key":"2028_CR850","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/mds.870090206","volume":"9","author":"GK Wenning","year":"1994","unstructured":"Wenning GK, Quinn N, Magalhaes M, Mathias C, Daniel SE (1994) \u201cMinimal change\u201d multiple system atrophy. Mov Disord 9:161\u2013166","journal-title":"Mov Disord"},{"key":"2028_CR851","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/BF01285553","volume":"104","author":"GK Wenning","year":"1997","unstructured":"Wenning GK, Jellinger K, Litvan I (1997) Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism. J Neural Transm 104:845\u2013865","journal-title":"J Neural Transm"},{"key":"2028_CR852","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/mds.23713","volume":"26","author":"GK Wenning","year":"2011","unstructured":"Wenning GK, Litvan I, Tolosa E (2011) Milestones in atypical and secondary parkinsonisms. Mov Disord 26:1083\u20131095","journal-title":"Mov Disord"},{"key":"2028_CR853","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S1474-4422(12)70327-7","volume":"12","author":"GK Wenning","year":"2013","unstructured":"Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S, Kollensperger M, Goebel G, Pfeiffer KP, Barone P, Pellecchia MT, Quinn NP, Koukouni V, Fowler CJ, Schrag A, Mathias CJ, Giladi N, Gurevich T, Dupont E, Ostergaard K, Nilsson CF, Widner H, Oertel W, Eggert KM, Albanese A, del Sorbo F, Tolosa E, Cardozo A, Deuschl G, Hellriegel H, Klockgether T, Dodel R, Sampaio C, Coelho M, Djaldetti R, Melamed E, Gasser T, Kamm C, Meco G, Colosimo C, Rascol O, Meissner WG, Tison F, Poewe W (2013) The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12:264\u2013274","journal-title":"Lancet Neurol"},{"key":"2028_CR854","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/ana.25132","volume":"83","author":"G Wenning","year":"2018","unstructured":"Wenning G, Trojanowski JQ, Kaufmann H, Wisniewski T, Rocca WA, Low PA (2018) Is multiple system atrophy an infectious disease? Ann Neurol 83:10\u201312","journal-title":"Ann Neurol"},{"key":"2028_CR855","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/mdc3.12584","volume":"5","author":"JL Whitwell","year":"2018","unstructured":"Whitwell JL (2018) Tau imaging in parkinsonism: what have we learned so far? Mov Disord Clin Pract 5:118\u2013130","journal-title":"Mov Disord Clin Pract"},{"key":"2028_CR856","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00702-017-1736-5","volume":"125","author":"T Wichmann","year":"2018","unstructured":"Wichmann T, Bergman H, DeLong MR (2018) Basal ganglia, movement disorders and deep brain stimulation: advances made through non-human primate research. J Neural Transm (Vienna) 125:419\u2013430","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR857","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.parkreldis.2008.07.005","volume":"15","author":"C Wider","year":"2009","unstructured":"Wider C, Dickson DW, Stoessl AJ, Tsuboi Y, Chapon F, Gutmann L, Lechevalier B, Calne DB, Personett DA, Hulihan M, Kachergus J, Rademakers R, Baker MC, Grantier LL, Sujith OK, Brown L, Calne S, Farrer MJ, Wszolek ZK (2009) Pallidonigral TDP-43 pathology in Perry syndrome. Parkinsonism Relat Disord 15:281\u2013286","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR858","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12035-018-1082-0","volume":"56","author":"A Wilkaniec","year":"2019","unstructured":"Wilkaniec A, Lenkiewicz AM, Czapski GA, Jesko HM, Hilgier W, Brodzik R, Gassowska-Dobrowolska M, Culmsee C, Adamczyk A (2019) Extracellular alpha-synuclein oligomers induce parkin s-nitrosylation: relevance to sporadic Parkinson\u2019s disease etiopathology. Mol Neurobiol 56:125\u2013140","journal-title":"Mol Neurobiol"},{"key":"2028_CR859","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1365-2990.2007.00837.x","volume":"33","author":"DR Williams","year":"2007","unstructured":"Williams DR, Holton JL, Strand K, de Silva R, Lees AJ, Revesz T (2007) Differences in tau load are associated with different clinical phenotypes in progressive supranuclear palsy observations (abstr.). Neuropathol Appl Neurobiol 33:248\u2013275","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2028_CR860","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2165\/00023210-200620060-00004","volume":"20","author":"CH Williams-Gray","year":"2006","unstructured":"Williams-Gray CH, Foltynie T, Lewis SJ, Barker RA (2006) Cognitive deficits and psychosis in Parkinson\u2019s disease: a review of pathophysiology and therapeutic options. CNS Drugs 20:477\u2013505","journal-title":"CNS Drugs"},{"key":"2028_CR861","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jns.2019.01.020","volume":"398","author":"H Wilson","year":"2019","unstructured":"Wilson H, Niccolini F, Pellicano C, Politis M (2019) Cortical thinning across Parkinson\u2019s disease stages and clinical correlates. J Neurol Sci 398:31\u201338","journal-title":"J Neurol Sci"},{"key":"2028_CR862","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-017-1762-2","volume":"135","author":"AL Woerman","year":"2018","unstructured":"Woerman AL, Kazmi SA, Patel S, Freyman Y, Oehler A, Aoyagi A, Mordes DA, Halliday GM, Middleton LT, Gentleman SM, Olson SH, Prusiner SB (2018) MSA prions exhibit remarkable stability and resistance to inactivation. Acta Neuropathol 135:49\u201363","journal-title":"Acta Neuropathol"},{"key":"2028_CR863","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00401-019-01959-4","volume":"137","author":"AL Woerman","year":"2019","unstructured":"Woerman AL, Oehler A, Kazmi SA, Lee J, Halliday GM, Middleton LT, Gentleman SM, Mordes DA, Spina S, Grinberg LT, Olson SH, Prusiner SB (2019) Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines. Acta Neuropathol 137:437\u2013454","journal-title":"Acta Neuropathol"},{"key":"2028_CR864","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong YC, Krainc D (2017) Alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat Med 23:1\u201313","journal-title":"Nat Med"},{"key":"2028_CR865","first-page":"258","volume":"43","author":"ZK Wszolek","year":"2005","unstructured":"Wszolek ZK, Slowinski J, Golan M, Dickson DW (2005) Frontotemporal dementia and parkinsonism linked to chromosome 17. Folia Neuropathol 43:258\u2013270","journal-title":"Folia Neuropathol"},{"key":"2028_CR866","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41419-019-1404-9","volume":"10","author":"Y Xia","year":"2019","unstructured":"Xia Y, Zhang G, Han C, Ma K, Guo X, Wan F, Kou L, Yin S, Liu L, Huang J, Xiong N, Wang T (2019) Microglia as modulators of exosomal alpha-synuclein transmission. Cell Death Dis 10:174","journal-title":"Cell Death Dis"},{"key":"2028_CR867","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jns.2006.05.064","volume":"249","author":"I Yabe","year":"2006","unstructured":"Yabe I, Soma H, Takei A, Fujiki N, Yanagihara T, Sasaki H (2006) MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA. J Neurol Sci 249:115\u2013121","journal-title":"J Neurol Sci"},{"key":"2028_CR868","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1074\/jbc.RA118.004471","volume":"294","author":"TR Yamasaki","year":"2019","unstructured":"Yamasaki TR, Holmes BB, Furman JL, Dhavale DD, Su BW, Song ES, Cairns NJ, Kotzbauer PT, Diamond MI (2019) Parkinson\u2019s disease and multiple system atrophy have distinct alpha-synuclein seed characteristics. J Biol Chem 294:1045\u20131058","journal-title":"J Biol Chem"},{"key":"2028_CR869","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1007\/s00415-014-7491-8","volume":"261","author":"S Yamashita","year":"2014","unstructured":"Yamashita S, Sakashita N, Yamashita T, Tawara N, Tasaki M, Kawakami K, Komohara Y, Fujiwara Y, Kamikawa M, Nakagawa T, Hirano T, Maeda Y, Hasegawa M, Takeya M, Ando Y (2014) Concomitant accumulation of alpha-synuclein and TDP-43 in a patient with corticobasal degeneration. J Neurol 261:2209\u20132217","journal-title":"J Neurol"},{"key":"2028_CR870","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/01.jnen.0000182977.79483.89","volume":"64","author":"M Yamazaki","year":"2005","unstructured":"Yamazaki M, Hasegawa M, Mori O, Murayama S, Tsuchiya K, Ikeda K, Chen KM, Katayama Y, Oyanagi K (2005) Tau-positive fine granules in the cerebral white matter: a novel finding among the tauopathies exclusive to parkinsonism-dementia complex of Guam. J Neuropathol Exp Neurol 64:839\u2013846","journal-title":"J Neuropathol Exp Neurol"},{"key":"2028_CR871","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2018.1005.1005","author":"X Yan","year":"2018","unstructured":"Yan X, Uronen RL, Huttunen HJ (2018) The interaction of alpha-synuclein and Tau: a molecular conspiracy in neurodegeneration? Semin Cell Dev Biol. https:\/\/doi.org\/10.1016\/j.semcdb.2018.1005.1005","journal-title":"Semin Cell Dev Biol"},{"key":"2028_CR872","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S1474-4422(18)30251-5","volume":"17","author":"HS Yang","year":"2018","unstructured":"Yang HS, Yu L, White CC, Chibnik LB, Chhatwal JP, Sperling RA, Bennett DA, Schneider JA, De Jager PL (2018) Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE epsilon4 haplotype status: a community-based cohort study. Lancet Neurol 17:773\u2013781","journal-title":"Lancet Neurol"},{"key":"2028_CR873","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/mdc1003.12370","volume":"4","author":"SM Yap","year":"2017","unstructured":"Yap SM, Lynch T, MacMahon P, Murray B (2017) Paraneoplastic atypical parkinsonism with anti-crmp5 antibodies and severe caudate and putaminal hypometabolism on 18-fluorodeoxyglucose positron emission tomography of the brain. Mov Disord Clin Pract 4:263\u2013265. https:\/\/doi.org\/10.1002\/mdc1003.12370","journal-title":"Mov Disord Clin Pract"},{"key":"2028_CR874","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s12035-012-8327-0","volume":"47","author":"T Yasuda","year":"2013","unstructured":"Yasuda T, Nakata Y, Mochizuki H (2013) Alpha-synuclein and neuronal cell death. Mol Neurobiol 47:466\u2013483","journal-title":"Mol Neurobiol"},{"key":"2028_CR875","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00401-007-0329-z","volume":"115","author":"O Yokota","year":"2008","unstructured":"Yokota O, Tsuchiya K, Terada S, Ishizu H, Uchikado H, Ikeda M, Oyanagi K, Nakano I, Murayama S, Kuroda S, Akiyama H (2008) Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study. Acta Neuropathol 115:561\u2013575","journal-title":"Acta Neuropathol"},{"key":"2028_CR876","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/bpa.12265","volume":"26","author":"Y Yokoyama","year":"2016","unstructured":"Yokoyama Y, Toyoshima Y, Shiga A, Tada M, Kitamura H, Hasegawa K, Onodera O, Ikeuchi T, Someya T, Nishizawa M, Kakita A, Takahashi H (2016) Pathological and clinical spectrum of progressive supranuclear palsy: with special reference to astrocytic tau pathology. Brain Pathol 26:155\u2013166","journal-title":"Brain Pathol"},{"key":"2028_CR877","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00401-017-1693-y","volume":"133","author":"JS Yokoyama","year":"2017","unstructured":"Yokoyama JS, Karch CM, Fan CC, Bonham LW, Kouri N, Ross OA, Rademakers R, Kim J, Wang Y, Hoglinger GU, Muller U, Ferrari R, Hardy J, Momeni P, Sugrue LP, Hess CP, James Barkovich A, Boxer AL, Seeley WW, Rabinovici GD, Rosen HJ, Miller BL, Schmansky NJ, Fischl B, Hyman BT, Dickson DW, Schellenberg GD, Andreassen OA, Dale AM, Desikan RS (2017) Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia. Acta Neuropathol 133:825\u2013837","journal-title":"Acta Neuropathol"},{"key":"2028_CR878","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/neup.12143","volume":"34","author":"M Yoshida","year":"2014","unstructured":"Yoshida M (2014) Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration. Neuropathology 34:555\u2013570","journal-title":"Neuropathology"},{"key":"2028_CR879","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00401-016-1665-7","volume":"133","author":"K Yoshida","year":"2017","unstructured":"Yoshida K, Hata Y, Kinoshita K, Takashima S, Tanaka K, Nishida N (2017) Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series. Acta Neuropathol 133:809\u2013823","journal-title":"Acta Neuropathol"},{"key":"2028_CR880","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1007\/s00415-018-8930-8","volume":"265","author":"H Yoshino","year":"2018","unstructured":"Yoshino H, Nishioka K, Li Y, Oji Y, Oyama G, Hatano T, Machida Y, Shimo Y, Hayashida A, Ikeda A, Mogushi K, Shibagaki Y, Hosaka A, Iwanaga H, Fujitake J, Ohi T, Miyazaki D, Sekijima Y, Oki M, Kusaka H, Fujimoto KI, Ugawa Y, Funayama M, Hattori N (2018) GCH1 mutations in dopa-responsive dystonia and Parkinson\u2019s disease. J Neurol 265:1860\u20131870","journal-title":"J Neurol"},{"key":"2028_CR881","volume-title":"Neuroanatomy, Basal Ganglia","author":"CB Young","year":"2018","unstructured":"Young CB, Sonne J (2018) Neuroanatomy, Basal Ganglia. StatPearls Publishing, Treasure Island"},{"key":"2028_CR882","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-018-8892-x","volume":"266","author":"T Yousaf","year":"2019","unstructured":"Yousaf T, Dervenoulas G, Valkimadi PE, Politis M (2019) Neuroimaging in Lewy body dementia. J Neurol 266:1\u201326","journal-title":"J Neurol"},{"key":"2028_CR883","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.parkreldis.2014.11.022","volume":"21","author":"X Yuan","year":"2015","unstructured":"Yuan X, Chen Y, Cao B, Zhao B, Wei Q, Guo X, Yang Y, Yuan L, Shang H (2015) An association analysis of the R1628P and G2385R polymorphisms of the LRRK2 gene in multiple system atrophy in a Chinese population. Parkinsonism Relat Disord 21:147\u2013149","journal-title":"Parkinsonism Relat Disord"},{"key":"2028_CR884","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1212\/01.wnl.0000306697.48738.b6","volume":"70","author":"J Zaccai","year":"2008","unstructured":"Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG (2008) Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort. Neurology 70:1042\u20131048","journal-title":"Neurology"},{"key":"2028_CR885","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2165\/00002512-200825080-00004","volume":"25","author":"LB Zahodne","year":"2008","unstructured":"Zahodne LB, Fernandez HH (2008) Pathophysiology and treatment of psychosis in Parkinson\u2019s disease: a review. Drugs Aging 25:665\u2013682","journal-title":"Drugs Aging"},{"key":"2028_CR886","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1242\/jcs.157867","volume":"128","author":"M Zaltieri","year":"2015","unstructured":"Zaltieri M, Grigoletto J, Longhena F, Navarria L, Favero G, Castrezzati S, Colivicchi MA, Della Corte L, Rezzani R, Pizzi M, Benfenati F, Spillantini MG, Missale C, Spano P, Bellucci A (2015a) Alpha-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons. J Cell Sci 128:2231\u20132243","journal-title":"J Cell Sci"},{"key":"2028_CR887","first-page":"108029","volume":"2015","author":"M Zaltieri","year":"2015","unstructured":"Zaltieri M, Longhena F, Pizzi M, Missale C, Spano P, Bellucci A (2015b) Mitochondrial dysfunction and alpha-synuclein synaptic pathology in Parkinson\u2019s disease: who\u2019s on first? Parkinsons Dis 2015:108029","journal-title":"Parkinsons Dis"},{"key":"2028_CR888","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1093\/brain\/awv138","volume":"138","author":"L Zange","year":"2015","unstructured":"Zange L, Noack C, Hahn K, Stenzel W, Lipp A (2015) Phosphorylated alpha-synuclein in skin nerve fibres differentiates Parkinson\u2019s disease from multiple system atrophy. Brain 138:2310\u20132321","journal-title":"Brain"},{"key":"2028_CR889","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fnagi.2018.00109","volume":"10","author":"XS Zeng","year":"2018","unstructured":"Zeng XS, Geng WS, Jia JJ, Chen L, Zhang PP (2018) Cellular and molecular basis of neurodegeneration in Parkinson disease. Front Aging Neurosci 10:109","journal-title":"Front Aging Neurosci"},{"key":"2028_CR890","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00702-019-01997-y","volume":"126","author":"S Zhai","year":"2019","unstructured":"Zhai S, Shen W, Graves SM, Surmeier DJ (2019) Dopaminergic modulation of striatal function and Parkinson\u2019s disease. J Neural Transm (Vienna) 126:411\u2013422","journal-title":"J Neural Transm (Vienna)"},{"key":"2028_CR891","doi-asserted-by":"publisher","first-page":"e26653","DOI":"10.7554\/eLife.26653","volume":"6","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Larcher KM, Misic B, Dagher A (2017) Anatomical and functional organization of the human substantia nigra and its connections. Elife 6:e26653","journal-title":"Elife"},{"key":"2028_CR892","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3389\/fnagi.2018.00370","volume":"10","author":"G Zhang","year":"2018","unstructured":"Zhang G, Xia Y, Wan F, Ma K, Guo X, Kou L, Yin S, Han C, Liu L, Huang J, Xiong N, Wang T (2018a) New perspectives on roles of alpha-synuclein in Parkinson\u2019s disease. Front Aging Neurosci 10:370","journal-title":"Front Aging Neurosci"},{"key":"2028_CR893","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3389\/fneur.2018.00809","volume":"9","author":"X Zhang","year":"2018","unstructured":"Zhang X, Gao F, Wang D, Li C, Fu Y, He W, Zhang J (2018b) Tau pathology in Parkinson\u2019s disease. Front Neurol 9:809","journal-title":"Front Neurol"},{"key":"2028_CR894","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10072-015-2414-8","volume":"37","author":"Q Zhao","year":"2016","unstructured":"Zhao Q, Yang X, Tian S, An R, Zheng J, Xu Y (2016) Association of the COQ2 V393A variant with risk of multiple system atrophy in East Asians: a case-control study and meta-analysis of the literature. Neurol Sci 37:423\u2013430","journal-title":"Neurol Sci"},{"key":"2028_CR895","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-019-0145-0","volume":"8","author":"ZD Zhou","year":"2019","unstructured":"Zhou ZD, Selvaratnam T, Lee JCT, Chao YX, Tan EK (2019) Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson\u2019s disease. Transl Neurodegener 8:6","journal-title":"Transl Neurodegener"},{"key":"2028_CR896","doi-asserted-by":"publisher","first-page":"27477","DOI":"10.1038\/srep27477","volume":"6","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Song X, Xu M, Hu X, Li E, Liu J, Yuan Y, Gao JH, Liu W (2016) Impaired interhemispheric synchrony in Parkinson\u2019s disease with depression. Sci Rep 6:27477","journal-title":"Sci Rep"},{"key":"2028_CR897","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S0002-9440(10)64390-8","volume":"161","author":"V Zhukareva","year":"2002","unstructured":"Zhukareva V, Shah K, Uryu K, Braak H, Del Tredici K, Sundarraj S, Clark C, Trojanowski JQ, Lee VM (2002) Biochemical analysis of tau proteins in argyrophilic grain disease, Alzheimer\u2019s disease, and Pick\u2019s disease : a comparative study. Am J Pathol 161:1135\u20131141","journal-title":"Am J Pathol"},{"key":"2028_CR898","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/mds.20083","volume":"19","author":"JC Zijlmans","year":"2004","unstructured":"Zijlmans JC, Daniel SE, Hughes AJ, Revesz T, Lees AJ (2004) Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 19:630\u2013640","journal-title":"Mov Disord"},{"key":"2028_CR899","doi-asserted-by":"publisher","first-page":"e0184040","DOI":"10.1371\/journal.pone.0184040","volume":"12","author":"L Zondler","year":"2017","unstructured":"Zondler L, Kostka M, Garidel P, Heinzelmann U, Hengerer B, Mayer B, Weishaupt JH, Gillardon F, Danzer KM (2017) Proteasome impairment by alpha-synuclein. PLoS One 12:e0184040","journal-title":"PLoS One"},{"key":"2028_CR900","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2019.02.019","volume":"126","author":"S Ztaou","year":"2019","unstructured":"Ztaou S, Amalric M (2019) Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson\u2019s disease. Neurochem Int 126:1\u201310","journal-title":"Neurochem Int"},{"key":"2028_CR901","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","volume":"155","author":"FA Zucca","year":"2017","unstructured":"Zucca FA, Segura-Aguilar J, Ferrari E, Munoz P, Paris I, Sulzer D, Sarna T, Casella L, Zecca L (2017) Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson\u2019s disease. Prog Neurobiol 155:96\u2013119","journal-title":"Prog Neurobiol"},{"issue":"92\u2013107","key":"2028_CR902","first-page":"e110","volume":"97","author":"F Zunke","year":"2018","unstructured":"Zunke F, Moise AC, Belur NR, Gelyana E, Stojkovska I, Dzaferbegovic H, Toker NJ, Jeon S, Fredriksen K, Mazzulli JR (2018) Reversible conformational conversion of alpha-synuclein into toxic assemblies by glucosylceramide. Neuron 97(92\u2013107):e110","journal-title":"Neuron"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-019-02028-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-019-02028-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-019-02028-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T10:44:59Z","timestamp":1694947499000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-019-02028-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,18]]},"references-count":916,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["2028"],"URL":"https:\/\/doi.org\/10.1007\/s00702-019-02028-6","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,18]]},"assertion":[{"value":"10 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}